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ABSTRACT 
It is important to understand the mechanisms which control arteriolar diameter, 
as these small diameter vessels provide the greatest resistance to peripheral blood flow. 
The aim of this thesis was to characterize the peripheral nerve-mediated control of the 
diameter of arterioles found within the stromal layer of the rat iris, using an in vitro 
preparation. The overall results of this thesis indicate that neurogenic responses of iris 
arterioles are not voltage-dependent, but rather result from the activation of intracellular 
messenger systems to influence smooth muscle tone. 
Sympathetic perivascular nerves release noradrenaline to produce 
vasoconstriction and, in most arterial vessels, a voltage-dependent non-adrenergic 
mechanism is responsible for all or part of the response. This thesis, however, 
demonstrates that in iris arterioles there is a purely a-adrenoceptor mediated response to 
nerve stimulation (10 Hz, 1 s) thus indicating that not all arterial vessels show a non-a-
adrenergic component to the response produced by sympathetic nerve stimulation. The 
contractile response in iris arterioles is initiated by the release of intracellular calcium, 
with a contribution to contraction at supramaximal stimulation being due to the influx 
of calcium through voltage-dependent calcium channels. This is consistent with 
neurogenic a-adrenoceptor mediated contractile responses previously recorded in other 
tissues. 
Repetitive nerve stimulation of iris arterioles activates sensory-motor nerves 
which release CORP to act post-junctionally to inhibit sympathetic nerve-mediated 
vasoconstriction. This occurs independently of membrane hyperpolarization but rather 
via an intracellular mediated mechanism involving cyclic AMP-dependent activation of 
nitric oxide which is proposed to lead to a reduction in levels of intracellular calcium. 
Thus the mechanism for this inhibition biochemically opposes the mechanism for 
constriction. This interaction may serve to increase blood flow to areas where sensory 
nociceptor afferents have been activated. It was further demonstrated that, unlike the iris 
arterioles, the dilator muscle does not receive sensory-motor innervation. It is proposed 
that sensory-motor nerves may only innervate a tissue where there may be some 
iv 
purpose for an interaction between second messenger systems mediating opposing 
. 
neurogeruc responses. 
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CHAPTER 1. 
GENERAL INTRODUCTION 
INTRODUCTION 
The circulatory system carries out a variety of functions in order to maintain 
homeostasis. These include the delivery of nutrients and oxygen to tissues, the removal 
of waste products and the facilitation of the processes of food absorption and waste 
excretion in specialized organs (Johnson, 1978). 
The extent of contraction or relaxation of vascular smooth muscle determines the 
contributes to 
diameter and hence blood flow within an arterial vessel (Johnson, 1978). Arterial 
A 
smooth muscle tone is subject to external influences, such as metabolic regulation or 
vascular nerve activity, as well as possessing intrinsic myogenic ability (Johnson, 
1978). In addition, endothelial cells lining arterial vessels release vasoactive factors in 
response to circulating hormones, changes in intravascular pressure, tissue injury or 
disease conditions (Husain and Moss, 1988; Burnstock and Ralevic, 1994). 
Moment-to-moment control of vascular tone is largely achieved through 
regulatory mechanisms which become apparent when local conditions, for example, 
tissue metabolism, change (Johnson, 1978). Neurotransmitters released from 
-
sympathetic and parasympathetic fibres of the autonomic nervous system nerves can act 
locally to regulate arterial tone. Efferent collaterals of sensory-nerves may also release 
neurotransmitters which cause vasodilatation (Holzer, 1992). Finally, systemically 
circulating hormones act to synergize with local mechanisms to adjust vascular 
reponses throughout the whole body. 
The integration of these various influences is achieved through the electrical and 
chemical coupling of smooth muscle cells. Electrotonic potentials generated by 
extracellular or intracellular current injection can be recorded at a distance much greater 
than one cell length away, and in the case of arterial smooth muscle several hundred 
µms, from the source (Abe and Tomita, 1968; Hirst and Neild, 1978). This property of 
smooth muscle allows the propagation of local responses not only along arterial vessels 
1 
but also through arterial walls, which may consist of several layers of smooth muscle 
cells (Rhodin, 1980). 
In this chapter, the various peripheral nervous influences on arterial diameter are 
reviewed. 
STRUCTURE OF ARTERIAL VESSELS 
The walls of arterial vessels are made up of three different layers (Rhodin , 
1980): 
1) tunica intima, or innermost layer, which contains the layer of endothelial cells 
which line the vessel wall and a thin basal lamina. Large elastic arteries, such as the 
aorta of some species, also contain a subendothelial layer of the intima which is 
composed of collagenous bundles, elastic fibrils and some smooth muscle cells. 
2) tunica media, or middle layer of the vascular wall, which contains the smooth 
muscle cells, bundles of collagenous fibrils and networks of elastic fibrils. The 
thickness of this layer varies between vascular beds and with orders of branching of a 
vessel. 
3) tunica adventitia, or the outermost, layer. The thickness of this layer also varies 
depending on the type and location of the vessel. 
Rhodin (1967) divided small arterial vessels into three groups according to the 
diameter _and structure of the vessel wall. Arterioles were defined as being small 
diameter vessels (50-100 µm) which have a medial layer only a few smooth muscle 
cells thick. In small dermal vessels of the rabbit, which had a media three to four 
smooth muscle layers thick, the outer most layer was arranged spirally and the 
innermost layers were arranged transverse to the long axis. 
Arterioles less than 50 µm in diameter were defined as terminal arterioles 
(sometimes called metarterioles). The media of these vessels was only one, sometimes 
two, smooth muscle cells thick. Individual smooth muscle cells in the walls of terminal 
arterioles had an average length of 40 µm, width of 5 µm near the nucleus and were 
oriented circumferentially around the vessel. Each smooth muscle cell had a nucleus, 
sarcoplasmic reticulum and several mitochondria. Their membranes were surrounded by 
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a basal lamina and were not smooth but contain invaginations or calveoli. Adjacent 
smooth muscle cells were frequently connected end to end as well as side to side. 
Membranous contacts were reported to decrease with increasing vessel diameter. Gap 
junctions (15-19 run) between smooth muscle cells provide low resistance pathways for 
the rapid spread of a signal and are proposed to be the sites of electrical coupling 
between these cells (Rhodin , 1980). 
The endothelial cells of the terminal arterioles were flat, approximately 2 µm in 
height at the nucleus and reached 50 µm in length. The plasma membranes of 
endothelial cells were very smooth, with occasional microvilli. The basal surface of the 
endothelial cells differentiated into f ootlike processes which made contact with smooth 
muscle cells. It was suggested that these structures may mechanically stabilize the 
vessel wall. Alternatively these myoepithelial junctions may be a pathway for the 
movement of humoral substances from the endothelial cells to the smooth muscle cells 
(Rhodin , 1967). 
Capillaries arose from terminal arterioles (Rhodin , 1967) and at these points the 
smooth muscle cells were arranged in a circular fashion and hence were referred to as 
precapillary sphincters. Precapillary sphincters were reported to have internal diameters 
of 7 µm, just wide enough to allow one red blood cell through at a time. The smooth 
muscle cell layer only extended 20-30 µm down the capillary beyond the precapillary 
sphincter. Unlike other arterial vessels, capillaries only had a tunica intima layer making 
up the vessel wall (Rhodin, 1967). 
AUTONOMIC INNERVATION OF ARTERIAL VESSELS 
SYMPATHETIC NERVES 
Sympathetic vasoconstriction 
Von Euler and colleagues (van Euler, 1956) were the first to identify 
noradrenaline as the neurotransmitter being released from the sympathetic nerves. 
Noradrenaline acts upon adrenoceptors, which were historically categorized as a and B 
(Ahlquist, 1948). Additionally, a-adrenoceptors are further subdivided into a 1- and 
a2-adrenoceptors and a1-adrenoceptors have been further subdivided into CllA, a lB 
3 
and CX1D subtypes (Hieble et al., 1995), while cx2-adrenoceptors have been divided 
into <l2A, CX2B and a2c (Bylund et al., 1994). Noradrenaline can modify vascular tone 
~ by 1) the activation of cx1- or cx2-adrenoceptors on arterial smooth muscle to 
produce vasoconstriction (Medgett and Ruffolo, 1988; McGrath, Flavahan and 
MCKean, 1982); 2) the activation of cx2-adrenoceptors on endothelial cells to produce 
vasodilatation (Cocks and Angus, 1983); 3) the inhibition of neurotransmitter release by 
the activation of prejunctional cx2-adrenoceptors (Rand et al., 1980); 4) the activation 
of postjunctional 8-adrenoceptors to cause vasodilatation (ltoh, Izumi and Kuriyama, 
1982) and 5) the facilitation of neurotransmitter release by the activation of 
prejunctional 8-adrenoceptors (Medgett et al., 1980). 
Sympathetic nerve stimulation produces vasoconstriction of most vascular beds 
(Hirst and Edwards, 1989). Umbilical vessels are reported to be devoid of any nerve 
supply (Lachenmayer, 1971), as are the aorta and pulmonary arteries of some species 
(MCLean, Twarog and Bergofsky, 1985). Sympathetic innervation of the rat mesentery 
extends to the terminal arterioles but not to the capillaries (Furness and Marshall, 1974), 
and some fine pial arteries are not innervated (Hill et al., 1986). 
In vivo, there is some evidence for differences between the rates of discharge of 
sympathetic nerves supplying resistance and capacitance vessels (Hadjiminas and 
Oberg, 1968). Sympathetic responses of resistance vessels in the skeletal hindlimb 
mucles ar~ maximal at 25 to 30 Hz, whereas 6 to 8 Hz stimulation produces maximal 
responses of the capacitance vessels (Mellander, 1960). 
As the stimulation of sympathetic nerves leads to the release of noradrenaline, 
then the activation of cx-adrenoceptors could be expected to play an important role in 
the control of vascular tone, and hence blood flow. However, this does not appear to be 
the general case. For instance, cx-adrenoceptor antagonists do not affect the sympathetic 
nerve-evoked vasoconstriction of the rabbit hindlimb in vivo (Hirst and Lew, 1987). 
Intracellular recordings from smooth muscle cells of many arterial vessels show 
that sympathetic nerve stimulation produces rapid excitatory junction potentials which 
are resistant to cx-adrenoceptor antagonists (see Table 1.1 ). Low frequency nerve 
stimulation evokes excitatory junction potentials which show facilitation. Higher 
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Table 1.1 
Some arterial vessels from which a-adrenoceptor antagonist resistant sympathetic 
nerve-evoked excitatory junction potentials have been recorded 
Vessel Species Reference 
basilar artery canine Fujiwara et al, 1982 
. . Karashima and Kuriyama, 1981 guinea pig 
rat* Hirst et al, 1982 
-
rabbit Suprenant et al, 1987 
ear artery guinea pig* Kajiwara et al, 1981 
Karishama and Kariyama, 1981 
rabbit Suzuki and Kou, 1983 
cerebral artery canine* Fujiwara et al, 1982 
-
middle cerebral artery canine Kou et al, 1982 
. . Karashima & Kurryama, 1981 guinea pig 
mesenteric artery canine Kou et al, 1982 
. . Kuriyama & Makita, 1983 guinea pig 
- rat (mature) Hill et al, 1983 
Angus et al, 1988 
rabbit* Holman & Suprenant, 1979 
saphenous artery guinea pig* Cheung & Fujioka, 1986 
submucosal arteriole guinea pig* Hirst & Neild, 1977 
tail artery rat Cheung, 1984 
uterine artery guinea pig* Bell , 1969 
* indicates vessels where the sole electrical response to sympathetic nerve stimulation is 
insensitive to a-adrenoceptor antagonist 
frequency stimulation causes summation of excitatory junction potentials and initiation 
of muscle action potential which is associated with arterial constriction (Hirst and 
Edwards, 1989). 
In some vessels an excitatory junction potential has been the sole electrical 
response recorded following nerve stimulation (see Table 1.1). In thermoregulatory 
vessels, such as the rat tail artery (Cheung, 1984) and rabbit ear artery (Suzuki and Kou, 
1983), the response to nerve stimulation consists of a rapid excitatory junction potential 
which is resistant to cx.-adrenoceptor antagonists, followed by a slower cx.-adrenoceptor 
mediated depolarization. In the guinea pig pulmonary artery (Suzuki, 1983) and the 
immature mesenteric artery (Hill, Hirst and van Heiden, 1983), however, the electrical 
responses to nerve stimulation are totally abolished by cx.-adrenoceptor antagonists. 
Nerve stimulation of short segments of submucosal arterioles produced 
excitatory junction potentials which were insensitive to cx.-adrenoceptor antagonists 
(Hirst and Neild, 1980a). Two types of responses have been recorded in response to 
ionophoretically applied noradrenaline on this preparation (Hirst and Neild, 1980a). A 
localized a-adrenoceptor mediated constriction of the arteriole, with no change in 
membrane potential, was the most common response recorded. A less frequent response 
to noradrenaline was a non-cx.-noradrenergic depolarization which was similar to the 
response to nerve stimulation. When the depolarization initiated an action potential, 
arteriolar 9onstriction was recorded. Thus, noradrenaline produced responses which 
mimicked responses to nerve stimulation only when applied to certain areas. It was 
suggested that specialized junctional non-cx.-adrenoceptors were activated by neurally-
released noradrenaline (Hirst and Neild, 1980a). These were named y-adrenoceptors 
according to the nomenclature put forward by Ahlquist (Hirst and Neild, 1980c; 
Ahlquist, 1948). Traditional cx.-adrenoceptors were suggested to be extrajunctional and 
not associated with neuroeffector transmission (Hirst and Neild, 1980a). 
A later study (Hirst and Neild, 1981) showed that in the majority of cases, 
ionophoretically applied noradrenaline produced depolarization of mesenteric arteries 
only when it was applied within 5 µm of varicose fluorescently-detected sympathetic 
nerve bundles on the surface of the vessel. The authors suggested that the receptors 
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activated by neurally-released noradrenaline were concentrated in regions beneath the 
sympathetic nerve varicosity (Hirst and Neild, 1981). 
From the above, there is substantial evidence for the existence of postsynaptic 
non-a-adrenoceptors at sympathetic neuromuscular junctions. However, unlike a-
adrenoceptors, there is no molecular equivalent described for the y-adrenoceptor, and a 
selective antagonist for these receptors is yet to be found. In addition to being an 
antagonist for a-adrenoceptors and serotonin receptors dihydroergotamine is also an ,, 
antagonist for y-adrenoceptors (Muller-Schweinitzer and Weidman, 1978). Sympathetic 
nerve stimulation produced a depolarization of sinus venosus cells of the toad, which 
was abolished by a, B-methylene ATP and dihydroergotamine. In the presence of a-
and B-adrenoceptor antagonists, dihydroergotamine abolished depolarizations of these 
cells which were produced by the exogenous application of the neurotransmitter for this 
synapse, adrenaline, but not those produced by applied ATP (Bramich, Edwards and 
Hirst, 1990). 
Dihydroergotamine also blocks sympathetic vasoconstriction (Thulin, 1976). 
in the presence of an a-adrenoceptor antagonist, 
Morris (1994b) demonstrated that" dihydroergotamine · abolished vasoconstriction 
produced by local application of noradrenaline in third and fourth order cutaneous ear 
arteries. Sympathetic constrictions of small ear arteries are also significantly reduced 
(Morris, 1994c) 
by dihydroergotamine. · Dihydroergotainine did not significantly affect constrictions 
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produced by applied ATP (Morris, 1994b ). Dihydroergotamine is therefore able to 
distinguish between vasoconstrictions produced by y-adrenoceptor activation and those 
produced by purinoceptor activation. Providing a-adrenoceptor and serotonin-mediated 
responses are excluded, dihydroergotamine is therefore the only selective antagonist 
described for junctional y-adrenoceptors. 
More recently, low affinity prazosin vascular a 1-adrenoceptors have been 
described (Flavahan and Vanhoutte, 1986) and denoted as CllL- or CllN-adrenoceptors 
(Muramatsu et al., 1990). According to this nomenclature, the previously described 
CllA-, CllB- and a10-adrenoceptors are proposed to belong to the CllH-adrenoceptor 
family, that is they show a high affinity for prazosin (Muramatsu, Kigoshi and Oshita, 
1990). The pharmacological, molecular and biochemical characterization of these 
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proposed low affinity a 1-adrenoceptors is, at present, insufficient for the International 
Union of Pharmacology (IUPHAR) to recognize them as additional a1-adrenoceptor 
subtypes (Hieble et al., 1995). However it will be interesting when more information is 
available about these receptors. It is tempting to speculate that the y-adrenoceptors 
described by Hirst and Neild ( 1980a) may correlate with one of the low prazosin 
affinity a 1-adrenoceptor subtypes more recently described. 
The relative contribution of different receptors mediating sympathetic 
vasoconstriction may vary along the length of a vessel. Morris (1994c) demonstrated 
that sympathetic vasoconstriction of the main guinea-pig ear artery was 50 to 70% 
blocked by the a 1-adrenoceptor antagonist, prazosin, and the remaining constriction 
was abolished by the non-selective receptor antagonist, suramin. However, sympathetic 
vasoconstriction of stnall ear arteries was significantly abolished by the y-adrenoceptor 
antagonist, dihydroergotamine (Morris, 1994c ).', , 
The contribution of a- and non-a-adrenoceptors to postsynaptic responses 
following sympathetic nerve stimulation is highly dependent on the stimulus parameters 
applied (Kennedy, Saville and Burnstock, 1986). Low frequencies and short pulse 
stimulus trains reportedly favour non-a-adrenoceptor responses, whereas higher 
frequencies and longer pulses trains favour a-adrenoceptor mediated responses. One 
interpretation of these results is that neurotransmitter released by short, low frequency 
stimuli activates junctional y-adrenoceptors (Hirst and Neild, 1980a). Following 
stimulus trains of several hundreds of pulses, neurotransmitter can overflow from the 
neuromuscular cleft (Morris and Gibbins, 1992). With these longer stimulus trains, 
noradrenaline would overflow onto extrajunctional a-adrenoceptors, as proposed by 
Hirst and Neild (1980a). 
Sympathetic nerve stimulation evokes excitatory junction potentials in smooth 
muscle cells of the basilar artery and these potentials are insensitive to a-adrenoceptor 
antagonists (Hirst, Neild and Silverberg, 1982). Only at high concentrations does 
noradrenaline (0.2 to 10 mM) cause a depolarization of this vessel. This depolarization 
is also insensitive to a-adrenoceptor antagonists (Hirst, Neild and Silverberg, 1982). 
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Dopamine, L- and D-noradrenaline ( 1 mM) were equipotent in producing 
depolarization of the basilar artery. Considering that, compared to L-noradrenaline, 
dopamine and D-noradrenaline are poor agonists for a-adrenoceptors (Altura, 1978), 
the receptor being activated by these agonists did not have an agonist order of potency 
defined for an a-adrenoceptor. Therefore, the authors concluded that the basilar artery 
contained only junctional y-adrenoceptors. These junctional receptors required high 
concentrations of noradrenaline for activation. Such high concentations of noradrenaline 
are reported to occur locally after the neural release of noradrenaline (Bell and Vogt, 
1971; Bevan et al., 1984). 
Benham and Tsien (1988) reported that activation of a non-a-, non-B-
adrenoceptor by noradrenaline increased a-dihydropyridine sensitive, L-type calcium 
channel in isolated smooth muscle cells. Although the concentration of noradrenaline 
used in this study was lower than concentrations previously used to activate y-
adrenoceptors (Hirst, Neild and Silverberg, 1982), it is possible that ·this current was 
due to activation of a y-adrenoceptor. This would be consistent with the finding that y-
adrenoceptor activation only produces a contraction when voltage-dependent 
conductance changes occur (Hirst, 1977). 
Concentrations of a2-adrenoceptor agonists which do not themselves cause 
constriction have been shown to have an inhibitory effect on sympathetic nerve-
mediated constriction, for example, in the rabbit ear artery (Xiao and Rand, 1989) and 
rabbit mesenteric artery (von Kugelgen and Starke, 1985). Cavero et al (1979) showed 
that the a-adrenoceptor antagonist, phentolamine, increased heart rate and increased 
the release of 3tt-noradrenaline measured in the dog coronary vein during sympathetic 
nerve stimulation. The a2-adrenoceptor agonist, clonidine, was shown to inhibit 
sympathetically-nerve evoked 3tt-noradrenaline release. Electrical field stimulation for 
longer than 10 s produces a biphasic constriction of ileoc_olicartery (Bulloch and Starke, 
1990), the first component being non-a-adrenoceptor mediated and the second being 
a-adrenoceptor mediated. An a2-adrenoceptor antagonist potentiated both components 
of the vasoconstriction in response to these longer periods of stimulation, but had no 
effect on the monophasic vasoconstriction produce by shorter trains of stimulation 
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(Bulloch and Starke, 1990). In this vessel, then, presynaptic az-adrenoceptor activation 
affects both a- and non-a-adrenoceptor mediated sympathetic vasoconstriction. 
Adler-Granshinsky and Langer (1975) were the first to show that prejunctional 
B-adrenoceptors may have a positive feedback on the release of noradrenaline from 
sympathetic nerve endings. A facilitatory effect of presynaptic 8-adrenoceptor 
activation on stimulation-evoked noradrenaline outflow has also been demonstrated in 
human omental and pulmonary arteries (Gothert and Hentrich, 1985). Cholera toxin 
permanently activates of Gs, the G-protein to which 8-adrenoceptors are coupled 
(Watson and Girdlestone, 1994). Cholera toxin increased sympathetic neurotransmitter 
release in mesenteric artery, as did a 8-adrenoceptor agonist (N ozaki and Sperelakis, 
1991), providing further evidence for pre-junctional facilitatory 8-adrenoceptors on 
sympathetic nerves. 
Sympathetic neuromuscular junction 
Sympathetic noradrenaline-containing nerves form a plexus at the adventitia-
medial border of arterial vessels (Norberg and Hamberger, 1964). It has been reported 
that sympathetic nerves enter the tunica media of some arteries, for example, the main 
branch of the pulmonary artery of several species (Cech and Dolezel, 1967; Knight et 
al., 1981). 
The density of the noradrenergic plexus depends upon the vascular region and 
on the size of the blood vessel. The responsiveness of different branching segments of 
an arterial vessel to sympathetic nerve stimulation has been the subject of a number of 
studies. For example, in the ear artery, the constrictor responses to 
nerve stimulation increases as the artery divides to first and second order arterioles, 
before diminishing in the terminal arterioles, parallelling neuronal density (Owen et al, 
1983). -
The terminal regions of sympathetic axons are varicose (Gordon-Weeks, 1988). 
Terminal varicosities predominantly contain small granular vesicles (30-60 nm 
diameter) which have an electron-dense core. Large granular vesicles (90-120 nm 
diameter) with a dense core and mitochondria are also present. Noradrenaline is stored 
in both types of vesicles (Gordon-Weeks, 1988). 
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The presence of specialized sympathetic neuromuscular junctions on arterial 
vessels is supported by the reconstruction of individual varicosities and adjacent arterial 
smooth muscle cells from serial sections (Luff, MCLachlan and Hirst, 1987; Luff and 
MCLachlan, 1989). Schwann cells wrap around bundles of terminal axons, however 
many varicosities are only partly enclosed by Schwann cells (Luff, MCLachlan and 
Hirst, 1987). In the majority of cases (84% and 94% in submucosal arterioles of the 
guinea pig intestine, (Luff, MCLachlan and Hirst, 1987), the part of the varicosity which 
is not covered by Schwann cells comes into close contact with the arterial smooth 
muscle cell. At these sites of close apposition, the basal lamina of the varicosity and the 
smooth muscle fuse to form a single layer. At these contact regions, small granular 
storage vesicles are concentrated near the varicosity membrane facing the smooth 
muscle cell and the distance between the smooth muscle cells and the varicosity is less 
than 100 run. 
The presence of sympathetic neuroeffector junctions on arterial vessels is 
consistent with the concept of specialized areas on arterial ves~els which contain 
synaptic y-adrenocept-ors, as suggested by Hirst and Neild (1980a). While at first it 
appeared that the presence of neuromuscular junctions could correlate with specialized 
postsynaptic y-noradrenergic responses, this is not always the case (Luff and 
MCLachlan, 1989). In some arteries where non-a noradrenergic responses are recorded 
following nerve stimulation, for example the rabbit and guinea pig basilar artery, no 
neuromuscular junctions have been found (Luff and MCLachlan, 1989). Conversely, in 
vessels which show a purely a-adrenoceptor mediated response to nerve stimulation, 
such as the rat mesenteric veins (van Helden, 1988), similar studies making 
reconstructions from serial sections have shown that the majority of sympathetic 
terminal varicosities form neuromuscular junctions (Klemm, van Helden and Luff, 
1993). Therefore, it is not possible to make a global generalization about the 
relationship between a particular response recorded in a blood vessel and the structural 
relationship between sympathetic nerve terminals and vascular smooth muscle cells. 
Co-transmission in the sympathetic nervous system 
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An alternative explanation which has been put forward for the inability of a-
adrenoceptor antagonists to inhibit sympathetic nerve-mediated vasoconstriction, or 
excitatory junction potentials, is that noradrenaline may not be the only 
neurotransmitter released following nerve stimulation. It was originally proposed by 
releases the same 
Dale that each pianch of the-same nerve makes and neurotransmitter, however, since 
" the 1970's it has been recognised that more than one neurotransmitter may be released 
from sympathetic nerves (Burnstock and Kennedy, 1986). It should be noted that not all 
sympathetic nerves contain the same repertoire of cotransmitters and that discrete 
populations of sympathetic nerves containing different combinations of potential 
neurotransmitters innervate particular organs within a species (Morris and Gibbins, 
1992). 
Adenosine Triphosphate (ATP) 
It has been proposed that ATP and noradrenaline are co-transmitters in the 
sympathetic nervous system, one reason for this being that noradrenaline and ATP are 
-
stored together in sympathetic neurones (Burnstock and Kennedy, 1986). 
ATP is rapidly dephosphorylated by smooth muscle ectonucleotidases (Olsson 
and Pearson, 1990). Burnstock (1978) first divided purinoceptors into P1-purinoceptors 
as being activated by adenosine and P2-purinoceptors as being activated by ATP. Since 
then, P1 -purinoceptors have been divided into A 1 and A2 subtypes and P2-
purinoceptors into P2x and P2y subtypes (Watson and Girdlestone, 1994). 
Furchgott ( 1966) was the first to demonstrate that ATP could produce 
vasodilatation or vasoconstriction. De Mey and Vanhoutte ( 1981) showed that the 
vasodilatation produced by ATP required an intact endothelium. In most vessels studied 
since then, ATP activates P2y-purinoceptors on endothelial cells to produce 
vasodilatation (Olsson and Pearson, 1990). Following the removal of the endothelium, 
the activation of P2x-purinoceptors on smooth muscle cells by ATP produces 
vasoconstriction (Bumstock and Kennedy, 1986). 
Adenosine produces vasodilatation by activating A2-adenosine receptors on 
arterial smooth muscle cells (Olsson and Pearson, 1990). Both ATP and adenosine can 
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inhibit the release of noradrenaline from perivascular nerves (Hedqvist and Fredholm, 
1976; Shinozuka, Bjur and Westfall, 1988). Adenosine activates prejunctional A1-
purinoceptors to inhibit noradrenaline release (von Kugelgen, 1994). However, in the 
rat tail artery it has been suggested that adenosine and ATP act through a common 
"hybrid" prejunctional P3-purinoceptor (Shinozuka, Bjur and Westfall, 1988). More 
recently, preliminary studies on the rabbit ear and saphenous artery suggest that 
facilatatory prejunctional purinoceptors exist on these vessels (Ishii et al., 1995; 
Todorov, Bjur and Westfall, 1994). 
The excitatory junction potentials produced by a brief application of ATP have 
been shown to mimic those produced by nerve stimulation (Suzuki, 1985). Excitatory 
junction potentials can be recorded in some tissues taken from animals pretreated with 
reserpine to deplete noradrenaline stores (Burns tock and Holman, 1966; Sneddon and 
Westfall, 1984), however very little of the sympathetic vasoconstrictor response in the 
spleen remains after reserpine treatment (Dixon, Mosimann and Weiner, 1979). 
Excitatory junction potentials can also be recorded after the inhibition of noradrenaline 
synthesis with a-methyl p-tyrosine (Cunnane and Manchanda, 1989), suggesting that 
they are purinergic in origin. 
Nerve-evoked a-adrenoceptor resistant excitatory junction potentials are often 
abolished by a, 8-methylene ATP (Meldrum and Bumstock, 1983; Burnstock and 
Kennedy, _1986). Meldrum and Bumstock (1983) demonstrated that a, 8-methylene 
ATP did not affect a-adrenoceptor mediated contractions, but abolished constrictions 
due to ATP, suggesting that this compound desensitizes P2-purinoceptors. 
The selectivity of this compound has, however, been questioned. Byrne and 
Large (1986) demonstrated in the basilar artery that depolarizations produced by 
noradrenaline activation of y--adrenoceptors or depolarizations produced by ATP were 
both significantly reduced by a, 8-methylene ATP. The depolarization produced by 
sympathetic nerve stimulation was also abolished by a, 8-methylene ATP. This study 
demonstrated that a, B-methylene ATP will not distinguish between excitatory junction 
potentials produced by P2-purinoceptor activation or y-adrenoceptor activation. 
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Additionally, in vivo a, 8-methylene ATP may reduce the release of NPY from 
sympathetic nerves (Lacroix et al., 1989). 
One explanation put forward by Byrne and Large (Byrne and Large, 1986) for 
the non-selectivity of a, 8-methylene ATP is that it may desensitize the channel which 
is utilized by both y-adrenoceptors and by P2-purinoceptors, and so may inhibit 
responses mediated by both receptors. However it has been argued that this is not the 
case, as the mechanism of producing vasoconstriction is different for the two receptors. 
(Edwards et al., 1989). ATP increases the calcium permeability of isolated arterial 
smooth muscle cells (Benham et al., 1987) and so may produce vasoconstriction with 
only small changes in membrane potential, while y-adrenoceptor activation causes 
contriction after depolarizations of smooth muscle which activate voltage-dependent 
conductances (Hirst, 1977). Thus it would appear that a, 8-methylene ATP is not a 
selective tool to· demonstrate purinergically-mediated, compared to y-adrenoceptor-
mediated, responses. 
Another line of evidence in favour of ATP as a cotransmitter with noradrenaline 
is that sympathetic nerve stimulation produces tetrodotoxin- and guanethidine-sensitive 
release of preloaded 3H-labelled purines (Bumstock and Kennedy, 1986). In some cases 
this overflow of ATP may, however, come from non-neuronal cells. For example, 
intracellular stores of purines can be released by both vascular smooth muscle and 
endothelial cells (Burnstock and Kennedy, 1986). In the rabbit aorta, most of the 
overflow of ATP and purines elicited by nerve stimulation disappeared after removal of 
the endothelium (Sedaa et al., 1990). It was found that the activation of a-
adrenoceptors on the endothelial cells lead to the release of ATP. The authors suggested 
that only 30% of the electrically-evoked ATP was actually neurally-released (Sedaa et 
al., 1990). Thus, when investigating 3H-labelled purine overflow it is important to 
distinguish between purines released from nerve endings and those released from post-
junctional sites (von Kugelgen et al., 1994). 
In conclusion, a number of lines of evidence have been put forward in the 
literature to suggest that ATP may be a co-transmitter with noradrenaline in arterial 
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vessels. In the absence of a selective antagonist for synaptic purinoceptors, this is still 
controversial. 
Neuropeptide Y ( NPY) 
NPY is a 36 amino acid peptide which was isolated from the porcine brain 
(Tatemoto, Carlquist and Mutt, 1982). NPY has been shown to be stored in, and 
released from, noradrenergic sympathetic nerves (Alm and Lundberg, 1988; Fleming et 
al., 1989; Lundberg et al., 1984a, Lundberg et al., 1989; Lundberg 1990b; Morris and 
Murphy, 1988; Uddman and Edvinsson, 1989). At low frequencies of nerve stimulation, 
noradrenaline exerts an inhibitory pre-junctional effect on the release of NPY, via the 
activation of a2-adrenoceptors (Lundberg,-Rudehill and Sollevi, 1989; Lacroix et al., 
1989). At the electron-microscopic level, NPY-like immunoreactive nerve terminals 
were found to be· close to the smooth muscle cells of the medial layer in mesenteric and 
uterine arteries (Edvinsson et al., 1989; Fallgren, Ekblad and Edvinsson, 1989). 
NPY acts upon at least three different types of NPY receptor (Grundemar and 
Hakanson, 1993). The_ vascular effects of NPY are mediated by Y1- and Y2-NPY 
receptors (Grundemar and Hakanson, 1993). NPY activates Y1-NPY receptors, and in 
some vessels Y2-NPY receptors, to produce vasoconstriction. Activation of 
postjunctional Y1 -NPY receptors may also potentiate the effects of other 
vasoconstrictors, whereas activation of pre-junctional Y2-NPY receptors suppresses 
neurotransmitter release from sensory-motor nerves, and the release of both NPY and 
noradrenaline from sympathetic nerves (Grundemar and Hakanson, 1993; Wong-
Dusting and Rand, 1988). As yet there are no commercially available specific 
antagonists for NPY receptors, although benextramine has been shown to have a low 
potency in reversibly antagonizing NPY receptors (Doughty et al., 1990). The 
development of specific antagonists for NPY receptors will be a valuable tool for 
confirming the vascular roles of NPY. 
NPY produces vasoconstriction of numerous vascular beds, being particularly 
potent in pial arteries (Hanko et al., 1986). The ability of NPY to produce 
vasoconstriction varies along consecutive lengths of some vascular beds. For instance, 
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NPY produces a weaker constriction of the proximal segment of the superior mesenteric 
artery than the more distal finer ramifications of this vessel which are close to the 
intestine (Edvinsson et al., 1989). In skeletal muscle vascular beds, the arterioles but not 
the supplying arteries, are sensitive to NPY (Lundberg et al., 1987). 
In the cutaneous vasculature of the guinea-pig, tyrosine hydroxylase-like 
immunoreactive fibres associated with arteries, but not arterioles, also showed NPY-like 
immunoreactivity (Gibbins and Morris, 1990). The ability of NPY to cause 
vasoconstriction correlated with the presence of NPY-like immunoreactive fibres 
(Morris, 1994a). 
NPY-mediated sympathetic vasoconstriction varies between different vascular 
beds, even though they may have similar diameters. The activation of postsynaptic Y 1-
NPY receptors contributes to sympathetic vasoconstriction of 3° mesenteric arteries, 
which have internal diameters of 370 µm, but not of femoral arteries, internal diameter of 
670 µm, even though Y1-NPY receptors are present on both vessels (Angus et al., 
1995). 
The vasoconstriction produced by NPY is described as being slower than that 
produced by noradrenaline (Lacroix et al., 1988; Morris and Murphy, 1988; Lundberg 
et al., 1989). In some arteries, a slow component of sympathetic vasoconstriction is 
non-noradrenergic and has a time-course similar to constriction produced by NPY 
(Lundberg_ et al., 1984a; Morris and Murphy, 1988). Both the slow component of 
sympathetic vasoconstriction and the slow constriction produced by applied NPY are 
reduced, or abolished, by desensitizing NPY receptors or by treatment with the 
endopepetidase, trypsin (Morris and Murphy, 1988). This provides some good evidence 
for NPY acting as a co-transmitter for sympathetic vasoconstriction. 
At concentrations below which NPY itself does not cause constriction, NPY 
may potentiate nerve-induced vasoconstriction (Edvinsson et al., 1985; Pemow, Saria 
and Lundberg, 1986; Vu, Budai and Duckles, 1989). Both the non-ex- and cx-
noradrenergic components of nerve-induced vasoconstriction may be potentiated by 
NPY (Saville, Maynard and Burnstock, 1990). 
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The contribution of NPY to sympathetic-evoked vasoconstriction also depends 
upon the stimulus parameters applied, being more pronounced at higher frequencies of 
stimulation (Morris and Murphy, 1988; Pernow et al., 1989). It was suggested by these 
authors that the release of large vesicles containing both ·noradrenaline and NPY were 
favoured by higher frequencies of stimulation. However, consideration of the 
organization of the sympathetic neuromuscular junction as described above may 
suggest that NPY receptors are located extrajunctionally on some vessels. NPY 
receptors would therefore only be activated by neurotransmitter overflow from the 
neuromuscular cleft following longer, or higher frequency, conditions of stimulation 
(Morris and Gibbins, 1992). 
NPY vasodilatation 
Sympathetic ganglia contain different populations of noradrenergic and peptide 
containing neurons and, in many cases, the combinations of neuropeptides in these 
neurons correlates well with their specific peripheral projection; this has been termed 
"chemical coding" (Costa, Furness and Gibbins, 1986; Furness et al., 1989). 
In lumbar sympathetic ganglia, -vasoconstrictor neurons contain tyrosine 
hydroxylase-like or tyrosine hydroxylase-like and NPY-like immunoreactivity 
(Gibbins, 1992). A second population of non-adrenergic NPY-like immunoreactive 
neurons which also contain vasointestinal peptide (VIP)-like immunoreactivity, project 
primarily to small arteries supplying skeletal muscle (Gibbins, 1992) to cause 
vasodilatation. Axons which project to the cerebral arteries from the superior cervical 
ganglia (SCG) also contain these two different populations of NPY-like 
immunoreactive axons (Gibbins and Morris, 1988). Additionally, in the paracervical 
parasympathetic 
ganglia, 90-95 % of neurons contain neuropeptides (Morris and Gibbins, 1987). Of 
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these, three populations of noradrenergic neurons and eight populations of non-
noradrenergic neurons have been identified (Morris and Gibbins, 1987). Two of these 
non-noradrenergic populations, in which the neuropeptide content in both includes 
NPY-like and VIP-like immunoreactive neurons, project mainly to the uterine artery 
(Morris et al., 1985). Electrical stimulation of these non-noradrengic nerves causes 
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vasodilation of this artery which is proposed to be mediated by VIP and nitric oxide 
(Morris, 1993 ). Sympathetic vasodilatory neurons innervate arteries feeding intra-
muscular vascular beds but do not innervate the distal arterioles (Gibbins, 1992). 
NPY may therefore be contained in both sympathetic vasoconstrictor and in 
vasodilatorparasympathetic nerves. NPY in vasoconstrictor nerves is proposed to mediate 
the slow component of sympathetic vasoconstriction (Morris and Murphy, 1988). The 
significance of NPY in vasodilatory nerves is still unclear. Morris ( 1990) suggested that 
as exogenous NPY inhibited exogenous VIP-induced vasodilatation in the guinea-pig 
uterine artery, the role of NPY in vasodilator nerves may be to modify the potency of 
primary vasodilatory neurotransmitters. 
Auto-regulation of neurotransmitter release 
Neurotransmitter release may be regulated by the activation of presynaptic 
receptors (Starke, 1977; Langer, 1982; Story et al., 1990). In this context, auto-
inhibitory feedback refers to the mechanism where neurotransmitter released from a 
nerve acts upon pre-synaptic receptors to inhibit further release of neurotransmitter 
from that nerve. Some examples of the presynaptic receptors which can be activated on 
sympathetic nerves have already been given. 
Presynaptic regulation of neurotransmitter release has been proposed to be one 
mechanis~ for preventing the accumulation of neurotransmitter at the neuromuscular 
cleft (Bevan et al., 1984 ). The physiological relevance of this mechanism should be 
considered. Sympathetic nerves obey the "vesicle hypothesis", that is, that 
neurotransmitters are secreted in quanta equal to the content of a single varicosity, as 
first proposed by de Castillo and Katz (1955). The release of noradrenaline from an 
individual varicosity is intermittent, due to a low probability of release (Hirst and Neild, 
1980b; Brock and Cunnane, 1987; Astrand and Stjarne, 1989). That is, the average 
varicosity will release a vesicular amount of noradrenaline in response to 1 or 2 out of 
100 nerve pulses. With such a low probability of release, it seems unlikely that 
neurotransmitter released from one site would act locally to inhibit subsequent release 
from the same or nearby site. Stimulation of nerves for long periods, or at high 
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frequencies, is required for neurotransmitter to overflow from the active synapse 
(Morris and Gibbins, 1992). 
It has been suggested that autoinhibition is a lateral rather than local effect 
(Brock and Cunnane, 1991). Following the release of noradrenaline from a particular 
vesicle, the probability of subsequent release is, if anything, slightly enhanced (Brock 
and Cunnane, 1991). The spread of noradrenaline to varicosities not yet activated could 
stimulate other prejunctionala receptors, thus decreasing the probability of release from 
other varicosities (Brock and Cunnane, 1991). This mechanism would function to 
reduce the overall magnitude of transmitter release from a nerve terminal network 
(Starke, 1987; Stjarne, 1989). 
PARASYMPATHETIC NERVES 
Parasympathetic nerve stimulation 
Acetylcholine was the first parasympathetic neurotransmitter identified (von 
Euler, 1959). Acetylcholine activates at least five types of muscarinic receptors on 
effector tissues, these- being Ml-, M2-, M3-, M4- and Ms- muscarinic receptors 
(Watson and Girdlestone, 1994 ). 
Parasympathetic nerve stimulation causes vasodilatation in some, but not all, 
vascular beds. Parasympathetic nerve-evoked dilatations are described in vascular beds 
such as th(?se supplying the nasal mucosa and tongue (Lundberg et al., 1990a; Izumi 
and Karita, 1994), the submandibular and submaxillary glands (Fazekas et al., 1987; 
Bhoola et al., 1965; Thulin, 1976). Thus parasympathetic vasodilatation has been 
predominantly observed in tissues involved in exocrine functions, however this is not 
strictly so as cervical neurons supply a cholinergic vasodilator innervation to the uterine 
artery (Bell, 1989). 
Interestingly, parasympathetic nerve stimulation has been reported to produce 
constriction of vessels in the pulmonary circulation (Donald, O'Shea and Lillywhite, 
1990). 
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Parasympathetic neuromuscular junction 
Cholinergic nerves form a plexus around the blood vessels they innervate. A 
superficial cholinergic nerve plexus has been localized in the outeradventitiallayer and a 
deeper cholinergic plexus localized in the adventitial-mediaijunction of the human 
pulmonary artery (Amenta et al., 1983). In smaller pulmonary arteries, a single 
cholinergic nerve plexus was observed at theadventitial-medialjunction (Amenta et al., 
1983). 
Cholinergic neuroeffector junctions, as well as noradrenergic junctions, have 
been described following reconstruction of serial sections at the electron microscope 
level in the sinus venosus of the toad and the guinea pig sinoatrial node (Steele and 
Choate, 1994; Klemm, Hirst and Campbell, 1992). Cholinergic varicosities were 
defined as having an axon profile with diameter greater than 0.3 µm diameter and 
containing chroinaffin negative synaptic vesicles (Gordon-Weeks, 1988). A large 
portion (82/96) of exposed varicosities (ie. part or all of the surf ace was free of 
Schwann cell wrapping) came into close contact with nearby sino-atrial node cells. The 
regions of close apposition showed similar characteristics as have been described for 
sympathetic neuromuscular junctions (Luff and MCLachlan, 1989). 
Cotrammission in the parasympathetic nervous system 
VIP and Peptide Histidine lsoleucineamide (PHI) 
VIP is a 28 amino acid peptide that was first shown to be a vasodilator substance 
present in extracts of porcine intestine (Carlquist, Mutt and Jornvall, 1979). PHI is a 27 
amino acid peptide which has 50% sequence homology with VIP, and is proposed to be 
an endogenous ligand of VIP and related receptors (Edvinsson and McCulloch, 1985; 
Huang et al., 1989). Recent reports have described the cloning of two VIP receptors, 
VIP1 and VIP2 (Ishihara et al., 1992; Lutz et al., 1993), however at the moment there 
are few pharmacological or biochemical tools available to distinguish between these 
two subtypes (Watson and Girdlestone, 1994 ). 
VIP-like immunoreactive nerves lie in the adventitial layer near the 
ladventitial-medial border of major arteries and regional vascular beds, in a similar 
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distribution to acetylcholinesterase-like immunoreactive fibres (Della et al., 1983; 
Barnes et al., 1986; Tatemoto and Mutt, 1981; Jansen et al., 1986; Edvinsson et al., 
1987). The mesenteric and pelvic vascular beds are most densely supplied by VIP-like 
immunoreactivity in the guinea-pig (Della et al., 1983). 
VIP, like other neuropeptides, is produced in nerve cell bodies and axonally 
transported to nerve terminals (Lundberg, Fahrenkrug and Brimijoin, 1981 ). In the cat 
submandibular gland, where both VIP and PHI are proposed to contribute to the 
atropine-resistant component of parasympathetic vasodilation, parasympathetic nerve 
stimulation releases VIP and PHI in a 1:1 ratio (Lundberg et al., 1984b). 
The peptide content of parasympathetic vasodilator nerves is different for 
different vascular beds and between species. Parasympathetic vasodilator neurons 
innervating guinea-pig pelvic vasculature contain VIP, NPY and dynorphin, and many 
contain somatostatin (Morris et al., 1985). VIP only is present in some, but not all, 
guinea-pig cranial parasympathetic neurons (Della et al., 1983; Hottenstein et al., 
1992), but co-exists with NPY in the rat cranial parasympathetic ne':}rons (Leblanc and 
Landis, 1988). 
Interestingly, VIP-like immunoreactive fibres have been found to be associated 
with arteries but not their distal segments. VIP-like immunoreactive fibres are abundant 
around blood vessels in the trachea but are sparse around blood vessels of the peripheral 
sympathetic 
bronchi of the pig (Martling et d , 1990) . VIP-like immunoreactive, fibres are associated 
-
A 
with arteries supplying the hindlimb skeletal muscle, although they are less dense than 
NPY-like and tyrosine hydroxylase-like immunoreactive fibres. These VIP-like 
immunoreactive fibres do not project to the intramuscular arterioles (Anderson et al. , 
1995). 
Parasympathetic nerve stimulation produces a biphasic vasodilatation in the 
submandibular and submaxillary glands (Fazekas et al., 1987; Darke and Smaje, 1972; 
Lundberg, Anggard and Fahrenkrug, 1982). The ability of the muscarinic receptor 
antagonist, atropine, to inhibit parasympathetic vasodilatation is frequency-dependent in 
these tissues. Atropine inhibits the initial phase of vasodilatation which is more 
pronounced at low stimulus frequencies, but not the secondary, prolonged 
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vasodilatation which is more pronounced following higher stimulus frequencies or 
repetitive stimulation (Darke and Smaje, 1972; Thulin, 1976). 
VIP, and possibly PHI, are proposed to mediate the atropine-insensitive 
sustained component of parasympathetic nerve-evoked vasodilatation (Lundberg et al., 
1981; Lundberg, Anggaard and Fahrenkrug, 1981a; Lundberg, Anggard and 
Fahrenkrug, 1981 b; Lundberg, Anggard and Fahrenkrug, 1982; Lundblad, Anggard and 
Lundberg, 1983; Lundberg et al., 1984b; Fazekas et al., 1987; Ito et al., 1987). These 
reports demonstrate several lines of evidence to indicate this. These include: 1) the 
presence of VIP-like immunoreactive parasympathetic fibres; 2) VIP release following 
parasympathetic nerve stimulation. This release was frequency dependent, thus 
correlating with the appearance of the atropine-insensitive vasodilatation; 3) both the 
non-cholinergic vasodilatation and the release of VIP were abolished by the nicotinic 
antagonist, hexamethonium, indicating that they both arise from the activation of 
postganglionic parasympathetic nerves and 4) the prolonged vasodilatation produced by 
VIP was similar to the slower component of the parasympathetic vasodilatation. The 
development of specific VIP receptor antagonists will enable the confirmation of the 
role of VIP as a cotransmitter with acetylcholine in the parasympathetic nervous 
system. 
Au~-regulation of parasympathetic neurotrammitter release 
Parasympathetic neurotransmitters may act prejunctionally to regulate 
parasympathetic neurotransmitter release. For example, acetylcholine may inhibit the 
release of VIP and PHI via muscarinic autoreceptors on fibres innervating the 
vasculature of the submandibular gland (Lundberg et al., 1984a). 
To summarize, the autonomic sympathetic and parasympathetic nerves 
innervating mammalian arterial vessels contain 'classical' neurotransmitters such as 
noradrenaline and acetylcholine, respectively. The release of these transmitters 
produces vasoconstriction and vasodilatation respectively and undergoes auto-
regulation. The classical neurotransmitters generally produce the initial response to 
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autonomic nerve stimulation. In addition, neuropeptides present in autonomic nerves 
are proposed to mediate responses to sympathetic or parasympathetic nerve stimulation 
which occur following longer, or higher frequency, stimulus trains. This may be due to 
the presence of peptide receptors away from the synaptic sites or due to variable release 
mechanisms. When required, these neuropeptides are thus able to mediate longer lasting 
effects of nerve stimulation. 
SENSORY-MOTOR NERVES 
Non-adrenergic, non-cholinergic vasodilatation 
peri vascular 
After noradrenergic and cholinergic transmission are blocked, nerve stimulation 
/\ 
may evoke a vasodilation. Stricker ( 187 6) was the first to observe that stimulation of the 
peripheral ends of cut dorsal roots induced vasodilation in the skin area supplied by the 
transected afferent nerve-fibres and it is now believed that upon activation, sensory 
nerve fibres send orthodromic impulses to the spinal cord and antidromic impulses are 
sent along collaterals from the sensory nerves to produce peripheral vasodilation (see 
Holzer, 1992). These collaterals have been called "sensory-motor nerves" to distinguish 
them from the other afferent fibres which have a purely sensory role and whose 
terminals contain few vesicles (Burnstock, 1990). The peripheral effect of sensory-
motor efferents can be induced by electrical stimulation or by direct activation of the 
sensory nerve terminals by stimuli such as capsaicin (Maggi and Meli, 1988). 
V asodilatation produced by sensory-motor nerves is predominant in the 
cutaneous vasculature, where it plays an important part in inflammation (Holzer, 1992). 
Sensory-motor nerves also produce vasodilatation of other vascular beds such as those 
in the nasal mucosa (Stjarne et al., 1991), airway (Matran, 1991), mesenteric artery (Li 
and Duckies, 1992) and arterioles in striated muscle (Porszasz and Szolcsanyi, 1994). 
Sensory-motor nerves play an important role in gastric mucosa! protection. When the 
barrier to gastric acid back-diffusion is disrupted, activation of these fibres leads to an 
increase in gastric mucosa! blood flow to help remove the back diffusing acid (Guth, 
1992). 
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Capsaicin 
The term "capsaicin-sensitive" nerve refers to afferent neurons which are 
transiently excited by the acute application of capsaicin, and permanently damaged by 
long term treatment of capsaicin (Holzer, 1991a). These neurons comprise most of the 
primary afferent neurons with small cell bodies and unmyelinated axons (C fibre) and 
some afferent neurons with thin myelinated axons (A8 fibre). Histochemical and 
biochemical evidence suggests that parasympathetic and sympathetic nerves remain 
unaffected after capsaicin treatment (Holzer, 1991a). 
Primary sensory neurons may contain tachykinins, calcitonin gene-related 
peptide (CGRP), somatostatin, cholecystokinin, bombesin, oxytocin, opioid peptides 
and galanin (Hokfelt et al., 1993). Substance P and CGRP are co-localized in the same 
large granular vesicles in trigeminal and dorsal root sensory ganglia (Merighi et al., 
1988). 
Substance P- and CGRP-like immunoreactive nerve fibres· have a similar 
distribution around guinea-pig blood vessels (Stjarne et al., 1989). Gibbins, Furness and 
Costa ( 1987) demonstrated that nerves containing certain combinations of peptides 
showed distinctive peripheral projections in the guinea pig. For example, neurons 
containing substance P-, CGRP- and cholecystokinin-like immunoreactivity were 
distributed to small blood vessels in skeletal muscle, and neurons containing 
substance P- and CGRP-like immunoreactivity were found mainly in the heart and 
systemic blood vessels and vessels of the abdominal viscera and the airways. 
Capsaicin treatment destroys all the substance P-like immunoreactive sensory 
neurons in neonatal rats (Holzer, 1991a). CORP-like immunoreactive neurons in 
sensory ganglia of the rat are divided into two subgroups: small-medium sized neurons 
which contain substance P in the same soma, and large neurons which lack substance P 
(Lee et al., 1985; Matsuyama et al., 1986). While neonatal capsaicin treatment 
abolishes the small-medium CGRP-like and substance P-like immunoreactive neurons 
of trigeminal sensory ganglia, the large CGRP-like immunoreactive neurons are 
unaffected (Matsuyama et al., 1986). On the other hand, both CGRP- and substance P-
like immunoreactive fibres associated with the cerebral artery were destroyed by 
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capsaicin treatment Therefore, although not all CGRP-immunoreactive sensory fibres 
are sensitive to capsaicin, in the rat and guinea-pig, all CGRP- and substance P-like 
immunoreactive fibres associated with blood vessels are capsaicin-sensitive (Wharton et 
al., 1986). 
CGRP 
CGRP is a 37 amino acid peptide which is generated from the calcitonin gene by 
alternative splicing (Amara et al., 1982). CGRP receptors have been divided into 
CGRP1 and CGRP2 (Watson and Girdlestone, 1994). CGRP2 receptors on sensory-
motor nerve terminals may mediate a negative feedback on the release of CGRP from 
-
these nerves (Nuki et al., 1994). CGRP is probably inactivated by enzymes, at least one 
of which also breaks down substance P (Nuki et al., 1994). 
The distribution on blood vessels of sensory-motor nerve fibres containing 
CGRP is similar to that of substance P containing fibres, although in the rat the content 
of CGRP is reported to be greater than that of substance P (Wharton et al., 1986). 
CGRP-like immunoreactivity is also higher in peripheral arteries than in the major 
blood vessels (Brain and Williams, 1985). Pial arteries show a well developed supply of 
CGRP-like immunoreactive fibres (Hanko et al., 1985). 
In the skin of the rat foot pad, CGRP-like immunoreactive fibres formed bundles 
which wer~ smooth (Ishida-Yamamoto, Senba and Tohyama, 1989). When individual 
CGRP-like immunoreactive fibres left a bundle to innervate a blood vessel they became 
varicose (Ishida-Yamamoto, Senba and Tohyama, 1989). Examination of serial sections 
indicated that CGRP-like immunoreactive fibres did not form synaptic contacts with the 
underlying blood vessels (Ishida-Yamamoto, Senba and Tohyama, 1989). 
Vessels where CGRP mediates capsaicin-sensitive vasodilation include the 
mesenteric artery (Han, Naes and Westfall, 1990), the rabbit skin (Hughes and Brain, 
1991), rat hepatic artery (Bratveit and Helle, 1991) and the cerebral artery (Saito et al., 
1989). 
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Substance P 
Substance P was the first member of the neuropeptide tachykinin family to be 
isolated by van Euler and Oaddum in 1931, and was sequenced in the early 1970's. 
Between 1983 and 1984 several groups reported the isolation of the other two 
mammalian tachykinins, neurokinin A and neurokinin B; and all three tachykinins all 
share a common C terminal sequence of Phe-Xaa-Oly-Leu-MetNH2 (see Maggi, 1995). 
Tachykinin synthesis occurs in the cell bodies of primary afferent neurons in the 
dorsal root ganglia (Too, Cordova and Maggio, 1989a; Helke et al., 1990). Tachykinins 
synthesized by dorsal root ganglia neurons are transported to their peripheral nerve 
terminals to produce their sensory-motor effects (Maggi et al., 1993). Neurokinin B 
levels in peripheral tissues are very low or, in many cases, undetectable (Too, Cordova 
and Maggio, 1989a; Tateishi et al., 1990; Moussaoui et al., 1992). 
The receptors for the tachykinins have been divided according to their order of 
sensitivity of activation by the endogenous ligands, although all three tachykinin 
receptors may be activated by all the tachykinins. The NK1 -tachykinin receptor is 
preferentially activated by substance P, NK2-tachykinin receptor by neurokinin A and 
NK3-tachykinin receptor by neurokinin B (Maggi, 1995). 
V asodilatation is produced by the intravenous application of tachykinins in vivo 
or their application to precontracted blood vessels (Maggi, 1995). This vasodilatation is 
mediated by the activation of tachykinin receptors on endothelial cells (Saito et al., 
1990; Saito et al., 1991). 
Several studies have addressed the issue of whether tachykinins released from 
sensory-motor nerves gain access to receptors located on the endothelial cells. 
Neurokinins, but not CORP, produce an endothelium-dependent vasodilatation of 
guinea-pig pulmonary arteries (Maggi et al., 1990). Although sensory-motor nerves 
release both CORP and neurokinins, the vasodilatation following stimulation of these 
nerves is not endothelium-dependent and is mediated by CORP (Maggi et al., 1990). 
Similar results have been found in coronary arteries (Franco-Cereceda, Rudehill and 
Lundberg, 1987), rat perfused mesenteric artery (Han, Naes and Westfall, 1990; Li and 
Duckies, 1992). In these vessels therefore, endothelial tachykinin receptors are not 
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affected by neurally-released peptide but rather CGRP mediates the neurogen1c 
vasodilatation. 
It is possible that in smaller blood vessels, which have thinner walls, neurally-
released tachykinins may reach endothelial receptors to produce vasodilatation. For 
instance, sensory-motor vasodilatation of submucosal arterioles is produced by both 
CGRP and substance P (Vanner, 1994; Galligan et al., 1990). 
Several peptidases terminate the physiological effects of tachykinins. 
Endopeptidase 24.11 (also known as neutral endopeptidase or enkephalinase) 
inactivates all three tachykinins (Hooper, Kennedy and Turner, 1985; Nau et al, 1986). 
Peptidyl dipeptidase A (also known as angiotensin converting enzyme) inactivates 
-
substance P (Hooper, Kennedy and Turner, 1985), while aminopeptidases inactivate 
neurokinin A (Hooper, Kennedy and Turner, 1985). 
Endopeptidase 24.11 also inactivates CGRP (Hooper, Kennedy and Turner, 1985). 
Peptidase inhibitors may 
potentiate the effects of neurally-released neurokinins. For example, in the guinea pig 
perfused lungs capsaicin increased the release of CGRP, but also further increased the 
release of neurokinin A and CGRP in the presence of the enkephalinase inhibitor, 
phosphoramidon, suggesting that the two peptides are broken down by a similar 
peptidase (Kroll et al., 1990). 
Capsaicin-sensitive, substance P-like immunoreactive fibres are localized in the 
advential-medial border of large peripheral arteries. No correlation was found between 
the degree of innervation of blood vessels, as detected histochemically, and the ability 
of substance P to change vascular tone, which led the authors to suggest that the 
substance P fibres were purely sensory in nature and did not subserve a vasomotor 
function (Barja, Mathison and Huggel, 1983). 
NERVES CONTAINING NITRIC OXIDE 
Li and Rand (1991) proposed the term 'nitrergic' to describe nitric oxide-
mediated neurotransmission. Recent reviews indicate that nitric oxide meets the criteria 
defining a neurotransmitter: nitric oxide synthesis is found within neurons, nitric oxide 
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is released during non-adrenergic, non-cholinergic nerve stimulation, exogenous nitric 
oxide mimicks the effect of nerve stimulation and the removal of nitric oxide occurs as 
a consequence of its rapid breakdown (Rand, 1992; Sanders and Ward, 1992). 
L-citrulline and nitric oxide are formed by the oxidation of a guanidinonitrogen 
atom of L-arginine (Moncada, 1992). This is at least a two step reaction which is 
catalysed by nitric oxide synthase (NOS). Two types of NOS have been identified: 
constitutive and inducible; both have binding sites for nicotinamide-adenine 
dinucleotide phosphate, flavin adenine nucleotide, flavin mononucleotide and a 
recognition site for calmodulin. The constitutive form of NOS consists of two isoforms: 
one found in endothelial cells and one found in neurons. The activity of this type of 
NOS is dependent on the concentration of calcium. Inducible NOS is found in 
macrophages after cytokine treatment. As calmodulin is always tightly bound to this 
type of NOS, this type of enzyme is calcium-independent (Leone et al., 1991). 
A number of L-arginine analogues, such as L-nitroarginine, L-N<i-monomethyl 
arginine (L-NMMA) and NU-nitro L-arginine methyl ester (L-NAME), are widely used 
as competitive inhibitors of nitric oxide synthesis as their effects are reversed to some 
degree by an excess of L-arginine (Rees et al., 1990; Liu et al., 1992; Greenblatt, Loeb 
and Longnecker, 1993). The selectivity of these compounds for the L-arginine-nitric 
oxide pathway has been questioned (Buxton et al., 1993; Thomas and Ramwell, 1992), 
however these compounds are still commonly used by investigators to investigate the 
action of nitric oxide. 
Loesch, Belai and Burnstock (1994) determined the ultrastructural distribution 
of the neuronal isoform of NOS in the rat basilar artery. Axon varicosities showing 
NOS-like immunoreactivity were characterised by the presence of spherical agranular 
vesicles with diameters of 40-50 nm. NOS-like immunoreactive axons innervating the 
lingual artery form direct neuromuscular junctions at the outer surface of the tunica 
media and make direct contacts with non-varicose and varicose segments of non-NOS 
reactive axons (Kummer and Mayer, 1993). 
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Penile and cerebral arteries have been described as having nitrergic innervation 
(Rand, 1992). Neuronal NOS is located in nerve fibres innervating coronary arteries and 
pulmonary vessels (Klimaschewski et al., 1992; Nozaki et al., 1993). Thin NOS-
immunoreactive fibres as well as many NOS-immunoreactive thicker nerve fibres and 
bundles occur in the outer media of monkey and canine cerebral, mesenteric and 
temporal arteries (Yoshida, Okamura and Toda, 1994). NOS-like immunoreactive fibres 
are also found in the adventitia of the human uterine artery (Toda et al., 1994). In both 
the guinea pig and the pig, the distribution of NOS-like immunoreactivity matches the 
presence of VIP/cholinergic postganglionic vasodilator fibres (Edvinsson et al., 1980; 
Gibbins, Brayden and Bevan, 1984; Ceccatelli et al., 1994), although some cholinergic 
vasodilator fibres, for example to the tongue, lack NOS-immunoreactivity (Kummer 
et al., 1992). Numerous NOS-containing fibres occur within the porcine pterygopalatine 
and trigeminal ganglion, while sensory ganglia of the vagal nerve also comprised a 
smaller number of fibres (Sienkiewicz et al., 1995). Damaging the· pterygopalatine 
ganglia, which contains numerous parasympathetic and sensory fibres, abolished NOS-
like fibres in the wall of the ipsilateral middle cerebral artery (Yoshida, Okamura and 
Toda, 1994; Ehinger, Sundler and Uddman, 1983). 
Non-adrenergic, non-cholinergic (NANC) nerve stimulation of bovine basilar 
and monkey cerebral arteries, temporal arteries and human uterine artery strips, which 
have been . endothelium-denuded, produces a vasodilatation which is abolished by 
inhibition of nitric oxide synthesis (Yoshida, Okamura and Toda, 1994; Stubbs et al., 
i992). In the bovine ciliary artery, part of the NANC vasodilatation is mediated by 
CGRP released from capsaicin-sensitive sensory nerves, but 85% of the relaxation is 
abolished by inhibition of neuronal nitric oxide synthesis (Wieneke et al., 1994). 
Work undertaken for the past 20 years by Toda and colleagues supports the 
hypothesis that the activation of nicotinic receptors on nitrergic vasodilator nerves 
increases the transmembrane influx of calcium and activates NOS and thus produces 
neuronal nitric oxide (Toda and Okamura, 1992). Nicotine induces a vasodilatation of 
cat middle cerebral and canine saphenous arterial strips which is totally abolished by 
inhibiting both nitric oxide production and CORP receptors (Okamura and Toda, 1994 ). 
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The literature therefore shows a good correlation between the presence of NOS-
containing nerves and a functional nitrergic innervation. Neuronal nitric oxide appears 
to be found in postganglionic parasympathetic and sensory, but not sympathetic, nerves 
(Modin, 1994). 
Nitric oxide is a very labile and freely diffusible molecule. A simple mechanism 
has been suggested to account for nitrergic neurotransmission (Sanders and Ward, 
1992). As previously mentioned, neuronal NOS is calcium-dependent and the influx of 
calcium into nitrergic varicosities following a nerve impulse would increase the 
production of nitric oxide. The nitric oxide produced could easily diffuse from the 
varicosity and produce effects on nearby muscle cells. 
-
Recently it was demonstrated that 3 days after ligating the vagus nerve, NOS-
like immunoreactivity accumulates on the ganglion side of the ligation (Lumme, 
Vanhatalo and Soinila, 1996). VIP-like immunoreactivity was co-localized with this 
NOS-like immunoreactivity, indicating that NOS may be transported in 
parasympathetic nerves. Some of the fibres accumulating NOS were also substance P-
like immunoreactive, suggesting that presumable sensory neurons of the nodose ganglia 
also transport NOS (Lumme, Vanhatalo and Soinila, 1996). 
While it has been demonstrated that NOS may be axonally transported, Stark et 
al. (1993) provided evidence that nitrergic neurotransmission does not depend upon the 
release of ~tored nitric oxide. In the jejunum, the inhibitory effects of L-NMMA on 
nitrergic inhibitory junction potentials occured within 10 min. There would only be a 
small amount of neurotransmitter stored if synthesis inhibition had such a quick time 
course. The time course was not affected by electrical field-stimulation during the L-
NMMA incubation period. If nitric oxide was stored, such stimulation would shorten 
the time course by accelerating depletion of neurotransmitter stores. 
EFFECTS OF NEUROTRANSMITTERS ON VASCULAR ENDOTHELIUM 
In response to stimulation of the appropriate receptors, the vascular endothelium 
releases a number of molecules which can cause either vasoconstriction or 
vasodilatation. 
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Endothelium-dependent vasodilatation 
Furchgott and Zawadzki (1980) were the fust to report that the vasodilatory 
response to acetylcholine was impaired when the endothelium was removed, and 
suggested this was because the enothelial cells release a relaxing factor which diffuses 
to the smooth muscle cells to produce vasodilation (EDRF). Other agonists which 
produce an endothelium-dependent vasodilatation include substance P, ATP, serotonin 
and histamine (Mione, Ralevic and Burnstock, 1990). Receptors for these agonists have 
been located on endothelial cells in various blood vessels (Loesch and Burnstock, 1988; 
Milner et al., 1989). 
Nitric oxide has been identified as one EDRF. Palmer and co-workers (1988) 
were the first to report that L-arginine was the physiological precursor for the formation 
of nitric oxide and that nitric oxide release can account for the biological activity of 
EDRF. 
Nitric oxide fotmed by endothelial NOS rapidly diffuses within the endothelial 
cell and across membranes to adjacent smooth muscle cells where it activates soluble 
guanylate cyclase to cause vasodilation (Palmer, Ashton and Moncada, 1988). In this 
way nitric oxide can convert a signal in endothelial cells, such as elevated intracellular 
calcium fo}lowing receptor activation, to a response in neighbouring smooth muscle 
cells. 
Under physiological conditions, the activation of constitutive NOS in endothelial 
cells by shear stress means that a continuous release of nitric oxide keeps the 
vasculature in a permanent state of vasodilation. Inhibition of synthesis of nitric oxide 
with L-NMMA in vivo causes a rapid, sustained elevation in blood pressure (Rees, 
Palmer and Moncada, 1989; Greenblatt, Loeb and Longnecker, 1993; Gardiner et al. , 
1990). Infusion of L-NMMA in conscious rats decreased blood flow and increased 
vascular resistance in the cerebrum, heart, kidney, spleen, gastrointestinal tract, skin, ear 
and white fat. The magnitude of increased vascular resistance was not uniform, the 
maximal effect being in the brown fat and the least in the heart. Interestingly, L-NMMA 
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infusion produced an increase in blood flow and decreased vascular resistance in the 
hepatic artery (Greenblatt, Loeb and Longnecker, 1993). The effect of inhibiting nitric 
oxide synthesis was greater in the large arteries of the cerebral vasculature ( diameter of 
275 µm) than in the arterioles (diameter of 62 µm; Faraci, 1991). Close intra-arterial 
infusion of L-NAME also reduces basal blood flow in the rabbit knee joint (Najafipour 
and Ferrell, 1993). 
The endothelium releases an inhibitory factor which is not related to nitric oxide 
and has been termed EDHF (Taylor and Weston, 1988). The effects of EDHF and 
EDRF can been differentiated by comparing the effect of acetylcholine with the effect 
of the guanylate cyclase inhibitor, nitroprusside, and the K+ channel opener, 
cromakalim, which hyperpolarizes smooth muscle independently of cyclic AMP or 
cyclic GMP (Taylor and Weston, 1988). Acetylcholine produces an endothelium-
dependent increase in cyclic GMP levels, a transient hyperpolarization and a long-
lasting vasodilatation (Plane, Pearson and Garland, 1995). The hyperpolarization was 
closely linked with an increase in the rate of efflux of K+, which was mimicked by 
cromakalim, but not n1troprusside (Taylor et al., 1988). The acetylcholine-induced 
increase in cyclic GMP was mimicked by nitroprusside but not cromakalim (Taylor et 
al., 1988). Haemoglobin, which inactivates EDRF, prevented the increase in cyclic 
GMP, but had no effect on the hyperpolarization (Chen, Suzuki and Weston, 1988). 
Therefore,- EDRF stimulates cyclic GMP formation, whereas EDHF-mediated 
hyperpolarizations are insensitive to inhibitors of nitric oxide, and result from the 
activation of K+ channels. 
The contribution of EDHF to endothelium-dependent vasodilatation has been 
questioned (Taylor and Weston, 1988). In the rat aorta and pulmonary artery, 75-80 % 
of the relaxation produced by acetylcholine was abolished by inhibiting nitric oxide 
synthesis, while the smooth muscle hyperpolarization was unaffected (Chen, Suzuki 
and Weston, 1988). The hyperpolarization or repolarization produced by endothelium-
dependent vasodilatory agonists is transient compared to the sustained dilatation (Plane, 
Pearson and Garland, 1995). The effects of EDRF and EDHF are usually studied on 
vessels which have been preconstricted, which means the smooth muscle cells may be 
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in a depolarized state. It has been suggested that EDHF provides the primary drive for 
relaxation, by hyperpolarizing or repolarizing the membrane potential and EDRF 
maintains the relaxation (Taylor and Weston, 1988; Plane, Pearson and Garland, 1995). 
In order to study endothelium-dependent vasodilatation, blood vessels are 
usually preconstricted. Recently it was demonstrated that the nature of acetylcholine-
induced vasodilatation clearly depends upon the agent used to preconstrict (Hayashi et 
al., 1994). Acetylcholine produced a sustained vasodilatation of renal afferent arterioles 
preconstricted with KCl or noradrenaline, but produced a transient dilatation followed 
by a small residual dilatation of arterioles preconstricted by elevated perfusion pressure. 
Following KCl-induced preconstriction, acetylcholine vasodilatation was 
prevented by inhibiting both cyclo-oxygenase, using indomethacin, and NOS, using 
nitro-L-arginine. The acetylcholine-induced transient vasodilatation of myogenically 
pre-constricted vessels was not due to cyclo-oxygenase products or nitric oxide. The 
small residual vasodilatation was sensitive to indomethacin, and possibly mediated by 
prostaglandin E2 (Hayashi et al., 1994). Nitro-L-arginine inhibited the sustained 
acetylcholine-induced vasodilatation of noradrenaline pre-constricted vessels, leaving 
an initial transient dilatation which was insensitive to indomethacin. The mediator of 
the transient vasodilatation produced by acetylcholine was not identified in this study, 
although it had a time course similar to the previously reported effects of EDHF (Chen, 
Suzuki and Weston, 1988). Therefore, different mechanisms may mediate agonist-
induced vasodilatation of a vessel, depending upon the nature of the underlying tone. 
Endothelium-dependent vasoconstriction 
Endothelial cells may also release vasoconstrictor agents, such as endothelin, a 
22 amino acid peptide discovered in 1988 (Yanagisawa et al., 1988). Endothelial-
derived angiotensin II and thromboxane A2 may also produce constriction of vascular 
smooth muscle cells (see Kuriyama, Kitamura and Nabata, 1995). 
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MODULATION OF V ASOCONSTRICTION AND V ASODILA TA TION 
There is now much evidence for interactions between nerves subserving 
different functions. Such effects may occur post-junctionally in the effector cells or pre-
junctionally to modify neurotransmitter release. 
Postjunctional effects 
Capsaicin pretreatment augments sympathetic vasoconstriction of isolated 
mesenteric arteries (Kawasaki et al., 1990a; Remak, Hottenstein and Jacobson, 1990; Li 
and Duckles, 1992). Neither capsaicin nor the sensory-motor neurotransmitter CGRP 
inhibit 3H-noradrenaline release following sympathetic nerve stimulation (Han, Naes 
and Westfall, 1990; Kawasaki et al., 1990a; Maynard and Bumstock, 1989). This 
suggests a postjunctional inhibitory effect of sensory nerves on sympathetic 
vasoconstriction. · 
Interactions between sympathetic and sensory-motor nerves also occur in vivo. 
Periarterial nerve stimulation reduces blood flow of the mesenteric artery, but peak 
vasoconstriction is followed by a recovery of blood flow, despite continuing nerve 
stimulation (Remak, Hottenstein and Jacobson, 1990). This autoregulation of 
sympathetic vasoconstriction was inhibited by capsaicin (Remak, Hottenstein and 
Jacobson, 1990), suggesting the involvement of sensory-motor nerves. 
Prejunctional effects 
Activation of prejunctional 5HT, H1- or H3-histamine or opioid receptors may 
inhibit sympathetic vasonconstriction (Schlicker et al., 1994; Molderings et al., 1987). 
While sensory-motor neurotransmitters act postjunctionally to inhibit 
sympathetic vasoconstriction, sympathetic neurotransmitters act prejunctionally to 
inhibit neurotransmitter release from sensory-motor nerves. For example, non-
cholinergic vasodilatation of the isolated mesenteric artery is only observed when a-
adrenoceptors and sympathetic neurotransmission are blocked (Kawasaki et al., 1990b). 
In this artery, noradrenaline, adenosine and NPY act upon afferent nerve endings to 
inhibit the sensory-motor release of CGRP (Kawasaki et al., 1991; Mantelli et al., 1993; 
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Li and Duckles, 1991). Activation of prejunctional a.2-adrenoceptors also reduces 
sensory-motor nerve relaxation of the pulmonary artery (Butler et al., 1993). 
Activation of µ opioid receptors on sensory-motor nerve terminals may also 
inhibit sensory-motor vasodilatation of the mesenteric artery (Li and Duckles, 1991; 
Ralevic, Rubino and Burns tock, 1994 ). In reserpine pretreated rats, naloxone facilitated 
sensory-motor nerve evoked vasodilatation at low frequency of stimulation (Ralevic, 
Rubino and Burnstock, 1994). The authors suggested that sympathetic nerves were a 
source of opioids, although opioids may also be released from enteric nerves supplying 
these vessels (Lindh, Hokfelt and Elfvin, 1988). 
Cholinergic and noradrenergic nerve terminals may be in close association with 
each other (Esterhuizen et al., 1968). This has implications for possible prejunctional 
and/ interactions between sympathetic vasoconstrictor mechanisms and parasympathetic or 
" 
nitrergic vasodilator mechanisms. Sympathetic nerve stimulation attenuates the nasal 
vasodilator response to subsequent parasympathetic nerve stimulation by the activation 
of prej~nctional Y2-NPY receptors (Lacroix, Ulman and Potter, 1994). In the carotid 
artery, activation of prejunctional M1-muscarinic receptors facilitates sympathetic 
neurotransmitter release (Casado, Marin and Salaices, 1992). However, the influence of 
prejunctional muscarinic receptors on sympathetic vasoconstriction appears to be 
vessel-dependent as, in the femoral artery, activation of sympathetic prejunctional M3-
muscarinic-receptors inhibits noradrenaline release (Fernandes et al., 1991). 
In conclusion, auto-inhibition is not the only mechanism by which 
neurotransmission may be modified. A balance between vasoconstrictor and vasodilator 
nerves provides an additional level of control of vascular tone. This control is important 
for maintaining homeostasis. For example, an imbalance between vasodilator and 
vasoconstrictor neurons may have pathophysiological relevance for the etiology of 
hypertension (Holzer, 1992). 
ARTERIAL RESISTANCE VESSELS 
The greatest contribution to peripheral resistance in the body is provided by the 
small arteriolar vessels. In the 1820's, Poiseuille studied blood flow and the relationship 
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between flow of fluids through tubes of different internal diameter and lengths. A 
modified version of the equation Poiseuille derived for the resistance to flow is: 
R= 8llht.r4 
where R is the resistance to fluid flow, Tl is the fluid viscosity and r is the radius of the 
tube. This model shows that the resistance to flow is inversely proportional to r4, thus a 
given degree of shortening of the smooth muscle in the vessel wall (ie. constriction) in a 
smaller diameter vessel will produce a much greater resistance to flow than in a larger 
diameter vessel. Conversely, dilatation of arterioles results in much greater change in 
flow than does dilatation of arteries. In fact, arterioles often have non-uniform diameters 
which means the resistance to flow in these vessels will be slightly greater than for a 
uniform tube used in the above model (Sugihara Seki, Minamiyama and Hanai, 1989). 
It is therefore important to understand the mechanisms which control arteriolar tone. 
IRIS V ASCULA TURE 
A transverse section through the dilator region of the albin~ rat iris shows that 
there are four layers comprising the iris tissue (Olson et al., 1988). These are (anterior 
to posterior): a thin squamous epithelial-like layer of cells, the stromal layer, a single 
layer of myoepithelial cells of the dilator muscle and a cuboid epithelial cell layer. The 
relatively thick stromal layer of loose connective tissue contains chromatophores, blood 
vessels an~ nerve fibres. Large nerve bundles containing both myelinated and 
unmyelinated nerve fibres are found amongst the blood vessels of the iris stroma. 
The eye has a dual vascular supply (Bill and Nilsson, 1985). The blood vessels 
of the uvea are distributed within the choroid, the ciliary body and the iris. The retinal 
blood vessels supply the inner parts of the retina. 
In the iris two arterial circles arise from the ciliary arteries (Freddo and Ra viola, 
1982). The major arterial circle is formed from branches of the posterior ciliary arteries. 
These vessels are predominantly related to iris functions. The intramuscular circle is 
derived from branches· of the anterior ciliary arteries. These vessels seem to be related 
functionally to the aqueous outflow and eye accommodation. A series of radial 
arterioles leaves the major circle of the iris, decreasing in diameter, to terminate in an 
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incomplete ring of arteriovenous anastomosis, known as the minor circle of the iris 
(Ojima and Matsuo, 1985; Rohen and Funlc, 1994). The arterial vessels show a bended 
spiral course. The collecting venules running towards the iris root appear quite straight 
and drain the capillaries of the two capillary layers (Rohen and Funlc, 1994 ). 
INNERVATION 
V asoconstriction 
The iris receives a rich sympathetic noradrenergic plexus (Olson et al., 1988). 
The adrenergic nerves to the iris are derived from sympathetic nerve fibres originating 
from the ipsilateral superior cervical ganglion (Olson et al., 1988). Stimulation of the 
cervical sympathetic chain reduces blood flow in all parts of the uvea, including the iris 
(Bill, 1975). Continuous stimulation at 10 Hz produced a steady-state near maximal 
reduction in total. blood flow. 
The distribution of NPY-like immunoreactive nerves closely mirrors the 
distribution of the catecholamine-containing sympathetic fibres in the eye (Stone, 
Kuwayama and Laties, 1987). Approximately 99% of these NPY-like immunoreactive 
fibres disappear after removal of the superior cervical ganglion (Olson et al., 1988). A 
rich innervation of NPY-like immunoreactive fibres supplies the choroidal blood 
vessels of the albino rat, with a lower density around anterior uveal blood vessels 
(Stone, Kuwayama and Laties, 1987). 
Interestingly, electrical stimulation of the oculomotor nerve (3rd cranial nerve) 
causes a redistribution of blood flow in the uvea, with a reduction of iris blood flow but 
an increase in choroidal blood flow (Stjernschantz, Alm and Bill, 1976). 
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V asodilatation 
Stimulation of the trigeminal ganglia causes an irritation response in the rabbit 
eye (Andersson and Bill, 1989). Neonatal capsaicin treatment abolishes the small-
medium CGRP- and substance P-like immunoreactive neurons of trigeminal sensory 
ganglia; the large CGRP-immunoreactive neurons are unaffected (Matsuyama et al., 
1986). 
Stimulation of the facial nerve produces a non-cholinergic increase in local 
blood flow of the choroid, and to a lesser extent, the uvea in monkeys, cats and rabbits, 
with near maximal effects obtained at 10 Hz (Bill and Nilsson, 1985). This increased 
blood flow was most likely to be due to vasodilatation as there was no associated 
change in mean arterial blood pressure (Bill and Nilsson, 1985). 
VIP is proposed to mediate the non-cholinergic vasodilatation in the choroid 
(Nilsson and Bill, 1984). Intravenous adminisitration of VIP or PHI increases local 
blood flow in the choroid, but not the anterior uvea (Nilsson and Bill, 1984). VIP-like 
immunoreactive nerves have been demonstrated to supply arterioles of the choroid and 
ciliary body (Andersson and Bill, 1989; Terenghi et al., 1982). The rat iris contains a 
relatively sparse irregular network of VIP-like immunoreactive nerves and the 
distribution of PHI-like immunoreactive nerves closely parallels that of VIP, suggesting 
the two peptides are co-localized (Olson et al., 1988 ). There is no apparent association 
of VIP-like/PHI-like immunoreactive nerves with blood vessels of the rat iris, but VIP-
like immunoreactive fibres have been found in association with the larger vessels in the 
choroid (Olson et al., 1988). Extirpation of the pterygopalatine ganglion results in the 
loss of intra-ocular VIP-like immunoreactive nerve fibres, indicating that these nerve 
fibres were in the facial nerve (Andersson and Bill, 1989). 
Nitric oxide plays a role _in canine basal occular blood flow in vivo. Infusion of 
an inhibitor of the synthesis of nitric oxide, nitro-L-arginine, significantly reduced 
porcine and canine iris blood flow (Deussen, Sonntag and Vogel, 1993; Vogel and 
Sonntag, 1994). In the rat, NOS-like immunoreactivity has been demonstrated in the 
endothelium of intraocular blood vessels, particularly those in the choroid, iris and 
retina (Yamamoto et al., 1993). 
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The posterior ciliary artery of the pig supplies both the uvea and the choroid (Su 
et al., 1994). Electrical field stimulation of this vessel produced a NANC vasodilatation. 
This vasodilatation was endothelium-independent and reduced to half by inhibition of 
nitric oxide synthesis (Su et al., 1994). This suggests that nitrergic nerves may innervate 
some ocular blood vessels and contribute to intra-ocular NANC vasodilatation. 
NOS-like immunoreactivity has been localized in nerve fibres supplying the rat 
choroidal blood vessels, with the anterior uvea being sparsely innervated (Yamamoto et 
al., 1993). Many neurons in the pterygopalatine ganglion showed NOS-like 
immunoreactivity and virtually all of these showed VIP-like immunoreactivity 
(Yamamoto et al., 1993). Pterygopalatine ganglionectomy significantly reduced the 
number of peripheral NOS-like immunoreactive fibres in the eye, indicating these fibres 
were mainly in the facial nerve (Yamamoto et al., 1993). 
Taken together, the above results indicate that VIP, PHI and nitric oxide act as a 
co-transmitters for non-cholinergic vasodilatation in the choroid, but not the uvea, of 
the rat eye. In addition, the iris of the rat receives a rich supply of sensory nerves but 
they have no apparent close association with iris blood vessels (Olson et al., 1988). 
THESIS OUTLINE 
The aim of this thesis was to characterize the nerve-mediated control of the 
diameter of arterioles found within the mature rat iris in vitro. The iris of the albino rat 
was chosen for the present study as it is well supplied with small arterial vessels which 
are readily visualized, thus making it a suitable preparation for in vitro physiology 
experiments. The study has been divided into the following chapters: 
Chapter 2. An outline of the methods and materials used in this thesis. 
Chapter 3. The role of sympathetic nerves in producing vasoconstriction. 
Chapter 4. The mechanism of sympathetic vasoconstriction. 
Chapter 5. The role of sensory-motor nerves in modulating vasoconstriction. 
Chapter 6. The mechanism of action of sensory-motor nerve modulation of 
sympathetic vasoconstriction. 
Chapter 7. The potential role of sensory-motor nerves in modulating other 
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sympathetic synapses. 
Chapter 8. General discussion arising from the results of this thesis. 
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CHAPTER 2. 
MATERIALS AND METHODS 
ANIMALS 
An unpigmented strain of Wis tar rats ( 4 to 6 weeks old, of either sex) was used 
to allow visualization of arterioles in whole mount preparations of the iris for in vitro 
physiology experiments. The rats had access to water and food pellets ad libitum. 
IN VITRO PREPARATION 
Rats were killed with an overdose of_anaesthetic ether. Immediately afterwards, 
both eyes were dissected out, the lens removed and the iris placed in a Krebs solution of 
the following composition (mM): NaCl, 119.8; KCl, 5.0; NaHC03 25.0; NaH2P04, 
1.0; CaCl2 2.5; MgCl2 2.0; glucose 22.0, which was gassed with 95% 02/5% CO2. 
Hyoscine hydrochloride ( 1 µM) was added to the Krebs solution to prevent the possible 
activation of muscarinic receptors following transmural nerve stimulation. 
Each iris contained, on average, four main arterioles. The iris was cut in half so 
that at least one arteriole was in each preparation. Half an iris was pinned out flat, 
anterior surface uppermost, by pins along the corneal and sphincter edges and along 
both cut edges of the dilator, in a 1 ml recording chamber, the base of which consisted 
of a coverslip coated with silicon resin (Sylgard 184, Dow Corning Corporation, 
Midland, USA). Figure 2.1 shows a diagramatic representation of a typical iris whole 
mount. For experiments examining elevated cyclic AMP, SarSP and capsaicin, the 
sphincter muscle was cut off before pinning out the preparation to prevent movement of 
the preparation, as these drugs cause constriction of the sphincter muscle. Preparations 
were viewed with an inverted compound microscope (Zeiss, Germany). The recording 
chamber was continuously perfused at 3 ml.min-I with carbogenated Krebs solution 
which was maintained at 33 to 34 oc, pH of 7 .4. For experiments involving changes in 
bath temperature, the temperature was continuously monitored using a probe which was 
connected to a digital thermometer (HH7 l thermometer, Omega Engineering Inc., 
Stamford, USA). 
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Figure 2.1 Diagram showing a typical iris whole mount preparation. Box indicates the general site of the arteriole on which experiments were done. 
The preparations were equilibrated for 30 minutes before commencing nerve 
stimulation. Transmural nerve stimulation was applied to the iris preparation via two 
platinum electrodes positioned in the silicon resin, near the iris sphincter and corneal 
edges. Stimulation parameters were: pulse duration 0.1-0.15 ms, 10 Hz for 1 s every 
3 min, 50-60 V or 100 mA. A section of arteriole was chosen, at the site indicated in 
Figure 2.1, where the vessel diameter in the stretched preparation was in the range of 30 
to 50 µm. 
An image of the preparation was visualized on a computer monitor via a camera 
mounted on the side of the microscope (see Figure 2.2). Stimulus-evoked changes in 
arteriolar diamemter were measured using the computer program DIAMTRAK (Neild, 
1989), which uses averaging techniques to locate the edges of the arterioles and records 
their difference as arteriolar diameter. Stimulus-evoked constrictions were recorded on 
a chart recorder for later analysis. When nerve-evoked dilator muscle contractile 
responses were to be measured, the sphincter muscle was cut off from the· iris before 
pinning out the preparation. The cut edge of the dilator was located using DIAMTRAK 
and the nerve-mediated contractions recorded on a chart recorder. 
EXPERIMENTAL PROTOCOLS 
Pharmacological experiments on vasoconstriction following nerve stimulation 
every 3 min 
For each experiment at least 3 consistent constrictions in response to trains of 
stimuli, applied 3 min apart, were recorded before the addition of any drug solution. 
Time controls were performed for all experimental protocols to show that responses 
remained the same for the time period required to perform the experiment. All drugs 
remained in contact with the preparation for at least 4 stimuli (12 min) or were left in, 
for up to 30 min, until the maximal response to the drug was obtained and responses 
became consistent with successive stimuli. Only one concentration of a drug was added 
to each preparation to prevent complications arising from possible desensitization of 
responses. 
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Figure 2.2 Photograph showing the segment of an iris arteriole corresponding to the 
marked site in Figure 2.1. The computer program, DIAMTRAK, uses the yellow dashes 
on the edges of the arterioles to measure arteriole diameter. Separation between 
calibration lines equals 10 µm. 

The a-adrenoceptor antagonist, benextramine, acts by irreversibly alkylating the 
receptor and may also have other reversible actions (Melchiorre et al., 1978; Plotek and 
Atlas, 1983). The effect of benextramine was therefore tested by perfusing the chamber 
with benextramine until the maximal effect on the nerve-mediated responsewas 
achieved and then returning to control Krebs for 10 to 15 min. 
In experiments testing the effect of forskolin in the presence of capsaicin, L-
NAME or D-NAME, these last 3 drugs were present in the Krebs for the entire 
experiment. After 30 min equilibration in the drug and after obtaining 3 to 4 responses 
to nerve stimulation, forskolin was added. 
Exogenous noradrenaline experiments 
The maximum magnitude of the constriction produced by perfused 
noradrenaline after 1 to 3 min of application was expressed as a % of the resting vessel 
diameter prior to the addition of noradrenaline. To investigate the effect of extracellular 
calcium removal on responses to noradrenaline, 3 to 4 control contractions to nerve 
stimulation were obtained before perfusing with calcium-free Krebs. Stimulation of the 
preparation continued until the response to nerve stimulation was gone, indicating that 
the removal of the calcium from the Krebs was effective. At this point noradrenaline 
was perfused in calcium-free Krebs, and the maximal constriction within 1 to 3 min of 
application was expressed as a% of the resting vessel diameter in calcium-free Krebs. 
Capsaicin treatment 
Newborn rats were injected with capsaicin (50 mg.m1-l in 10 % ethanol, 10 % 
Tween 80 in saline) on post-natal days 2, 10 and 17. Animals were visually monitored 
and kept warm until recovery from the injection. This treatment has been reported to lead 
to the long-term loss of substance P-containing nerves from the iris of rats (Hill and 
Vidovic, 1989). Control littermates were injected following the same regime with vehicle 
only. At 6 to 8 weeks of age the rats were killed and both irides removed. Contractile 
responses to trains of stimuli every 3 min and every 15 s were recorded from arterioles 
taken from vehicle- and capsaicin-treated rats. 
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Removal of superior cervical ganglia 
Littermate weaner Wistar rats were anaesthetised (Ketamine hydrochloride 25 
mg.kg- I, Rompen 8 mg.kg-1, i.p.). Rats were laid ventral side up and neck region 
shaven before removing both superior cervical ganglia, via an incision made in the skin. 
The incision was sewn up and the rats were monitored until recovery from the 
anaesthetic. Rats were killed 7-12 days after sur.gery and both eyes removed and used for 
experimental 
in vitro experi1nents. One preparation from each group was processed for catecholrunine 
A 
fluorescence (Faglu , Furness et al, 1978) to demonstrate that the iris was denervated. 
Preparations taken from unoperated age 1natched rats served as controls for these 
ex peri1nen ts. 
Exogenous capsaicin experiments 
The acute effect of capsaicin was studied on untreated rats. Control responses to 
nerve stimulus trains every 3 min and every 15 s were recorded. The preparations were 
then perfused with capsaicin and stimulated every 3 min. When the vasoconstrictor 
responses had returned to precapsaicin levels, the preparations were stimulated with 
trains of pulses every 15 s. Control experiments over comparable time periods showed 
vehicle had no effect on the loss of nerve stimulation with trains of pulses every 15 s. 
Contractile responses in the above experiments were expressed as a % of the resting 
vessel diameter. 
Effect of antagonists on responses to nerve stimulation every 15 s 
The effect of a number of receptor antagonists was tested on the contractile 
response elicited by trains of stimuli every 15 s. Three responses to trains of stimuli 
every 3 min were recorded in control Krebs and 3 min later, six trains of stimuli were 
applied every 15 s. Five min after the last pulse of this stimulus, trains of stimuli 
recommenced every 3 min. When responses to stimulus trains every 3 min were the 
same magnitude as control responses, the antagonist was added and stimulation every 
3 min continued in the presence of the antagonist. 
L-NAME, a pseudo-substrate for NOS; D-NAME, the inactive isomer of L-
NAME; or the CGRP1-receptor antagonist, CGRPg_37; were perfused for 20 min, and 
RP 67580, a NK1-tachykinin receptor antagonist; and L-659877, a NK2-tachykinin 
receptor antagonist; either singly or together, were perfused for 30 min, before 
stimulating with six trains of stimuli every 15 s. 
L-NAME (10 µM) significantly reduced the vessel diameter (80 + 3 % of 
control diameter, n=5, compared with 95 + 2 %, n=3, in the presence of D-NAME, 
unpaired t-test). This occurred within 10 to 15 min after the addition of L-NAME and 
indicated L-NAME was present and effective within the tissue. 
RP 67580 has been shown to be a highly selective competitive antagonist for 
NKt-tachykinin receptors, and at 1 µM is reported to have no cross reactivity with 
NK2- or NK3-tachykinin receptors (Garrett et al., 1991). L-659877 has been similarly 
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shown to be selective for NK2-tachykinin receptors (Maggi et al. , 1991 ; McKnight et 
al., 1991) and was used at 1 µMin this study. 
Intracellular recordings 
Irides for intracellular recording experiments were taken from 3 to 4 week old 
Wistar rats, of either sex, as it was easier to make stable impalements of arterioles taken 
from rats at this age, compared to arterioles from 4 to 5 week old rats. The sphincter 
muscle was cut off before pinning out the iris to assist in the immobilization of the 
arteriole. Experiments were undertaken in an electrically shielded room. Intracellular 
recordings were made using conventional techniques with fine borosilicate glass 
electrodes (1.5 mm O.D x 0.86 mm I.D., Clark Electromedical Instruments, England), 
filled with 0.5 M KCI and having resistances of 100-200 Mil. The earth electrode 
consisted of a covered Ag-AgCl plug attached to a silver wire. 
Membrane potential was measured with an Axoclamp 2A (Axon Instruments, 
Foster City, California, USA). Impalements were achieved by gentle tapping of the 
microelectrode manipulator. Successful impalements were associated with a downward 
deflection on the voltage record. Deflections of less than 40 m V were considered to 
represent poor impalements. Sometimes after a deflection of less than 40 m V the 
membrane potential would continue decreasing over the next few minutes and the 
electrode would "seal" in a cell. Stable intracellular recordings could be maintained for 
up to 2.5 hours. The resting membrane potential was obtained by the difference between 
the potential of the electrode in the cell and the potential when the electrode was 
withdrawn from the cell, and was determined for each impalement. All membrane 
potential records were low-pass filtered with a cut-off frequency of 1 KHz. 
Simultaneous changes in membrane potential and changes in vessel diameter, in 
the region where the cell was impaled, in response to nerve stimulation were stored on 
computer disk for later analysis. 
In one series of experiments the individual responses to 1 to 10 pulses at 10 Hz 
were recorded for cells showing depolarizing responses. In other experiments, the effect 
of a drug on nerve-mediated contraction and depolarization was measured by recording 
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3 to 4 control responses and then changing from the control solution to Krebs 
containing the appropriate concentration of the drug. Throughout all of these 
experiments, the responses to nerve stimulation (10 Hz) were measured every 2 to 
3 min. Drugs were perfused for at least 10 min, or until the maximal effect on the 
contraction and depolarization was recorded. 
DATA ANALYSIS 
Pharmacological experiments on nerve-evoked vasoconstriction 
For each experiment, the 3 to 4 consistent responses to nerve stimulation 
obtained before the addition of a drug were averaged to obtain a mean control response. 
When the effect of a drug was maximal, 3 contractile responses to nerve stimulation 
were averaged and expressed as a % of the control response. For each drug, this % 
value was obtained for a number (n) of preparations from different animals and the 
combined results expressed as a mean ± s.e.m. Some of the drugs tested caused a 
change in resting vessel diameter. In order to standardize for the drug-induced change in 
diameter, in addition to the effects on nerve-mediated contractions, the nerve-mediated 
contractile response in drug solution was expressed as a ratio of the resting vessel 
diameter in drug solution prior to the stimulus, and then as a % of the response in 
control solution, where the latter control contraction was also expressed as a ratio of the 
resting ves~el diameter. In the case of noradrenaline, the maximum magnitude of the 
contractile response was expressed as a % of the resting vessel diameter. 
Intracellular recordings 
The magnitude of the depolarization and the time to maximum depolarization 
from the first pulse of the stimulus were measured. Contractions were analysed for the 
magnitude of the contraction, the time from the first pulse of the stimulus to the onset of 
contraction and the time from the first pulse of the stimulus to peak contraction. The 
maximal effect of a drug on the nerve-evoked depolarization was expressed as a % of 
the nerve-evoked depolarization in control solution. Results are expressed as 
mean + s.e.m. of a number of preparations. 
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Statistics 
Where appropriate, statistical significance of a drug effect was tested using 
Student's t-test. If multiple comparisons were made, an analysis of variance with 95% 
confidence limits was performed to show a difference between treatment groups, 
followed by Student's t-tests with Bonferroni correction for multiple groups. A 
probability, P, of <0.05 was taken as statistically significant. 
The half maximal inhibitory concentration (IC50) for a-adrenoceptor 
antagonists was determined from responses lying between 20 % and 80 % on a fitted 
linear regression. 
IMMUNOHISTOCHEMISTRY 
Freshly dissected irides were stretched, pinned over sylgard and fixed in 
Zamboni fixative (2 % paraformaldehyde, 0 2% picric acid in 0.1 M sodium phosphate 
buffer, pH 7.0) for 1 hat 4 oc. Picric acid was removed by washes in 80% ethanol. The 
whole mounts were then treated with dimethyl sulphoxide (3 x 10 min), washed in 
phosphate buffered saline (PBS), preincubated in PBS containing 0.2% Triton-X and 
7 mg.m1-l carrageenan for 10 min before incubating in rabbit antibodies against SP 
(1:400, Auspep Pty. Ltd., Australia) or CORP (1:600, Milab, Sweden) for visualizing 
sensory nerves, or mouse monoclonal antibodies against tyrosine hydroxy lase ( 1: 10, 
Boehringer-Mannheim) for visualizing adrenergic nerves. Substance P and CORP were 
detected following incubation in FITC-anti-rabbit IgO ( 1: 100, Wellcome) and tyrosine 
hydroxylase following sequential incubation in biotinylated anti-mouse IgO (1 :200, 
Vector Labs) and Texas Red conjugated to streptavidin (1:200, Amersham). Irides were 
also fixed overnight before sectioning on a cryostat at 10-µm. Sections were stained as 
above with the antibody for substance P (1:1500) and the antibody against tyrosine 
hydroxy lase (1 :40). 
Preparations were mounted in buffered glycerol and viewed with an Olympus 
BH microscope with appropriate blue and green filter combinations (barrier filters 530 
and 610 nm respectively) or with a Leica TCS-4D confocal microscope fitted with 
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Photographs were taken using Ektachrome 160 ASA film in camera mounted on Olympus 
microscope. Reconstructed confocal images were stored as PICT files and photographs 
developed by the Photography Unit at John Curtin School of Medical Research. 
Omnichrome Krypton laser. No fluorescent structures were seen in preparations for 
which the primary antibodies were omitted, or in preparations exposed to primary 
antibody solutions which had been previously incubated at 4 °c overnight with the 
appropriate antigen. 
REVERSE TRANSCRIPTION · POLYMERASE CHAIN 
REACTION (RT-PCR) 
RNA isolation 
Total cellular RNA was extracted from freshly dissected iris tissue using a 
single-step protocol for RNA isolation ('RNAzol B', Cinna/Biotecx). Both the sphincter 
-
muscle and the ciliary processes were dissected from the iris, leaving the dilator muscle 
and stroma. The manufacturer's recommended protocol for isolation of RNA was 
followed. Briefly, tissue was collected into RNAzol solution, homogenized at room 
temperature and the homogenate separated into two phases. The RNA was precipitated 
from the aqueous phase with isopropanol and the RNA pellet dissolved in water. 
Optical density readings were made to estimate the total amount of RNA before it was 
used in reverse transcription-polymerase chain reaction (RT-PCR). 
Oligonucleotide primers 
Oligodeoxynucleotide primers for the 3 tachykinin receptors for use in RT-PCR 
were synthesized using an Applied Biosystems Model 380B Nucleic Acid Synthesizer 
and solid phase synthesis. At the time of these experiments, CORP receptors had not 
been sequenced and so their expression could not be investigated. Oligonucleotides for 
the rat NK1 -tachykinin receptor were designed from published sequences of cDNA 
isolated from rat brain cDNA library (Yokota et al., 1989); the forward primer 5'-
CACGGTCATCGTGGTGACTTCCGT-3' and reverse primer 5'-
ACAGTGTACGCGTAGCCGATCACC-3' were used to generate a 537 base pair 
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fragment. The cDNA sequence for the rat NK.2-tachykinin receptor, derived from RNA 
isolated from the rat stomach (Sasai and Nakanishi, 1989), was used to design the 
forward 5'-ATCAACCTGGCCTTGGCGGACCTC-3' and reverse primer 5'-
ATGACACTGTAAGCCCCGAACATC-3' which generated a 443 base pair fragment. 
For the NK3 -tachykinin receptor, the forward primer 5'-
GCAGTCTTCGGAAACCTCATCGTT-3' and reverse primer 5'-
CAGTACACCAGGATGATCACAATG-3' were designed from the sequence obtained 
from rat brain cDNA (Shigemoto et al., 1990) and generated a 476 base pair fragment. 
The three sets of primers were designed to span intrans to avoid false positives 
being generated from the RT-PCR due to any genomic DNA present in the extracted 
RNA. The ability of the primer sets to amplify the appropriate message was tested by 
using cDNA reverse-transcribed from RNA isolated from the rat cerebral cortex. A 
cDNA fragment of the predicted size was generated by each set of primers. 
RT-PCR 
RNA (3.3 µg) was reverse transcribed w1th oligo dT (100 ng.µ1-l) or random 
primer (100 ng.µ1-l). Samples were incubated for 10 min at 65 oc, cooled at room 
temperature and the following reagents added: 5 µl lOX first strand buffer, 1 µl RNase 
block, 2 µl 25 mM dNTP and 1 µl reverse transcriptase (StrataScript RNase H-, 
50 U/µl). rJle reaction was carried out in a volume of 50 µland 2 µl from this cDNA 
pool was used in each PCR reaction using either the NK1-, NK2- and NK3-tachykinin 
receptor primers. 
The reaction mixture for the PCR comprised 10 mM Tris-HCl, pH 9, 50 mM 
KCl, 1.5 mM MgCl2, 0.01 % gelatin, 0.1 % Triton X-100, 200 µM of each of the 
deoxyribonucleoside triphosphates (dNTPs) dATP, dCTP, dGTP and dTIP, 20 pmole 
of forward and reverse primer and 0.2 U Supertaq DNA polymerase per 20 µl reaction 
(P.H. Stehelin and Cie, Ag, Basel, Switzerland). Samples were heat sealed and 30 
cycles of PCR carried out in a capillary tube thermal cycler (Corbett Research, Sydney, 
Australia). The first cycle consisted of denaturation at 94 oc for 1 min, annealing at 
63 °c for 1 min, and extension at 72 oc for 1 min, the remaining cycles consisted of 
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94 oc for 10 s, 63 oc for 10 s and 72 °c for 59 s. The amplification products were 
separated in 2 % agarose gel, stained with ethidium bromide and visualized using 
UV light. 
AUTORADIOGRAPHY 
Freshly dissected iris whole mounts were stretched on glass slides, which had 
been coated with a 2 % solution of 3-aminopropyltrithoxysilane, air dried and stored 
frozen at -70 oc until used. Iris tissue was frozen rapidly in mounting medium (CryO-
M-bed, Bright Instrument Company Limitied, Huntingdon, England) and 10 µm 
sections cut on a cryostat, thaw mounted onto coated slides and stored dry at -70 oc. 
For labelling with [125_J]-Bolton-Hunter-[Sar9, Met(02)l l ]SP (BHSarSP), 
slides were preincubated in 3 x 5 min washes of 50 mM Tris-HCl buffer containing 
0.02 % bovine serum albumin (BSA, pH 7 .4, 25 OC). Slides were then incubated at 
25 oc for 60 min in 50 mM Tris-HCl buffer containing 0.02 % BSA (pH 7.4, 25 OC), 
3 mM MnCl2, 1 µM phosphoramidon and 4 µg.mi-1 chymostatin at pH 7.4 with 75 pM 
BHSarSP. Non-specific-binding was determined on some slides by co-incubating with 
1 µM unlabelled [Sar9, Met(02)ll]SP (SarSP). 
For [ 1251]-CGRP labelling, slides were preincubated in 2 x 5 min washes in 
50 mM Tris-HCl buffer containing 0.02 % BSA (pH 7 .4, 25 OC) followed by a third 
5 min wash in the same buffer containing 40 µg.m1- l bacitracin. Slides were then 
incubated for 60 min in 50 mM Tris-HCl buffer containing 0.02 % BSA (pH 7 .4, 
25 °C), 100 mM NaCl, 1 µM phosphoramidon, 40 µg.m1-l bacitracin, 4 µg.m1- l 
chymostatin and 60 pM [1251]-CGRP (pH 7.4, 25 OC). Non-specific binding was 
determined on some slides by co-incubation with 1-µM CORP. 
After incubation, all slides were washed ( 4 x 4 min for sections; 3 x 10 min for 
whole mounts) in 50 mM Tris-HCl buffer (pH 7 .4 at 4 OC) containing 0.02 % BSA, 
fixed in ice-cold 4 % paraformaldehyde in phosphate buffered saline (PBS), rinsed in 
ice-cold distilled water and dried rapidly. Labelled slides were dipped into liquid 
photographic emulsion (LM-1, Amersham) at 42 oc and allowed to expose in the dark 
at 4 °c for 13 days (BHSarSP) or 8 days ([ 1251]-CGRP). Slides were then developed 
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( developer from Kodak, Australasia), stained with pyronin (pH 7 .4) and viewed using 
light and dark field microscopy (Burcher et al., 1986). Adjacent sections were stained 
with haematoxylin and eosin. 
MATERIALS 
Drugs 
The following drugs were purchased commercially: 
isethionic acid, sodium salt (Acros Organics, New Jersey, USA); caffeine (Ajax 
Chemicals, Sydney Australia); CGRPt-37 (rat), CGRP8-37 (rat), [Sar9, Met (02)11 ]-
substance P (Auspep, Melbourne, Australia); capsaicin (Fluka Chemie, Switzerland); 
-paraformaldehyde (ICN Biomedical, USA); mecamylamine hydrochloride (Merck, 
Sharp and Dome, South Granville, NSW, Australia); chloroethylclonidine (CEC), L-
659877, phenylephrine hydrochloride, [2-(2,6-dimethoxyphenoxyethyl)-minomethyl-
1,4-benzodioxane] (WB4101) (Research Biochemicals International, Natick, USA); 
dideoxyadenosine, ~-nitro-D-arginine methyl ester hydrochlorid~ (D-NAME), ~-
nitro-L-arginine methyl ester hydrochloride (L-NAME) (Sapphire Bioscience Pty Ltd, 
Sydney, Australia); (-)-arterenol bitartrate (noradrenaline), bacitracin, benextramine 
tetrachloride, captopril, cholera toxin, chymostatin, N6 ,2'-0-dibutyryladenosine 3 ':5'-
cyclic monophosphate (dibutyryl cyclic AMP), dantrolene sodium salt, diltiazem 
hydrochlo~de, forskolin, flufenamic acid, hexamethonium chloride, (-)-hyoscine 
(scopolamine) hydrochloride, 3-iso-butyl-1-methyl-xanthine (IBMX), nifedipine, 
phosphoramidon, prazosin hydrochloride, thapsigargin, verapamil hydrochloride, 
yohimbine hydrochloride (Sigma Chemical Co, St Louis, USA). 
RP 67580 was kindly supplied by Rhone-Poulenc Rorer, France. All other 
reagents and chemicals were of analytical grade. 
Drug solutions 
dail All drugs were ·made up J 1000 times stocks. Stock solutions for capsaicin 
A 
{10 mM), flufenamic acid (250 mM), forskolin (50 mM), IBMX and nifedipine (1 mM)O mM) 
were dissolved in absolute alcohol. Noradrenaline (10 mM) stock was dissolved in 2 % 
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ascorbic acid. Prazosin was dissolved in methanol ( 10 % volume) and made up to 
volume with water. RP 67580 .was dissolved in 5 µM methanesulfonic acid, L-659877 
was dissolved in 0.05 % dimethylformamide. Control experiments using Krebs 
containing 1 part per 1000 of diluent showed there was no effect of any of these 
diluents on arteriolar responses. 
Caffeine and dibutyryl cyclic AMP were dissolved directly into Krebs by 
stirring and gentle heating. All other drugs were dissolved in deionized distilled water 
as stock solutions (1000 x). 
Peptides were dissolved in deionized distilled water, aliquoted and stored at 
-20 oc until used. Concentrated solutions of peptides used for autoradiography 
(500 µM) were stored in 10 mM acetic acid (containing 1 % 8-mercaptoethanol) at 
-20 oc until use. 
All stock solutions of drugs were diluted into Krebs to give the appropriate bath 
concentration. Solutions of light-sensitive drugs were protected from light using 
aluminium foil and illuminating preparations with only long wavelength (>610 nm) 
light. 
For calcium-free Krebs, the calcium was omitted from the Krebs. For low 
chloride experiments, the NaCl in the Krebs was replaced with an equimolar quantity of 
sodium methyl sulfate or sodium isethionate. For 50 mM KCl, the NaCl concentration 
in the Krebs was reduced by the corresponding equimolar amount. 
[1251] Bolton Hunter reagent was purchased from Amersham, U.K. The radioligands 
were prepared by Mr. J. Strigas as previously described (Burcher et al, 1986). 
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CHAPTER 3. 
SYMPATHETIC V ASOCONSTRICTION 
INTRODUCTION 
Activation of sympathetic nerves plays an important role in the regulation of 
arterial resistance and blood flow (Osswald and Guimaraes, 1983). The terminal regions 
of sympathetic axons bear small swellings, or varicosities, in which noradrenaline is 
stored (Gordon-Weeks, 1988). Electron microscopical studies of reconstructed serial 
sections of blood vessels have shown synaptic neuroeffector specializations where 
varicosities come into close contact with the smooth muscle (Luff and McLachlan, 
1989). Neurotransmitter released by sympathetic nerve stimulation is proposed to act 
upon synaptic receptors, whereas circulating catecholamines act upon extrajunctional 
receptors (Hirst et al., 1992). 
Pharmacological studies on nerve-mediated contractile responses of arteries 
have illustrated differences in the receptors(s) mediating constriction in different 
vessels. Postjunctional a 1-adrenoceptors are activated by noradrenaline released from 
sympathetic nerves to produce vasoconstriction in vessels such as the pulmonary artery 
(Suzuki, 1983) and the immature rat mesenteric artery (Hill, Hirst and van Heiden, 
1983), while a2-adrenoceptors reportedly mediate neurogenic vasopressor responses in 
cutaneous vessels (Flavahan et al., 1984; Medgett and Ruffolo, 1987). Specialized 
junctional y-adrenoceptors have been implicated in nerve-mediated responses in vessels 
such as the rat basilar artery (Hirst, Neild and Silverberg, 1982), the rat mesenteric 
artery (Hill, Hirst and van Heiden, 1983) and the vasculature of the rabbit hindlimb 
(Hirst and Lew, 1987). Other proposed mediators of sympathetic vasoconstriction 
include NPY or ATP, both of which have been implicated as sympathetic nerve co-
transmitters with noradrenaline (Hanko et al., 1986; Bumstock, 1972). 
Activation of junctional y-adrenoceptors produces excitatory junction potentials, 
which summate upon repetitive nerve stimulation to cause the opening of voltage-
dependent calcium channels for the influx of calcium and vasoconstriction (Hirst and 
52 
Edwards, 1989). Only small membrane potential changes are, however, associated with 
a-adrenoceptor mediated constriction of the rat tail artery (Cheung, 1984 ). 
Furthermore, as the constriction precedes the slow depolarization for this a-
adrenoceptor mediated response, it has been suggested that the calcium required for a-
adrenergic contraction is released from intracellular or membrane-bound calcium stores 
(Hirst and Edwards, 1989). 
The iris of the albino rat has a relatively rich vascular supply (Bill and Nilsson, 
1985). The iris arterioles have a plexus of catecholamine-containing nerve fibres over 
their surfaces (Olson et al., 1988). This chapter describes the sympathetic 
vasoconstriction of these iris arterioles to firstly, characterize pharmacologically the 
synaptic receptor type and secondly, to identify the source of calcium responsible for 
the constriction. 
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RESULTS 
General observations 
The main arterioles of the iris project at an angle from the ciliary edge out 
towards the sphincter before bending and returning to the ciliary edge (Figure 2.1). 
Smaller vessels arise from these arterioles and these give rise to capillaries which 
ultimately feed into radially collecting venules. The venules of the iris were generally of 
greater diameter than the arterioles and did not respond to nerve-stimulation. The 
vessels described in this thesis can been identified morphologically as arterioles, as 
defined by (Rhoden, 1967), as the vessel wall contains only a single layer of smooth 
muscle cells (S. Sandow, personal communication, 1995). 
In all preparations, the arteriole showed some degree of pulsatile activity after 
the 30 min equilibration period, as observed by the rhythmic movement of red blood 
cells. In some preparations the arterioles showed regular spontaneous contractions (with 
a frequency of between 0.07 and 0.1 Hz). The venules showed no spontaneous activity. 
The in vitro experiments were undertaken on arterioles in stretched preparations 
of iris. The diameter of these arterioles was between 20 to 40 µm. From observations of 
these arterioles at the ultrastructural level (S. Sandow, personal communication, 1995) 
it can be estimated that the measured diameter in stretched preparations would be 
approximately 20 % greater than the actual diameter in vivo. 
As the arterioles project away from the ciliary body they become smaller in 
diameter. When the arteriolar diameter was less than approximately 20 µm the arteriole 
did not usually respond to nerve stimulation. Sphincters were frequently detected at the 
sites of origin of the smaller side branches from the main arteriole. Nerve stimulation 
caused these sphincters, and sometimes a short (5 µm) segment of the side branch, to 
constrict down to occlude blood flow down the side branch. 
Response evoked by transmural sympathetic nerve stimulation 
Transmural electrical stimulation (10 Hz, 1 s every 3 min) produces a consistent 
constriction of iris arterioles. Tetrodotoxin (1 µM; n=3) abolished these constrictions 
(Figure 3.1), indicating they were due to nerve stimulation (Adams and Swanson, 1994) 
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Figure 3.1 Chart recording showing the effect of tetrodotoxin (1 µM) on the nerve-mediated constriction of an iris arteriole. Dots indicate the onset of 
nerve stimulation ( 10 Hz, I s). 
and not a result of direct muscle stimulation. Arterioles taken from rats killed 7 to 
12 days after surgical removal of both superior cervical ganglia (SCG) showed no 
constriction in response to transmural nerve stimulation, although a long, slow 
vasodilatation was recorded in these arterioles (Figure 3.2 B). Nerve-mediated 
constrictions were recorded from iris arterioles taken from littermate control rats 
(Figure 3.2 A) and these were sometimes followed by long, slow vasodilatation although 
J 
less often than in preparations from denervated animals (Table 3.1). Thus, nerve-
evoked constriction of iris arterioles appear to be due to the activation of sympathetic 
nerves projecting to the iris from the SCG. 
Effect of a-adrenoceptor antagonists on sympathetic vasoconstriction 
The nerve-mediated constriction of iris arterioles was abolished by the 
irreversible a-adrenoceptor antagonist, benextrarnine (10 µM, n=3; Figure 3.3). The 
loss of response was maintained after washout with control Krebs (Figure 3.3), 
indicating that the constriction resulted from the activation of an cx-adrenoceptor. 
Concentration-response curves were constructed for the cx1-adrenoceptor 
preferring antagonist, prazosin, and the a 2-adrenoceptor preferring antagonist, 
yohimbine. Prazosin (half maximal inhibitory concentration = IC50 = 0.74 nM) was 
more potent in inhibiting the nerve-mediated vasoconstriction than yohimbine 
(IC50 = 260 nM; Figure 3.4), indicating that the response was due to the activation of 
an a1-adrenoceptor. The a-adrenoceptor antagonist, WB4101 showed an IC50 of 
14 nM (Figure 3.4). 
Effect of Chloroethylclonidine (CEC) on vasoconstriction 
CEC inhibited the nerve-mediated contraction of iris arteroles (Table 3.2), 
suggesting the involvement of ex IB-adrenoceptors. 
A postjunctional action of CEC was confirmed by studying vasoconstriction to 
noradrenaline. Perfusion of the bath with noradrenaline produced a concentration-
dependent arteriolar constriction (Figure 3.5 A). Noradrenaline (1 µM; n=3) produced a 
constriction which was not significantly different from that produced by nerve-
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A. Chart recording showing the response to nerve stimulation of an iris arteriole taken 
from a control littermate. 
B. Representative chart recording showing the response to nerve stimulation of an iris 
arteriole taken from a rat 7 to 12 days after the surgical removal of both SCGs. 
Dots indicate the onset of nerve stimulation (10 Hz, 1 s every 3 min). 
Table 3.1 
Quantitation of vasodilatation measured after nerve-stimulation in litter-matched control unoperated and double-denervated animals. 
Animal group 
Control unoperated (12) 
Double denervation (11) 
( ) indicates number of ani1nals in each group. 
Values are expressed as 1nean + s.e.m. 
Total# of 
preparations 
21 
29 
#of Magnitude of vasodilation 
preparations ( % resting vessel diameter) 
showing 
vasodilatation l 
-6 5.0 + 0.8 % 
21 8.4 + 2.4 o/o 
Control Benextramine (10 µM) Washout 
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Figure 3.3 Traces showing the nerve-evoked contractile responses of an iris arteriole in control Krebs, in the presence of benextramine ( 1 µM) and 
after washout of benextramine. Dots indicate the onset of nerve stimulation ( 10 Hz, 1 s ). 
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Figure 3.4 Average nerve-mediated vasoconstriction of iris arterioles in the presence 
of prazosin (squares; n=3), WB4101 (triangles; n=5) and yohimbine (circles; n=5) 
expressed as a o/o of the control response. Each concentration of antagonist was in 
contact wtih the preparation for at least 20 minutes. Points represent the mean + s.e.m. 
for the number of preparations as indicated. 
Table 3.2 
Effect of CEC on nerve-evoked contraction of iris arterioles . 
Concentration Nerve-Mediated Contractile Response 
(µM) ( % Control Contractile Response) 
Mean + S.E.M. n 
1 80+8 % 5 
3 36 + 11 % 9 
10 4+2% 12 
Results are expressed as a o/o of the contractile response in control Krebs for each preparation. 
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Figure 3.5 Iris arteriolar responses to nerve stimulation and noradrenaline. 
A. Arteriolar constriction produced by different concentrations of noradrenaline. 
B. Control arteriolar contractile responses are shown as an average of 3 contractions 
produced by nerve stimulation (NS) or as the maximal constricted diameter recorded 
within 3 min contact with noradrenaline (NA; 1 µM). After returning to control 
solution, CEC (10 µM) was added to the bath and 15 min later, when the response to 
nerve stimulation was blocked (CEC, NS), NA ( 1 µM) was added (CEC, NA). 
Columns represent the mean and s.e.m. (vertical bars) of 3 to 4 preparations. 
* indicates significantly different from NA response in the absence of CEC (t-test with 
Bonferroni correction for Figure 3.5 B). 
stimulation (Figure 3.5 B). When CEC (10 µM) had abolished the nerve-mediated 
vasoconstriction, the constriction produced by noradrenaline ( I µM) was significantly 
reduced (n=3; Figure 3.5 B). Time controls showed that a second exposure to 
noradrenaline ( 1 µM) produced a constriction not significantly different from the 
constriction produced by the first exposure to noradrenaline ( 1 µM; results not shown). 
CEC therefore inhibited · both nerve-mediated vasoconstriction and constriction 
following applied noradrenaline, indicating a postjunctional site of action on a lB-
adrenoceptors. 
Effect of voltage-dependent calcium channel antagonists 
Nerve-mediated arteriolar constrictions were not abolished by the L-type 
voltage-dependent calcium channel antagonists, nifedipine (1 µM; n=3), diltiazem 
(1 µM; n=5) or v·erapamil (1 µM; n=ll; Figure 3.6). Verapamil (1 µM) caused a small, 
but significant (P<0.05, paired t-test), reduction of the nerve-mediated· vasoconstriction 
(Figure 3.6). 
Involvement of intracellular calcium 
Experiments were undertaken in calcium-free Krebs to determine the role of 
intracellular calcium in arteriolar constriction produced by perfusing the bath with 
noradrenaline. In control Krebs, noradrenaline ( 10 µM) produced a significantly 
(P <0.05, paired t-test) greater vasoconstriction than that produced by nerve-stimulation 
(n=4; Figure 3.7 A). In the presence of calcium-free Krebs, the nerve-mediated 
vasoconstriction was abolished and the addition of noradrenaline ( 10 µM) produced a 
constriction of the arteriole which was not significantly different to the constriction 
produced in control Krebs (n=4; Figure 3.7 B). 
The contribution of intracellular calcium release to nerve-mediated constriction 
of iris arterioles was further investigated using caffeine, which releases a subpopulation 
of intracellular calcium stores (Lipscombe et al., 1988) and may activate the ryanodine 
receptor and inhibit the inositol trisphosphate (IP3) receptor (Ehrlich et al, 1994), 
dantrolene, which inhibits ryanodine-sensitive calcium-induced-calcium-release in 
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Figure 3.6 Effect of the L-type calcium channel antagonists nifedipine (1 µM; n=3), 
diltiazem (1 µM; n=5) or verapamil (1 µM ; n= 11) on the arteriolar contractile response 
to nerve stimulation. Results are expressed as a % of the contractile response in control 
Krebs. Control bar represents the variability of the control response in all the 
preparations (n= 19). Each column represents the mean and s.e.m. ( vertical bars) of the 
number of preparations indicated. * indicates differs significantly from control 
(P<0.05). 
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Figure 3. 7 Arteriolar contractile responses to the perfusion of noradrenaline ( 10 µM) 
in the presence and absence of extracellular calcium. A. Control arteriolar contractile 
response is shown as an average of 3 contractions produced by nerve stimulation (NS). 
Perfusion of the preparation with noradrenaline (NA, 10 µM) constricted the arteriole. 
B. An average of 3 contractile responses to NS were recorded before perfusing the 
preparation with calcium-free Krebs. When the contractile respon e to NS was gone 
(Low Ca++, NS), NA (10 µM) wa added (Low Ca++, NA). 
Each column represents the mean and s.e.m. of 4 preparations. 
* indicates significantly different from NS (t-test with Bonferroni correction for Figure 
3.7 B). 
skeletal muscle and longitudinal muscle of the intestine (Kuemmerle, Murthy and 
Makhlouf, 1994 ), and thapsigargin, which inhibits the calcium-ATPase pump 
responsible for the uptake of calcium into intracellular stores (Thastrup et al., 1990). 
Caffeine (1 mM) inhibited nerve-mediated vasoconstriction (n=4; Table 3.3). 
The solubility of dantrolene restricted the maximum concentration at which it could be 
perfused through the bath to 100 µM. There was no significant difference in the nerve-
mediated vasoconstriction in the presence of dantrolene at 10 µM (n=5) compared to 
100 µM (n=4; unpaired t-test, Table 3.3), suggesting that a 40 % reduction in 
vasoconstriction may be the maximum effect of this drug. 
Thapsigargin (2 µM) reduced the nerve-mediated vasoconstriction to 
61 + 11.3 % of control (n=3; Figure 3.8). An additional effect of thapsigargin is to 
increase calcium influx (Thastrup et al., 1989) into cells through voltage-insensitive 
calcium channels (Zweifach and Lewis, 1993) which may be inhibited by high 
concentrations of verapamil (Hughes et al., 1986). In the presence of verapamil (1 µM), 
thapsigargin (2 µM) abolished nerve-mediated vasoconstriction (n=4; Figure 3.8). This 
suggests that in iris arterioles, calcium influx through verapamil-sensitive calcium 
channels may refill thapsigargin-sensitive intracellular calcium stores, a mechanism 
which has previously been described (Takemura et al., 1989). Such an effect could not 
account for the incomplete inhibitory effect of dantrolene, since the nerve-mediated 
response in the presence of dantrolene (0.1 mM) and verapamil (1 µM; n=4) was not 
significantly different than the response in the presence of dantrolene (0.1 mM) alone 
(n=4; Figure 3.8). 
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Table 3.3 
Effect of caffeine and dantrolene on nerve-evoked contractions of iris arterioles. 
Drug Nerve-Mediated Contractile Response 
(µM) ( % Control Contractile Response) 
Mean + S.E.M. n 
Caffeine 
10 87.0 + 6.0 4 
100 60.4 + 9.8 5 I 
1000 0.0 + 0.0 4 
Dantrolene 
1 100.1 + 2.4 3 
10 77 .2 + 8.2 5 
100 60.8 + 8.2 4 
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Figure 3.8 Effect of a combination of a L-type calcium channel antagonist, verapamil 
(Verap ), and an intracellular calcium mobilizer, thapsigargin (Thaps) or dantrolene 
(Dant), on nerve stimulated arteriolar contractile response. Control bar represents the 
variability of the response in control Krebs in all of the preparations examined (n= 15). 
Treatment are (left to right): Verap (1 µM; n=8), Thaps (2 µM; n=3), Verap (1 µM) 
then addtion of Thaps (2 µM ; n=4), Dant (0.1 mM; n=4), Verap (1 µM ) then addition of 
Dant (100 µM ; n=4). Each column represents the mean and s.e.m. (vertical bar) of the 
number of preparations indicated in parenthesi . # indicates significantly different from 
thapsigargin alone (P<0.05). 
DISCUSSION 
Transmural stimulation of the sympathetic nerves which project to the iris from 
the SCG produces a vasoconstriction of the iris arterioles. These experiments were 
undertaken in the presence of hyoscine to prevent parasympathetic, cholinergic 
responses. The results of this chapter indicate that this vasoconstriction was due to the 
activation of a1B-adrenoceptors and the mobilization of intracellular calcium. These 
arterioles are therefore unusual, as the sympathetic nerve-mediated responses of most 
arterial vessels involves non-a-adrenoceptor mediated mechanisms (Hirst and 
Edwards, 1989). 
The nerve-mediated constriction of iris arterioles was abolished by the a-
adrenoceptor antagonist, benextramine, indicating the response was due to the 
activation of an a-adrenoceptor. Five major subtypes of adrenoceptors have been 
characterized, a.1, a.2, 81, 82 and 83 (Watson and Girdlestone, 1994). Subtypes of each 
have been identified pharmacologically and more recently by molecular cloning of the 
cDNA or gene for each subtype (Bylund et al., 1994; Strasser, Thl-Vahl and Marquetant, 
1992). The greater sensitivity of the nerve-mediated iris arteriolar constriction to the 
a 1-adrenoceptor selective antagonist, prazosin, than the a.2-adrenoceptor antagonist, 
yohimbine, implicated activation of an a.1-adrenoceptor (Bylund et al., 1994). 
The heterogeneity of a 1-adrenoceptor subtypes was suggested initially by 
functional studies on adrenoceptor responses (for example see MCGrath, 1982), and by 
radioligand binding studies (Morrow and Creese, 1986). The literature regarding the 
characterization of a.1-adrenoceptors has been quite confusing in the past few years, 
however at present the consensus is that three native a 1-adrenoceptors have been 
identified: O.lA, O.lB and a.10 (Hieble et al., 1995). In addition, a.1-adrenoceptors are 
proposed to show a high (a1H) or a low (a.IL) affinity for prazosin (Flavahan and 
Vanhoutte, 1986). Oshita et al. (1992) suggested that the native receptors belong to the 
a lH-group of adrenoceptors. 
A number of receptor antagonists distinguish between a.1-adrenoceptor 
subtypes. It was originally demonstrated that CEC inactivates a subpopulation of a 1-
adrenoceptors, and that the CEC-sensitive and -insensitive receptors correlated with 
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WB4101-insensitive and -sensitive receptors, which were designated a1B- and a1A-
adrenoceptors respectively (Minneman, Han and Abel, 1988). Since then it has been 
determined that the a-adrenoceptor antagonist, WB4101, is more than 1 O times less 
potent on a1B-adrenoceptors (affinity 7-8) than on CllA- or a10-adrenoceptors 
(affinity 9-10; Hieble et al., 1995; Bylund et al., 1994). The order of sensitivity to 
inactivation of a1-adrenoceptors by CEC is a1B- being most sensitive, a10- being 
less sensitive and a lA-adrenoceptor being relatively insensitive (Hieble et al., 1995; 
Bylund et al., 1994). The receptor antagonists 5-methylurapidil (affinity 9), (±)-
niguldipine (affinity 9-10) and SNAP, each show 30- to 100-fold more selectivity for 
the a lA-adrenoceptors than the other two subytpes (Bylund et al., 1994). More 
recently, the receptor antagonists BMY 7378 and SK&F 105854 have been 
demonstrated to show· 50- to 100-fold more selectivity for the a 10- than the a1A- or 
a1B-adrenoceptor subytpes (Hieble et al., 1995). The low sensitivity of the nerve-
mediated constriction of iris arterioles to WB4101 (IC50 of 14 nM), and the abolition of 
the neurogenic response by CEC are indicative of activation of an a1B-adrenoceptor. 
Recently, an additional presynaptic a2-adrenoceptor agonist effect of CEC has 
been described (Bultmann and Starke, 1993). Such an effect would reduce 
neurotransmitter release and hence reduce nerve-mediated constriction. In the present 
study, however, the arteriolar nerve-mediated vasoconstriction was less sensitive to 
CEC than was the effect on neurotransmitter release as previously reported; in the vas 
deferens, 1 µM CEC reduced ~eurotransmitter release by 80 % (Bultmann and Starke, 
1993), but at this concentration CEC only reduced the arteriolar vasconstriction by 
20 %. Thus the sensitivity of CEC in the present study is more consistent with the 
higher concentrations reported to inactivate a lB-adrenoceptors. Furthermore, it was 
confirmed that CEC does have a postsynaptic effect on iris arterioles, by demonstrating 
that CEC abolished the vasoconstriction produced by exogenous noradrenaline. 
It has been demonstrated using RT-PCR that the iris tissue, which comprises 
both dilator muscle and iris arterioles but not the sphincter muscle, expresses only 
mRNA for the cloned a 1 b- (cloned by Cotecchia et al., 1988) and a lc-adrenoceptor 
(cloned by Schwinn et al., 1990) subtypes (Gould, Vidovic and Hill, 1995). According 
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to the lastest concensus on a1-adrenoceptor nomenclature (Hieble et al., 1995), the two 
receptor subtypes detected in this tissue correspond to the native a 1 B- and a lA-
adrenoceptor subtypes respectively. The sensitivity of the nerve-mediated 
vasoconstriction to CEC indicates that the receptor is not an a lA-adrenoceptor. Thus 
this mRNA expression confirms the pharmacological identification of the a lB-
adrenoceptor as mediating sympathetic vasoconstriction in iris arterioles. 
Smooth muscle contraction occurs as a result of an increase in intracellular 
calcium (Hirst and Edwards, 1989). It was originally proposed that the pathway for 
increasing intracellular calcium following a 1-adrenoceptor activation was subtype-
specific (Han, Abel and Minneman, 1987; Minneman, 1988). Alpha1A-adrenoceptor 
activation was associated with calcium influx through G-protein coupling to voltage-
dependent calcium channels, while a 1 B-adrenoceptors coupled to the G-protein 
activation of phospholipase C and the release of intracellular calcium through the 
production of IP3 (Minneman, 1988). Consistent with this, the a lA-adrenoceptor-
mediated component of vasoconstrictor responses to periarterial nerve-stimulation in 
-
the rat kidney is abolished by dihydropyridines (Blue Jr., Vimont and Clarke, 1992). 
However, all three expressed, cloned a 1-adrenoceptor subtypes may couple to 
IP3-mediated increase intracellular calcium (Perez, De Young and Graham, 1993; Han, 
Esbenshade and Minneman, 1992; Schwinn et al., 1991). In addition, from receptor 
expression studies in cell lines, it has been demonstrated that activation of the a lB-
adrenoceptor subtype may activate several distinct effector pathways. For instance, 
activation of a lB-adrenoceptors in COS-1 cells causes an accumulation of IP3, an 
increase in cyclic AMP and an increase in arachadonic acid levels (Perez, De Young and 
Graham, 1993). The adrenaline-stimulated a1B-adrenoceptor-mediated arachadonic 
acid release was abolished by dihydropyridines but the increase in IP3 was not (Perez, 
De Young and Graham, 1993). 
Studies in cell lines (Schwinn et al., 1991) and isolated tissue (Burt, Chapple and 
Marshall, 1995) have demonstrated that the activation of a1B-adrenoceptors leads to 
the mobilization of intracellular calcium and the influx of calcium through voltage-
insensitive calcium channels. L-type voltage-dependent calcium channel blockers did 
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not abolish nerve-mediated vasoconstriction of iris arterioles, although the intracellular 
calcium mobilizer caffeine did not abolish the response. The constriction produced by 
exogenous noradrenaline was also independent of extracellular calcium. These results 
suggest that the contraction of iris arterioles is dependent on the release of intracellular 
calcium and the influx of calcium through voltage-dependent calcium channels was not 
essential for the initiation of arteriolar constriction. 
Dantrolene inhibits ryanodine-sensitive calcium channels (Kuemmerle, Murthy 
and Makhlouf, 1994 ). These stores demonstrate calcium-induced-calcium-release 
(Ehrlich et al., 1994). Dantrolene produced a 40 % decrease in the nerve-mediated 
vasoconstriction and the presence of verapamil did not alter the magnitude of the 
inhibitory effect of dantrolene on the contractile response. Caffeine totally abolished the 
neurogenic contractile response. In addition to inducing intracellular calcium release 
(Endo et al., 1990), caffeine activates the ryanodine receptor-calcium release channel in 
skeletal muscle and has an inhibitory effect on the IP3 receptor in excitable and non-
excitable cells (Ehrlich et al., 1994). IP3-induced calcium release is inhibited by 
caffe~ne in smooth muscle cells of the rat portal vein (Loirand, Gregoire and Pacaud, 
1994). Therefore, in iris arterioles, the release of intracellular calcium from caffeine-
sensitive stores following a lB-adrenoceptor activation appears to activate calcium-
induced intracellular calcium release, which contributes some calcium for the arteriolar 
contraction. Such a mechanism for calcium propagation occurs in cultured vascular 
smooth muscle cells, where IP3-induced release of calcium spreads through the cell to 
activate calcium-induced calcium release (Blatter and Wier, 1992). 
Measurements of calcium in the smooth muscle cell line, DDT1, have shown 
that noradrenaline induced a biphasic response comprising a transient component, 
which was dependent on intracellular calcium, and a sustained component, which was 
dependent on extracellular calcium (Han, Esbenshade and Minneman, 1992). CEC 
abolished both of these components and also eliminated IP3 responses to noradrenaline. 
This, and other pharmacological data, suggested that the DDT1 cell line contained 
exclusively the UlB-adrenoceptor subtype (Han, Esbenshade and Minneman, 1992). 
While the activation of a 1 B-adrenoceptors in these cells may lead to the influx of 
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extracellular calcium, this does not occur through voltage-sensitive calcium channels 
(Reynolds and Dubyak:, 1985; Burt, Chapple and Marshall, 1995). 
Three main mechanisms of voltage-independent calcium influx have been 
described (Felder, Singer Lahat and Mathes, 1994): firstly, the activation of receptor-
operated calcium channels which are coupled tightly to the receptor and activation of 
which occurs independently of intracellular messengers. Secondly, depletion-operated 
calcium channels (DOCC), activation of which provides a source of calcium for 
refilling of calcium stores and is regulated by the concentration of calcium in the store. 
Michell (1975) first suggested that empty IP3-sensitive stores recruit plasma membrane 
calcium influx for the refil_ling of calcium pools. Putney proposed the capacitative 
model for this current, whereby receptor-generated IP3 binds to its receptor on calcium 
stores to trigger the release of calcium (Putney, 1986; Putney, 1991). The depletion of 
the store triggers the release of a messenger which then activates the DOCC on the 
plasma membrane. Thapsigargin may lead to the activation of these channels (Felder, 
Singer Lahat and Mathes, 1994). Thirdly, a second messenger-operated calcium 
channel, activation of which is regulated by calcium itself, or second messengers 
released following receptor activation. Activation of this channel occurs independently 
of the filled state of the calcium store. In addition to activating the release of 
intracellular calcium, IP3 may act alone, or in conjunction with IP4, to activate this 
channel (Irvine, 1992). It has not been established whether these channels are involved 
in the refilling of intracellular calcium pools (Felder, Singer Lahat and Mathes, 1994). 
According to Putney's capacitative model (Putney, 1986; Putney, 1991), refilling 
of the arteriolar smooth muscle intracellular calcium stores would occur in response to 
the depletion of the caffeine-sensitive stores. High concentrations of verapamil inhibit 
calcium influx through calcium channels other than voltage-sensitive ones (Hughes et 
al., 1986). Thapsigargin, which inhibits the calcium-ATPase responsible for 
maintaining calcium in intracellular organelles (Inesi and Sagara, 1992), discharges 
agonist-sensitive intracellular calcium stores and subsequently stimulates the influx of 
extracellular calcium in acinar cells (Bird et al., 1992; Takemura et al., 1989), reduced 
the arteriolar contractile response by 40 %. In the presence of verapamil, the contractile 
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response of the iris arterioles was abolished by thapsigargin. Thus, activation of a1B-
adrenoceptors on the iris arterioles appears to result in the release of calcium from 
internal stores, and that these stores are refilled by calcium influx through verapamil-
sensitive calcium channels, thus supporting Putney's hypothesis of receptor-regulated 
calcium entry. Therefore, verapamil may be inhibiting extracellular calcium influx 
through DOCC in iris arterioles. 
The arteriolar constriction produced by perfusion of the bath with a submaximal 
concentration of noradrenaline was totally inhibited by CEC, suggesting that only CEC-
sensitive adrenoceptors are present on this vessel. Since the RT-PCR studies have 
shown that the only other a 1-adrenoceptor expressed in the iris is the a lA-
adrenoceptor (Gould, Vidovic and Hill, 1995), which is insensitive to CEC (Hieble et 
al., 1995), these results suggest that only UlB-adrenoceptors exist on the surface of the 
iris arterioles. 
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CHAPTER 4. 
MEMBRANE POTENTIAL CHANGES 
ASSOCIATED WITH SYMPATHETIC 
NEUROEFFECTOR TRANSMISSION 
INTRODUCTION 
In most arterial vessels, the postjunctional response to sympathetic nerve 
stimulation is due to the activation of non-a-adrenoceptors alone, or both a- and non-
a-adrenoceptors (Hirst and Edwards, 1989). Contraction following non-a-
adrenoceptor activation occurs as a result of membrane depolarization (Hirst and 
Edwards, 1989). In arteries such as the adult rat mesenteric artery (Hill, Hirst and van 
Heiden, 1983), a single brief supramaximal electrical stimulus produces a rapid 
excitatory junction potential which is resistant to a-adrenoceptor antagonists and which 
does not initiate a contraction. With repetitive nerve stimulation, successive excitatory 
junction potentials summate to produce a larger depolarization which, upon reaching 
the threshold for the opening of voltage-dependent calcium channels, results in calcium 
influx and contraction. On the other hand, a-adrenoceptor mediated vasoconstriction is_ 
accompanied by postjunctional voltage changes which do not appear to be essential for 
the constriction. In the rat tail artery, for example, these voltage changes are much 
slower than the non-a-adrenoceptor mediated excitatory junction potentials and are 
preceded by a-adrenoceptor mediated constriction (Cheung, 1984). 
In contrast to the above results, studies in veins (Holman et al., 1968; van 
Heiden, 1991) and in the pulmonary artery (Suzuki, 1983) have found that the responses 
to sympathetic nerve stimulation are mediated purely by a-adrenoceptors. In the 
previous chapter it was also shown that the vasoconstriction of arterioles found within 
the stromal layer of the rat iris is also a purely a-adrenoceptor mediated response, 
which is due to the release of intracellular calcium, and is not totally dependent upon 
the entry of calcium through voltage-dependent calcium channels. 
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This chapter addresses the question of whether the nerve-mediated constriction 
of these iris arterioles is accompanied by any membrane potential changes and, if so, 
how these potentials compare with those previously described to accompany a- and 
non-a.-adrenoceptor responses in other vessels. 
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RESULTS 
Intracellular responses to transmural nerve stimulation 
Two groups of cells could be identified in iris arterioles on the basis of their 
resting membrane potential values. Within the first group of cells, which had an average 
resting membrane potential of -74 + 1 m V (n=69), the majority of cells showed no 
membrane potential change (average resting membrane potential of -74 ± 1 mv; n=56) 
in response to nerve stimulation (10 pulses at 10 Hz; Figure 4.1 A). In some cells, 
however, a small hyperpolarization was recorded following the first train of nerve 
stimulation, although subsequent stimuli often failed to elicit a response (average 
resting membrane potential of -73 ± 2 mv; n=l3). 
The impression was gained that cells of the first group were impaled when it was 
more difficult to make recordings, for example, in the earlier experiments, or in later 
experiments when the preparation seemed to get tough and more force was required to 
impale the cell. For these reasons these cells are proposed to lay deeper in the 
preparation than the second group of cells from which recordings were more commonly 
made~ particularly in the later experiments. 
The second group of cells had an average resting membrane potential value of 
-64+ 1 m V (n=93) and responded to nerve stimulation with a depolarization. Within 
this group of cells, two subgroups could be identified on the basis of the size and shape 
of the depolarization. Following nerve stimulation (10 Hz for 1 s) some cells showed a 
small, smooth depolarization of 8 + 1 . m V (average resting membrane potential of 
-61 ± 2 mV; n=28) 1 and others showed a large, biphasic depolarization of 40 + 1 mV 
(average resting membrane potential of -65 + 1 mV; n=65; Figure 4.1 B). 
In the earlier experiments, the two types of depolarizing cells were recorded 
from with approximately an equal frequency, however, as time went by, recordings 
were made more often from the cells showing the large depolarizations, to a point 
where recordings were rarely recorded from the cells with the small depolarizations. 
These latter cells may represent either damaged cells or another type of cell in deeper 
cell layers of the iris. For these reasons, the remainder of the experiments were 
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Figure 4.1 Intracellular recordings from cells of iris arteriole showing A. no membrane 
response or B. a depolarization in response to nerve stimulation (dot; 10 Hz, 1 s). 
conducted only on the cells showing the large, biphasic depolarizations in response to 
nerve stimulation. 
Membrane potential changes were recorded in the group of depolarizing cells 
when the number of pulses in a train at 10 Hz was increased from 1 to 10 (Figure 4.2). 
A unimodal depolarization of some 8 m V was recorded in response to I pulse, while 
2 pulses produced a larger depolarization of the same shape (Figure 4.2, 4.3 B). The 
membrane potential respo.nse to 3 to 10 pulses in these cells consisted of two 
components, an intial large 30 to 40 m V transient peak and a smaller, slower 
depolarization (Figure 4.2). There was a clear decrease in the time to peak potential 
with an increase in the number of pulses in the stimulus (Figure 4.2). This can be seen 
more clearly in Figure 4.3 A, where the time to peak potential (open circles) decreased 
with an increase in the number of pulses in the stimulus, up to 3 pulses. For further 
increases in the · number of pulses, the time to peak potential remained relatively 
constant. The achievement of the shortest time to peak potential coincided with the 
appearance of the biphasic membrane potential response. 
Relationship between contraction and depolarization 
Simultaneous recordings of the large depolarization and the associated 
contraction of the arteriole showed that the peak depolarization occured at the same 
time as the onset of the contraction (Figure 4.3 A). This relationship held for stimulus 
trains containing from 1 to 10 pulses (Figure 4.3 A). The peak amplitude of the 
contraction occured consistently later than the peak depolarization (Figure 4.3 A). 
The amplitude of the depolarization showed the same relationship to the number 
of pulses in the stimulus as did the amplitude of the contraction; both increased to reach 
a maximum amplitude by 3 to 4 pulses (Figure 4.3 B). 
Confirmation of an a.-adrenoceptor-mediated response to nerve stimulation 
Both the depolarization and the contraction were abolished by tetrodotoxin 
(1 µM; n=2; Figure 4.4), indicating they resulted from nerve activation (Adams and 
Swanson, 1994). The neurogenic depolarization and contraction were also abolished by 
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Figure 4.2 Intracellular responses to increasing numbers of pulses in the stimulus train, 
recorded from an iris arteriole cell showing a large, biphasic depolarization. Dot 
indicates onset of stimulation with 1, 2, 5 or 7 pulses at 10 Hz. 
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Figure 4.3 Comparison of the characteristics of the contraction of the iris arterioles and 
the large, biphasic depolarizations recorded in response to increasing number of pulses 
in the stimulus train ( 10 Hz). Panel A shows the changes in the time to onset of 
contraction (open squares), the time to peak contraction (closed squares) and the time to 
peak depolarization ( open circles) with increasing number of pulses in the stimulus 
train. Panel B shows the change in amplitude of the contractions (squares) and the 
depolarizations (circles) with increasing number of pulses in the stimulus train. 
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Figure 4.4 Traces showing nerve-evoked contraction and associated depolarization of an iris arteriole in control Krebs and after 7 min in the presence 
of tetrodotoxin ( I µM). Dots indicate the onset of nerve stimulation ( 10 Hz). 
the irreversible a-adrenoceptor antagonist, benextramine ( 10 µM; n=7, Figure 4.5) and 
the a-adrenoceptor antagonist, prazosin (0.1 µM; n=3 ; Figure 4.6). Following return to 
control solution after benextramine, a small depolarization was sometimes recorded 
I 19 ± 1 % control, n=3) , the reason for this was not clear. In none of the experiments did the 
contraction return after washout in control Krebs. These observations indicate that both 
the neurogenic depolarization and the contraction resulted from the activation of a-
adrenoceptors. 
Temperature dependence of the depolarization 
The depolarization recorded in response to nerve stimulation at 30.6 °c and 
34.5 oc are shown in Figure 4.7. While a decrease in temperature did not affect the 
amplitude of the depolarization, the time to peak depolarization increased significantly 
from 1.13 + 0.07 s at 34.5 oc to 1.61 + 0.08 s at 30.6 °c (n=3). The onset of the 
contraction continued to coincide with maximum depolarization irrespective of the 
actual temperature. It was not possible to obtain a Q1 o for the response, as a larger 
-
change in temperature led to dislodgement of the electrode. It is unclear why this was 
so. 
Effect of nifedipine and caffeine on the depolarization 
Neither the nerve-mediated depolarization nor the contraction were abolished by 
the antagonist of the L-type voltage-dependent calcium channels, nifedipine (Adams 
and Swanson, 1994) at 1 µM (n=6; Figure 4.8 A). At this concentration, nifedipine had 
little effect on the magnitude of the contraction, the magnitude of the depolarization or 
the time course of the depolarization (Table 4.1). The amplitudes of the contraction and 
depolarization were decreased by 10 µM nifedipine (n=6; Table 4.1; Figure 4.8 B). 
In the presence of 10 µM nifedipine, the contraction in 
response to 50 mM KCl was reduced by 73.0 ± 2.2 % (n=3). In these experiments, the 
arterioles were preincubated in 10 µM benextramine to prevent the effects of KCl-
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Figure 4.5 Traces showing cell depolarization and associated constriction of an iris 
arteriole in control Krebs and in the presence of benextramine (10 µM). Dots indicate 
the onset of nerve stimulation (10 Hz). 
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Figure 4.6 Traces showing nerve-evoked cell depolarization and associated 
constriction of an iris arteriole in control Krebs and in the presence of prazosin 
(0.1 µM). Dots indicate the onset of nerve stimulation ( 10 Hz). 
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Nerve Stimulation 
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Figure 4. 7 Traces showing the effect of a change in bath temperature from 34.5 °c to 
30.6 °c on the nerve-mediated depolarization recorded from an iris arteriolar cell. Dot 
indicates the onset of nerve stimulation (10 Hz, 1 s). 
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Figure 4.8 Traces showing cell depolarization and associated constriction in control 
Krebs and in the presence of A. 1 µM nifedipine or B. 10 µM nifedipine. Dots indicate 
the onset of nerve-stimulation (10 Hz). 
Table 4.1 Effect of nifedipine and caffeine on nerve-mediated depolarization 
recorded from an arteriolar cell and associated contractile response. 
Drug Treatment 
Control 
Nif edipine (1 µM) 
Control 
Nifedipine (10 µM) 
Control 
Caffeine (1 mM) 
Magnitude of 
contraction 
(µm) 
3.1 + 0.8 
2.5 + 0.7 
2.6+ 0.5 
1.8 + 0.3* 
3.8 + 0.7 
0 + O* 
Time to 
. 
maximum 
depolarization 
(s) 
1.2 + 0.0 
1.3 + 0.1 
1.2 + 0.1 
1.3 + 0.1 
1.4 + 0.1 
1.6 + 0.1 
Results are expressed as the mean + s.e.m. of 6 preparations. 
Magnitude of 
depolarization 
(mV) 
41 + 2 
37 + 3* 
42+ 1 
37 + 1* 
40+ 3 
19 + 3* 
* indicates significant difference from paired control (t-test with Bonferroni correction) 
induced release of noradrenaline. The residual 27 % of the contraction presumably 
results from the KCl-induced release of other neurotransmitters, for example, NPY. 
Possible effects of acetylcholine were prevented by the presence of hyoscine 
hydrochloride (1 µM). 
In contrast to nifedipine, the intracellular calcium mobilizer caffeine (1 mM) 
abolished the nerve-mediated contraction and substantially reduced the magnitude of 
the depolarization (n=6; Figure 4.9). In the presence of caffeine (1 mM), the time to 
maximum depolarization was longer than in control (Table 4.1), indicating the loss of 
the peak component of the depolarization. 
Ionic current underlying the depolarization 
Replacement of sodium chloride in the Krebs with sodium methyl sulfate 
(120 mM) reduced the magnitude of the depolarization to 8 + 5 % of control 
(n=4; Figure 4.10) and abolished the contraction. This effect could be reversed by 
washing out the drug. A similar effect on the depolarization and 
-
contraction was produced by chloride replacement with sodium isethionate (120 mM; 
data not shown). Flufenamic acid, which is reported to block calcium-dependent 
chloride channels in Xenopus oocytes (White and Aylwin, 1990), blocked both the 
depolarization and the contraction (250 µM; n=6; Figure 4.11). In the presence of these 
drugs which interfere with chloride channels the contraction was abolished before the 
drugs had their maximal effect on the depolarization (Figure 4.10, 4.11 ). 
Spontaneous depolarizations in iris arterioles 
(n=33) 
Spontaneous depolarizations were recorded in some ms arterioles. The ,. 
frequency of these depolarizations was quite constant between different preparations, 
being about 1 per 10 s. Large spontaneous depolarizations were usually associated with 
spontaneous contractions of the iris arteriole (Figure 4.12 A). In Figure 4.12 A, the 
depolarizations were accompanied by spontaneous contractions of the arteriole 
throughout the record. The depolarizations become progressively smaller in amplitude 
as the cell membrane itself depolarized. In other preparations, in which small 
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Figure 4.9 Traces showing the effect of caffeine (1 mM) on ceJI depolarization and associated arteriolar constriction evoked by nerve stimulation 
(IO Hz). Dots indicate the onset of nerve stimulation (IO Hz). 
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Figure 4.10 Traces showing nerve-mediated cell depolarization and associated constriction of an iris arteriole in control Krebs and after lowering 
external chloride with sodium methyl sulfate (120 mM) for 6 min, when the contraction was abolished, and 9 min, showing the maximal effect on the 
depolarization. Dots indicate the onset of nerve stimulation (10 Hz). 
Control Flufenamic acid (250 µM) 
Contraction 1 min · 4min 
1 sµm 
Depolarization 
-----/\ - -- ,~----- ....... - I lOmV 
• Nerve Stimulation • • 
(10 Hz) 
3s 
Figure 4.11 Traces showing nerve-evoked cell depolarization and associated constriction of an iris arteriole in control Kreb and in the presence of 
flufenamic acid (250 µM) for 1 min, when the contraction was abolished,and for 4 min, when the depolarization was abolished. Dots indicate 
onset of nerve stimulation (IO Hz). 
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Figure 4.12 Spontaneous depolarizations recorded from iris arteriolar cells. In A, the depolarizations are large and are consistently accompanied by 
-
spontaneous contractions of the arteriole. Note also that, while the individual depolarizations are becoming smaller with time, the cell membrane is 
gradually depolarizing. In B, the spontaneous depolarizations are smaller and are not accompanied by contractions. Nerve stimulation does, however, 
evoke a contraction. Dots indicate onset of nerve stimulation (IO Hz). 
spontaneous depolarizations of the arteriole were recorded, there was no significant 
spontaneous contraction of the arteriole, although nerve-stimulation produced a large 
depolarization and a contraction of these arterioles {Figure 4.12 B). Spontaneous 
depolarizations recorded from iris arterioles were substantially reduced by caffeine 
( 1 mM; Figure 4.13), further indicating the dependence of arteriolar depolarization on 
the mobilization of intracellular calcium. 
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Figure 4.13 Trace showing spontaneous depolarizations recorded from an iris 
arteriolar cell. Bar indicates perfusion of the bath with caffeine (1 mM). Note that the 
spontaneous depolarizations return within 10 min of returning to Krebs from caffeine. 
DISCUSSION 
Transmural nerve-stimulation of the isolated iris of the rat causes a 
vasoconstriction due to the activation of a 1 B-adrenoceptors. Using the intracellular 
recording technique, two distinct types of cells in the iris arterioles have been identified 
on the basis of both average resting membrane potential and the membrane potential 
response associated with nerve-evoked vasoconstriction. One group of cells had quite 
negative resting membrane potentials and showed no response or a hyperpolarization 
following nerve-stimulation (-74 m V). In the second group of cells, the average resting 
membrane potential was more positive (-64 m V) and a small or large depolarization 
was recorded following nerve stimulation. 
The cells from which large depolarizations were recorded in response to nerve 
stimulation showed a close correlation between the characteristics of the membrane 
potential changes and the characteristics of the nerve-evoked vasoconstriction. 
Stimulation of the nerves with one pulse produced a small contraction of the arteriole 
and a small membrane depolarization of these cells. With increasing number of pulses, 
a dep9larization comprising a rapid 30 to 40 m V transient peak followed by a slower, 
smaller component, was recorded. Further more, the amplitude of the contraction 
mirrored that of the depolarization. Recordings from this group of cells is the ref ore 
proposed to represent recordings from the smooth muscle cells of the arteriole. It is of 
interest, then, that the average resting membrane potential of these cells lies within the 
ranges previously reported for arterial smooth muscle (Holman, 1969; Hirst and 
Edwards, 1989; Kuriyama, Kitamura and Nabata, 1995). 
Studies using two microelectrodes, one to inject current and one to measure the 
current reaching another cell, confirm that the proposed smooth muscle cells of the iris 
arterioles,that is those in which a large depolarization was recorded following nerve 
stimulation, are electrically coupled in the iris arterioles (Hirst et al, 1996, submitted for 
publication). 
In addition, the cells in which either no response or a small hyperpolarization 
were recorded in response to nerve stimulation are proposed to represent the endothelial 
cells of the iris arteriole. Activation of K+ channels in endothelial cells is reported to 
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lead to hyperpolarization (Revest and Abbott, 1992). The average resting membrane 
potential of these cells is significantly more negative than those of the proposed smooth 
muscle cells. This difference, and the difference in response to nerve stimulation 
between the two cell groups, suggests that the endothelial cells and the smooth muscle 
cells are not electrically coupled. Studies using two microelectrodes have indeed 
confirmed that these two cell layers are not electrically coupled in the iris arterioles 
(Hirst et al, 1996, submitted for publication). In two . other vessels, the resting 
membrane potential of the endothelial cells has been reported to be more positive than 
the values in the present study (Marchenko and Sage, 1993; Xia, Little and Duling, 
1995). In contrast to the iris arterioles, in both of these vessels, it has been shown that 
the endothelial cells and smooth muscle cells are electrically coupled (Xia, Little and 
Duling, 1995; Marchenko and Sage, 1994). 
Both the nerve-evoked vasoconstriction and the large depolarization result from 
the activation of an a-adrenoceptor by neurally-released neurotransmitter. The time to 
maximum depolarization of approximately one second is also consistent with the time 
course of neurogenic -a-adrenoceptor mediated depolarizations previously reported, for 
example, in the rat anococcygeus muscle (Creed, Gillespie and Muir, 1975; Byrne and 
Large, 1984) and the rat tail artery (Cheung, 1984). The iris arterioles are unusual in 
that with the stimulus parameters used, nerve stimulation failed to produce a rapid 
excitatory junction potential but instead the membrane potential changes showed a 
purely a-adrenoceptor mediated response. Slow a-adrenoceptor mediated 
depolarizations and contractions in response to nerve stimulation have been recorded 
from veins (Holman et al., 1968; van Heiden, 1991). Nerve stimulation of most 
mammalian arterial vessels, with parameters comparable to those used in this study, 
evokes an excitatory junction potential only, or an excitatory junction potential as well 
as a slower, a-adrenoceptor mediated component (Hirst and Edwards, 1989). To our 
knowledge, the only other arterial vessels where nerve-mediated depolarization occurs 
soley as a result of a-adrenoceptor activation only are the guinea-pig pulmonary artery 
(Suzuki, 1983) and the immature mesenteric artery of the rat (Hill, Hirst and van 
Heiden, 1983). 
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Nerve-evoked constriction of iris arterioles is mediated by an a IB-adrenoceptor 
(Chapter 3). Activation of this receptor leads to the formation of IP3 which acts to 
liberate intracellular calcium, which in tum activates the contractile apparatus for 
contraction (Han, Abel and Minneman, 1987). The sensitivity of the time course of the 
large depolarization, and the contraction, to a change in temperature of only 4 °c 
further suggests that the synaptic a 1 B-adrenoceptor is activating an intracellularly-
mediated response. Neither the nerve-evoked large depolarization, nor the contraction, 
was abolished by the L-type voltage-dependent calcium channel antagonist nifedipine. 
At 10 µM, nifedipine reduced the magnitude of the contraction and abolished the 
transient peak of the depolarization. Caffeine abolished the nerve-evoked 
vasoconstriction, abolished the the transient peak of the depolarization and reduced the 
magnitude of the slower component of the depolarization, in addition to virtually 
abolishing spontaneous depolarizations. Caffeine acts intracellularly to inhibit IP3-
mediated liberation of intracellular calcium, either by depleting calcium stores or 
interferipg with IP3 receptor activation (Parker and Ivorra, 1991). It is possible that, at 
1 mM, caffeine does not release all of the intracellular calcium stores and consequently 
the depolarization would not be totally abolished. Higher concentrations of caffeine, 
which have been used in other studies (Lamb, Volle and Shibata, 1994; Robinson and 
Burgoyne, 1991; Hogg et al., 1993; Klockner, 1993; Lamb, Volle and Shibata, 1994) 
have an additional effect in the heart, in that they reduce the release of transmitter 
(3 mM; H. Cousins, personal communication, 1995), and so were not used in this study. 
The results of these experiments are consistent with the release of intracellular 
calcium which simultaneously activates the constriction and initiates the depolarization 
of iris arterioles. The results further suggest that the influx of calcium through a 
voltage-dependent mechanism contributes only a small component of the increase in 
intracellular calcium and that this additional component augments, but does not initiate, 
the contraction. 
In smooth muscle cells of blood vessels, elevated intracellular calcium has been 
reported to activate a depolarizing membrane ionic current through the opening of 
calcium-dependent chloride channels. Calcium-dependent chloride conductances have 
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been demonstrated in smooth muscle cells of the rat portal vein (Pacaud et al., 1989), 
rabbit ear artery (Amedee, Large and Wang, 1990), human mesenteric artery (Klockner, 
1993) and rabbit coronary artery (Lamb, Volle and Shibata, 1994). The slow a-
adrenoceptor mediated depolarization recorded in venous smooth muscle cells 
following noradrenaline perfusion (Byrne and Large, 1988; van Heiden, 1991; Pacaud 
et al., 1989; Pacaud et al., 1991) or iontophoresed noradrenaline (van Heiden, 1991), is 
due to an increase in a calcium-dependent chloride conductance. The a-adrenoceptor 
mediated depolarization of the rat iris dilator muscle and anococcygeus muscle is 
abolished by chloride ion replacement (Hill et al., 1993; Large, 1984). In the present 
study, the nerve-mediated depolarization of the iris arterioles was reduced substantially 
by replacement of the chloride ions in the petfusion solution with sodium methyl sulfate 
or with sodium isethionate. Furthermore, flufenamic acid, which blocks the calcium-
dependent chloride current activated by elevated intracellular calcium in Xenopus 
oocytes (White and Aylwin, 1990), blocked the nerve-evoked depolarization in iris 
arterioles. These results suggest that the neurogenic a-adrenoceptor mediated 
depolarization of iris ·arterioles is produced by intracellular calcium, liberated from 
caffeine sensitive stores, activating a calcium-sensitive chloride conductance. Thus, 
there would appear to be two simultaneous responses to elevated intracellular calcium 
in these arterioles; one being the activation of the contractile apparatus and 
vasoconstriction, the other being activation of cell membrane chloride channels, and 
chloride outflow to produce a depolarization. 
The changes in the amplitude and time to maximum depolarization recorded in 
the iris arteriolar smooth muscle cells in response to an increasing number of stimulus 
pulses are consistent with the non-linear relationship between increasing levels of 
photo-released IP3 and membrane chloride currents recorded in Xenopus oocytes 
(Parker and Miledi, 1989; Parker and Ivorra, 1992) or hepatocytes (Ogden et al., 1990). 
The magnitude of the chloride current is reported to be proportional to the rate of rise of 
the intracellular calcium rather" than the absolute concentration following release from 
IP3-sensitive stores (Parker and Yao, 1994). With increasing intensity of illumination of 
caged IP3 in Xenopus oocytes, the membrane chloride currents recorded became larger, 
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more transient and had shorter latencies (Parker and Miledi, 1989). Rapid elevation of 
IP3 in Xenopus oocytes evokes a chloride current consisting of an initial large transient 
spike and a slower, more sustained component (Gillo et al., 1987) reminiscent of the 
two component voltage changes recorded in the cells in the present study. 
Surprisingly, the nerve-mediated vasoconstriction in the present study was also 
abolished by chloride replacement and flufenamic acid. It is unlikely that these drugs 
interfere with neurotransmitter release as preliminary experiments showed that they also 
prevent vasoconstriction produced by perfusion of phenylepherine (data not shown). In 
the rat anococcygeus muscle, iontophoretic application of either noradrenaline or 
phenylephrine produced a depolarization of the smooth muscle membrane and a 
biphasic contraction. Reduction of the external chloride ion concentration lead 
to a loss of the depolarization and a loss of the initial rapid phase of the contraction 
(Hogg, Wang and Large, 1994 ). One explanation for these effects on arteriolar 
contraction, then, is that these drugs which interfere with chloride channels may be 
interacting with internal chloride channels, possibly on the sarcoplasmic reticulum, and 
thereby affecting intracellular calcium release. Indeed, flufenamic acid is alcohol 
soluble and may therefore permeate cell membranes to act intracellularly. The 
localization of chloride channels with caffeine-sensitive calcium stores has been 
suggested in the rat pulmonary artery (Hogg et al., 1993). In rat parotid acinar cells, a 
model has also been proposed whereby IP3-sensitive calcium release sites are co-
localized with chloride channels (Hassoni and Gray, 1994; Hassoni and Gray, 1994). 
Chloride channels are present on the sarcoplasmic reticulum membrane of cardiac and 
skeletal muscle (Kawano and Hiraoka, 1993), where it is proposed that chloride 
movement into the cytosol is required to maintain charge neutrality across the 
sarcoplasmic reticulum following the release of intracellular calcium. This movement of 
chloride ions, through internal chloride channels, into the cytosol would increase the 
intracellular chloride concentration. Elevated intracellular calcium in cardiac myocytes 
is sequestered into internal stores by a calcium pump and extruded from the cell via the 
sodium/calcium exchanger (Vassort et al., 1978; Somlyo et al., 1985; Crespo, 
Grantham and Cannell, 1990). The increased intracellular chloride concentration could 
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be lowered by movement of chloride ions out of the cells through calcium-activated 
chloride channels, resulting in the depolarization recorded in the present study 
following a-adrenoceptor activation in iris arterioles. 
Drugs which interfere with chloride channels abolished the contraction before 
having their maximal effect on the depolarization. It is possible, then, that the chloride 
channel in the cell membrane is more sensitive to calcium than is the contractile 
apparatus, implying that the contractile apparatus has a higher threshold for activation 
by calcium than does the chloride channel in the cell membrane. Further support for this 
hypothesis is derived from cells showing regular .spontaneouk depolarizations. Large 
spontaneous depolarizations were associated with spontaneous contractions of the 
arteriole but small spontaneous depolarizations were not. It is interesting that the 
spontaneous release of calcium from IP3-sensitive stores has been reported to occur 
with similar frequencie·s as those for the spontaneous depolarizations reported here 
(Berridge and Galione, 1988; Terrar and White, 1989). Thus, spontaneously released 
calcium from intracellular stores may activate a cell membrane chloride channel and 
depol~zation. If the intracellular calcium oscillations were sufficiently large, they 
would also activate the contractile apparatus and produce spontaneous contractions. 
In summary, intracellular recordings have been used to investigate membrane 
potential changes associated with nerve-mediated constriction of iris arterioles. The 
results of these experiments suggest that both the nerve-mediated constriction and 
depolarization are due to the activation of a-adrenoceptors by neurally-released 
transmitter. Influx of calcium through voltage-dependent calcium channels following 
chloride-channel-mediated depolarizations, can augment vasoconstriction, but is not 
responsible for the initiation of the contraction. 
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CHAPTERS. 
MODULATION OF SYMPATHETIC 
VASOCONSTRICTION BY SENSORY-MOTOR 
NERVES 
INTRODUCTION 
Non-cholinergic vasodilatation following nerve stimulation has been observed in 
may 
a number of vascular beds and result from the release of substance P and/ or CORP A 
from capsaicin-sensitive sensory-motor nei:ves (Holzer, 1992). 
Several lines of evidence suggest that mutual interactions occur between these 
peptidergic sensory-motor nerves and the sympathetic vasoconstrictor nerves. Both 
noradrenaline and NPY, which are co-released from sympathetic nerves, have been 
reported to act presynaptically on sensory-motor nerves to inhibit release of 
neuropeptides (Lindgren et al., 1987; Matran, Martling and Lundberg, 1989; Kawasaki 
et al., 1990b; Kawasaki et al., 1991; Fuder and Selbach, 1993). On the other hand, in 
the rabbit central ear artery and in rat mesenteric arteries, neurotransmitters released 
from sensory-motor nerves have been reported to act postsynaptically to inhibit 
vasoconstriction produced by exogenous noradrenaline or sympathetic nerve 
stimulation (Kawasaki et al., 1990a; Maynard, Saville and Burnstock, 1990; Remak, 
Hottenstein and Jacobson, 1990). This latter effect was mediated via CGRP and not 
substance P (Han, Naes and Westfall, 1990; Li and Duckies, 1992; Maynard, Saville 
and Burnstock, 1990). In mesenteric vessels, the nerve-mediated vasoconstriction 
results from the entry of calcium through voltage-dependent calcium channels (Hill, 
Hirst and van Heiden, 1983). In these vessels, the inhibitory effect of CGRP has been 
suggested to be due to sensory-motor nerve-induced hyperpolarization and a 
corresponding reduction in adrenergic excitatory junction potentials (Meehan, 
Hottenstein and Kreulen, 1991). Indeed, CGRP has been shown to activate ATP-
sensitive K+ channels and cause a hyperpolarization of arterial smooth muscle cells 
(Saito et al., 1989; Nelson et al., 1990). 
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Sympathetic vasoconstriction of iris arterioles is mediated by CllB-adrenoceptor 
activation and the mobilization of intracellular calcium. In these arterioles, blockade of 
voltage-dependent calcium channels did not prevent the contraction (Chapter 3). Thus, 
vasoconstriction may be seen to be largely independent of depolarization of the muscle 
membrane. This chapter investigates whether sensory modulation of 'sympathetic 
vasoconstriction is also found in these arterioles which do not require the operation of 
voltage-dependent calcium channels for the initiation of contraction. 
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RESULTS 
Effect of time interval between stimulus trains 
Stimulation of the intramural nerves at 10 Hz for 1 s every 3 min produced 
contractions which were consistent in amplitude (Figure 5.1). When the interval 
between stimulus trains was reduced to 15 s, however, the responses rapidly decreased 
in size and were frequently abolished by the third stimulus (Figure 5.1). When intervals 
between stimulus trains of 15 s to 3 min were tested, it was found that contractile 
responses were attenuated when trains of stimuli were separated by less than 2 min, the 
greatest attenuation occurring for stimuli separated by 15 s, which was the minimum 
time tested (Figure 5.2). 
In preparations in which the blood vessels were spontaneously active, transmural 
stimulation elicited vasoconstriction which was followed by a silent period during 
which time the spontaneous contractions were absent (Figure 5.3). 
Effect of capsaicin treatment 
When the responses of iris blood vessels from capsaicin-treated rats were tested 
to stimulus trains separated by 15 s, it was found that the contractions persisted at a 
constant amplitude while those of blood vessels from vehicle-treated littermates were 
rapidly lost. Pooled results from preparations from capsaicin-treated and vehicle-
treated rats are shown in Figure 5.4. Note that the first contractile response in arterioles 
from capsaicin-treated rats was slightly greater than in arterioles from control rats. 
While the contractions in the preparations from the control rats were eliminated by the 
third stimulus, those in the preparations from the capsaicin treated rats persisted for as 
long as the stimuli were pre~nted1(significantly · ~ifferent for the 2nd to 6th ·stimulus pulse, 
t-test with Bonferroni correction). . 
. 
Treatment of control preparations with capsaicin (10 µM) led to an initial rapid 
loss of nerve mediated vasoconstriction (Figure 5.5) but over the next 15 min, the 
contractile response to nerve stimulation recovered. These observations correspond with 
the previously documented effects of acute capsaicin, i.e. massive release of 
neuropeptides from sensory-motor nerves followed by a prolonged loss of sensory-
motor function due to desensitization and a blockade of nerve conduction (Holzer, 
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Figure 5.1 Representative traces showing contraction of an iris arteriole in response to transmural nerve stimulation at IO Hz for I s either every 
3 min (Panel A.) or every 15 s (Panel B). Note that the contractions remain constant in amplitude when stimulus trains are separated by 3 min but are 
rapidly desensitized when trains are separated by only 15 s. 
40 
QJ 
~ 
= ,-._ Q s. 30 
C. QJ 
~ ..... 
QJ QJ 
~= ~ 
QJ ·-9Q 
~-~ QJ 
s. ~ 
..... ~ 20 = QJ c> 
. u OJ) 
~ ·= QJ ..... 
..... ~ ~ QJ 
~~ 
QJ ~~ 
I -_, 10 QJ -;;;... 
s. 
QJ 
z 
0 
0 1 2 3 4 5 6 
Number of Stimuli 
Figure 5.2 Effect of the time interval between stimulus trains on the amplitude of the 
vasoconstriction to transmural nerve stimulation. The magnitude of the nerve-mediated 
contractile responses are expressed as the % of the resting vessel diameter. Each point 
represents the mean and s.e.m. for 4 preparations. Responses were recorded for 6 
consecutive stimulus trains where the individual trains were separated by 15 s ( open 
squares), 30 s (open circles), 1 min (open triangles), 2 min (closed circles) and 3 min 
(closed squares) . 
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Nerve Stimulation 
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Spontaneous contractions 
• 20µm 
30s 
Figure 5.3 Contractile responses to trains of stimuli (10 Hz, I s) separated by 3 min in a preparation showing spontaneous contractions every 
13 s. Note that a larger contraction immediately follows the nerve stimulation and that, for the next 40 to 50 s, the spontaneous contractions are 
abolished. 
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Figure 5.4 Contractile re ponse (expressed as a % of the resting vessel diameter) of 
iris arteriole to consecutive train of stimuli (10 Hz, 1 s) separated by 15 s from a 
vehicle-treated (n=4, open quare ) and cap aicin-treated (n=7, closed squares) rat . 
Value are expre ed a the mean and s.e.m. Note the rapid los of the nerve-mediated 
a ocon triction of the arteriole from the ehicle treated animal but the persi tence of 
the contraction in the arteriole from the animal treated neonatally with capsaicin 
(50 mg.kg-1). 
Control 
3min · 
• • 
Nerve Stimulation every 3 min 
(10 Hz, 1 s) 
I 
Capsaicin (10 µM) 
15min 40 
20 
7s 
~ 
-· ,-.. ~ 1= 8 8 ~ 
'-'~ 
~ 
"1 
Figure 5.5 Traces showing the immediate effect of bath perfusion with capsaicin (10 µM) on the contractile response evoked by nerve stimulation 
every 3 min (10 Hz, ls). Dotted line indicates resting vessel diameter. Note that there was a rapid inhibition of the constriction accompanied by a 
vasodilatation. Within 15 min, however, the vasoconstrictor response had recovered to its pretreatment size. 
1991a). When the contractile response had returned to its pretreatment level, the 
preparations were stimulated every 15 s. In the presence of the capsaicin, the contractile 
responses after the first stimulus were maintained at constant amplitude (Figure 5.6). 
Before capsaicin, contractile responses of arterioles in these preparations rapidly 
decreased in amplitude when the nerves were stimulated every 15 §... lhese results (significantly different for 3rd to 6th stimulus pulse, t-test with Bon(erroni correction). 
suggest tne involvement of sensory-motor nerves in the inhibition of sympathetic 
vasoconstrictiori. 
Effect of SarSP and CGRP on sympathetic vasoconstriction 
Perfusion of the preparations with SarSP led to a rapid and concentration-
dependent loss of the nerve-mediated vasoconstriction (Table 5.1). CORP was also 
effective in inhibiting the nerve mediated vasoconstriction, although slightly less potent 
than SarSP (Table 5.1). ln ·addition to the effect on nerve stimulation, perfusion of the 
bath with SarSP ( 10 nM) or CORP ( 10 nM) produced a vasodilatation of the iris 
arterioles (Figure 5.7). Interestingly, the vasodilatation produced by CORP was longer-
lasting than the inhibitory effect on the sympathetic vasoconstriction (result not shown). 
Does the sensory-motor modulation of sympathetic vasoconstriction involve 
hyperpolarization? 
Simultaneous intracellular recordings and measurement of the contractile 
responses to trains of stimuli every 15 s showed that the magnitude of both the 
depolarization and contraction decreased with successive stimuli (n=3; Figure 5.8). The 
decrease in size of the depolarization was, however, not accompanied by 
hyperpolarization. 
Effect of inhibition of nitric oxide synthesis 
The effect of inhibition of nitric oxide synthesis on the loss of nerve-mediated 
vasoconstriction during repetitive stimulation was tested using L-NAME. Preincubation 
of preparations for 20 min in the inactive isomer, D-NAME (10 µM), had no effect on 
the loss of nerve-mediated vasoconstrictions following nerve stimulation every 15 s 
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Figure 5.6 Effect of capsaicin on the desensitization of the vasoconstrictor response 
following repetitive nerve stimulation when the individual trains of stimuli (10 Hz, 1 s) 
were separated by 15 s. Points represent the mean and s.e.m. for 4 preparations which 
were repetitively stimulated in control Krebs, before the addition of capsaicin ( open 
square ) and after the addition of capsaicin to the perfusion solution at a time when the 
vasoconstrictions had returned to pretreatment levels (closed squares). Note that the 
responses rapidly desensitized before the addition of capsaicin but remained constant in 
amplitude when repetitively stimulated after capsaicin had been perfusing through the 
recording chamber for at least 15 min. 
Table 5.1 
Effect of SarSP and CGRP on contractile responses of iris arterioles produced by nerve 
stimulation every 3 min. 
Agonist Nerve-Mediated Contractile Response 
concentration ( % Control Contractile Response) 
(nM) 
SarSP CGRP 
0.1 94 + 5.4 (4) 85.0 + 4.0 (3) 
1 . 54.3 + 18.6 (4) 77.3 + 11.2 (3) 
-
10 3.2 + 3.2 (5) 25.8 + 9.4 (6) 
100 1.5 + 1.5 (7) 19.9 + 9.5 (4) 
Results are expressed as mean + s.e.m. of the number of preparations in parenthesis. 
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Figure 5.7 Traces showing the effect of SarSP (10 nM; Panel A) and CGRP (10 nM; 
Panel B) on the arteriolar contractile response to nerve stimulation every 3 min. Dots 
indicate the onset of nerve stimulation (10 Hz, 1 s). 
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Figure 5.8 Traces showing simultaneous recording from an ins arteriole of 
intracellular responses and associated arteriolar contractile responses to nerve 
stimulation (10 Hz, 1 s) every 15 s. 
(n=3; Figure 5.9 A). Preincubation in L-NAME (10 µM) led to a decrease in resting 
vessel diameter suggesting the involvement of nitric oxide in the maintenance of basal 
tone of the vessels. This change in basal tone had no effect on subsequent responses to 
nerve-stimulation (Figure 5.10). L-NAME prevented the loss of nerve-mediated 
vasoconstriction during repetitive stimulation (Figure 5.9 B). These results suggested 
the involvement of nitric oxide in this response. 
Involvement of nitric oxide in the inhibitory effect of SarSP and CGRP on 
sympathetic vasoconstriction 
Preparations were preincubated in L-N AME ( 10 µM) for 20 min before the 
-
addition of either SarSP or CORP. The magnitude of the vasoconstriction produced by 
nerve-stimulation every 3 min in the presence of the peptide was compared to that in 
preparations incubated for the same times in control Krebs or in Krebs containing only 
L-NAME (Figure 5.10). SarSP (10 nM; n=4) and CORP (10 nM; n=6) caused a 100 % 
and 75 % decrease in the magnitude of the nerve-mediated vasoconsttiction respectively 
(Figure 5.10). The inhibitory effect of SarSP (10 nM; n=3) and of CORP (10 nM; n=4) 
on sympathetic vasoconstriction were prevented by preincubation in L-NAME 
(10 µM, Figure 5.10). Thus, both SarSP and CORP inhibited nerve-mediated 
vasoconstriction via the production of nitric oxide. 
Effect of antagonists to neuropeptide receptors 
In order to determine whether substance P or CORP was involved in the loss of 
the vasoconstrictor responses, the effect of antagonists to the NK1- and NK2-tachykinin 
receptors, RP 67580 (1 µM; n=4) and L-659877 (1 µM; n=3) respectively, and the 
antagonist for CORP1 receptors, CORPS-37 (1 µM; n=4) were tested. Neither the NK1-
nor NK2-tachykinin receptor antagonist was able to prevent the loss of the 
vasoconstriction in response to nerve stimulation every 15 s (Figure 5 .11; 
closed squares; closed triangles respectively), nor were they able to prevent the effect 
when present in combination (n=4; Figure 5.11, closed circles). On the other hand, the 
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Figure 5.9 Effect of preincubation in A. D-NAME (10 µM) and B. L-NAME (10 µM) 
on an iris arteriole contractile response to nerve stimulation ( 10 Hz, 1 s) every 15 s. 
Note that the resting vessel diameter has been reduced in the presence of L-NAME. 
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Figure 5.10 Effect of preincubation in L-NAME (10 µM ) on the inhibition of nerve-
mediated vasoconstriction produced by SarSP (10 nM) and CGRP (10 nM). Note that 
preincubation in L-NAME prevented the effect of both SarSP and CGRP. * indicates 
significantly different from L-NAME and SarSP; ** indicates significantly different 
from L-NAME and CGRP. 
50 
~ 40 
r;I.) 
= 0 c.. 
r;I.) ,.-_ 
~ s. ~ ~ 
.... 
~ ~ 30 
=-= = ~ ~ 
~·-s. Q 
.... 
=,... 
0 ~ 
u~ 
"'O > 20 
~Oil 
~ = 
·- ·-"'O .... ~ r;I.) ~~ 
~~ 10 s. ,_, ~ z-
0 
0 1 2 3 4 5 6 
Number of Stimuli 
Figure 5.11 Effect of antagonists of CGRP- and tachykinin-receptors on the 
vasoconstrictor responses to trains of nerve stimulation ( 10 Hz, 1 s) every 15 s. The 
NK 1 antagonist, RP 67580 (10 µM), and the NK2 antagonist, L-659877 (10 µM ), had 
no effect on the reduction in amplitude of the vasoconstrictions seen in control Krebs 
(open circles), when present either singly (closed squares and closed triangles , 
respectively) or in combination (closed circles) . The CGRP1 antagonist, CGRPg_37 
(10 µM, closed diamonds), however, prevented the desensitization of the 
vasoconstrictions. Points represent the mean and s.e.m. for 3 to 4 preparations. 
CGRP1-receptor antagonist did prevent the loss of nerve-mediated vasoconstriction due 
to repetitive nerve stimulation (Figure 5.11, closed diamonds). 
lmmunohistochemistry 
Immunohistochemical staining with antibodies against tyrosine · hydroxy lase 
revealed a dense plexus of fibres throughout the iris and a perivascular plexus of fibres 
around the larger arterioles. This observation was consistent with other studies (Olson et 
al, 1988). The patterns of staining with antibodies against substance P and CGRP were 
also consistent with those previously described (Seiger et al., 1985). A moderately 
dense plexus of fibres throughout the iris and apparent correspondence in this plexus 
between the preparations stained with substance P and those stained with CGRP was 
observed. However, there was no evidence for any perivascular plexus of either 
substance P-like or CGRP-like immunoreactive fibres around the larger arterioles 
described above. Instead, substance P and CGRP fibres crossed the arterioles at right 
angles to their axis at intervals of 30 to 40 µm (Figure 5.12). These fibres appeared in 
the same focal plane as the adrenergic perivascular plexus as they crossed the vessels 
(Figure 5.12). 
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Figure 5.12 Immunohistochemistry of an arteriole from an iris treated simultaneously 
with antibodies against substance P to visualize sensory fibres and with tyrosine 
hydroxylase to visualize sympathetic fibres. Panel A shows the perivascular plexus 
formed by the varicose, adrenergic sympathetic fibres around the arteriole. Panel B 
shows the same adrenergic plexus with superposition of the fibres showing substance P-
like immunoreactivity (arrows). This was reconstructed from eight optical sections, 
using a confocal microscope and appropriate filters to demonstrate the Texas Red-
stained sympathetic fibres and the FITC-stained sensory fibres. Note how close together 
the varicosities of the two fibre types lie. Also note that, although the fibres showing 
substance P-like immunoreactivity do not form a perivascular plexus, they do lie in the 
same focal plane as the sympathetic fibres. Magnification bar represents 10 µm. 

DISCUSSION 
Transmural nerve stimulation of the rat iris at 10 Hz for 1 s every 3 min 
produced a consistent vasoconstriction of the iris arterioles. When the nerves were 
stimulated repetitively, with the interval between successive trains of stimuli being less 
than 2 min, these contractile responses showed a rapid desensitization. Similarly, in 
arterioles showing spontaneous contractions, nerve stimulation caused a 
vasoconstriction which was followed by a silent period of some 40 to 50 s during which 
the spontaneous activity was absent. These results demonstrate that repetitive 
stimulation of non-cholinergic nerves produces an immediate vasoconstriction followed 
by a long lasting inhibition of contractile activity. This could result from either, down 
regulation of the adrenergic receptors or molecules involved in their second messenger 
pathways, prejunctional inhibition of sympathetic nerve activity or an interaction with 
sensory-motor nerves. 
The iris of the rat 1s richly supplied with nerve fibres of sympathetic, 
parasympathetic and sensory origin (Olson et al., 1988). In the present study, the 
actions of the cholinergic, parasympathetic nerves have been prevented by the addition 
to the perfusion medium of hyoscine hydrochloride ( 10 µM). The influence of the 
sensory-motor fibre activation on the sympathetic vasoconstriction of iris arterioles was 
determined by treating newborn rats with multiple injections of capsaicin, which has 
been reported to selectively destroy the small, substance P-, CORP-containing primary 
afferent sensory-motor neurones (Holzer, 1991a). Such treatment leads to the loss of the 
substance P-containing nerves within the iris (Hill and Vidovic, 1989). When arterioles 
from capsaicin-treated animals were tested for contractile responses to nerve stimulation 
it was found that the sympathetic nerve-induced vasoconstrictions were significantly 
larger than those in the vehicle-treated control animals. Similar results have been 
described in the mesenteric arteries from capsaicin-treated animals and have been 
attributed to the absence of sensory-motor nerve-mediated vasodilatation (Kawasaki et 
al., 1990a; Remak, Hottenstein and Jacobson, 1990; Li and Duckies, 1992). Permanent 
ablation of capsaicin-sensitive neurons can lead to an increase in the transmitter content 
and/or the innervation density of sympathetic nerve endings (Terenghi et al., 1986; 
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Luthman et al., 1989; Hill and Vidovic, 1989). Reciprical interactions between sensory-
motor and sympathetic nerves may explain the decreased blood flow observed in adult 
rats which have been treated as neonates with capsaicin (Hottenstein et al., 1992). 
When the trains of nerve stimuli were separated by shorter intervals, for 
example, 15 s, the contractile responses of iris arterioles from capsaicin-treated animals 
remained constant in amplitude rather than being rapidly reduced as occurred in the 
animals injected with the vehicle alone. Thus the loss of the vasoconstrictor response 
following rapid, repetitive nerve stimulation in normal animals appears to be due to 
activation of sensory-motor vasodilator nerves and not due to desensitization of the 
adrenergic receptors themselves. This phenomenon then corresponds to the sensory-
motor nerve-mediated recovery of blood flow in the superior mesenteric artery that 
occurs with persistent sympathetic nerve stimulation (Remak, Hottenstein and 
Jacobson, 1990). · 
The prolonged inhibitory effect of such sensory-motor nerve stimulation seen in 
the present study, lasting up to 2 min, is consistent with the long lasting vasodilatation 
observed after stimulation of afferent nerves in previous studies (Low and Westerman, 
1989; Koltzenburg, Lewin and McMahon, 1990). This suggests that either the peptides 
themselves are long lived, or that the effect of receptor activation is associated with a 
more profound change than occurs following sympathetic nerve stimulation. 
Further support for the involvement of sensory-motor nerves in inhibiting 
sympathetic vasoconstriction was derived from experiments in which capsaicin was 
applied to the in vitro iris preparation. Immediate effects of capsaicin include excitation 
due to release of neuropeptides, fallowed by prolonged desensitization and a block of 
nerve conduction in the sensory C-fibres and AB-fibres (Holzer, 1991a). In the iris 
arterioles, the immediate effect of capsaicin was to cause a vasodilatation and an 
abolition of the sympathetic vasoconstriction. This provided further support for the 
ability of the sensory-motor nerves to modulate the action of the sympathetic nerves in 
this tissue. Within the next 15 min, the sympathetic vasoconstriction returned to 
precapsaicin levels presumably due to either desensitization of the neuropeptide 
receptors or a block in the conduction of the sensory-motor nerves. At this time, rapid, 
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repetitive transmural nerve stimulation caused a contraction which was maintained at a 
constant amplitude for as many stimuli as were delivered. Thus, in both the capsaicin 
treated animals and in the preparations treated in vitro with capsaicin, prevention of the 
release of neuropeptides from the sensory-motor nerves enabled the sympathetic nerve-
induced vasoconstriction to be maintained at a constant amplitude even following rapid 
repetitive stimulation. 
The sensory nerves affected by capsaicin have been reported to contain both 
substance P and CGRP, as well as neurokinin A, galanin, VIP and somatostatin (Holzer, 
1991a). In the mesenteric arteries and in the rabbit central ear artery, vasodilatation and 
the inhibition of the sympathetic vasoconstriction have been reported to be mediated by 
CGRP (Han, Naes and Westfall, 1990; Kawasaki et al., 1990a; Maynard, Saville and 
Burnstock, 1990; Li and Duckies, 1992). CGRP in these arteriolar beds is extremely 
potent as a vasodilator with effective concentrations in the sub-nanomolar range 
(Kawasaki et al., 1988; Han, Naes and Westfall, 1990; Kawasaki et al., 1990a), while 
substance P is relatively ineffective (Kawasaki et al., 1988; Kawasaki et al., 1990a; Li 
and Duckies, 1992). In the arterioles of the rat iris, both the NK1-neurokinin receptor 
agonist, SarSP, and CGRP were effective in inhibiting sympathetic vasoconstriction. 
It was observed that the vasodilatation produced by CGRP was longer-lasting 
than than the inhibitory effect on the sympathetic constriction. This suggests that CGRP 
is producing these effects by two different mechanisms. Further experiments are 
required to examine this vasodilatation and to determine if the vasodilatation can be 
inhibited independently of the inhibitory effect on the constriction. 
Experiments using antagonists for the neurokinin receptor subtypes, NK1 and 
NK2, and for CGRP1 receptors indicated that CGRP released from the sensory-motor 
nerves may inhibit sympathetic vasoconstriction of the arterioles of the rat iris. Since 
the NK1-neurokinin receptor selective agonist, SarSP, was also capable of inhibiting 
sympathetic vasoconstriction in the same arterioles, these results further suggested that, 
either substance P is not co-released with CGRP from the sensory-motor nerves, or that 
the tachykinin concentration is insufficient to activate neurokinin receptors on the 
arterioles, possibly due to rapid degradation. This latter hypothesis could be tested by 
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comparing responses to trains of stimuli every 15 s in the presence of peptidase 
inhibitors to prevent the breakdown of neurokinins, and then testing the effect of the 
tachykinin-receptor antagonists, alone and in the presence of the CGRP receptor 
antagonist. 
Anatomically, arteries have been said to be innervated by particular nerve types 
according to the presence of perivascular networks of fibres. Thus, the main mesenteric 
arteries are described as being densely innervated by peptide-containing fibres while the 
precapillary arterioles and veins are sparsely innervated (Furness et al., 1982; Barja, 
Mathison and Huggel, 1983; Uddman et al., 1986). Similarly, the larger of the arterioles 
of the rat iris have been described as receiving a sympathetic, adrenergic innervation 
(Olson et al., 1988). On the other hand, immunohistochemical studies of substance P-
containing fibres in the rat iris have found no obvious association of these fibres with 
blood vessels (Seiger et al., 1985). 
The present study, has demonstrated that capsaicin-sensitive sensory-motor 
nerve fibres have a vasodilatory effect on these arterioles. Substance P-like and CGRP-
like immunoreactive fibres do not form the perivascular plexuses over the iris arterioles, 
as the adrenergic fibres do. Instead the fibres cross the arterioles at right angles to the 
axis of the vessels. Using the confocal microscope, however, it was demonstrated that 
the peptidergic fibres lie as close to the smooth muscle cells as do the fibres of the 
adrenergic perivascular plexus and frequently, as they cross the arterioles, their 
varicosities are in close association with the varicosities of the adrenergic fibres. The 
paucity of peptidergic fibres and the demonstration of their functional interaction with 
the blood vessels suggests that either the peptides are capable of diffusing over quite 
long distances before inactivation, or that the second messenger molecules activated by 
the peptides must be capable of extensive diffusion. 
The effect of CORP in inhibiting sympathetic vasoconstriction in the present 
study could be either prejunctional and due to a reduction in noradrenaline release, or 
postjunctional and due to an action within the smooth muscle of the arterioles 
themselves. The immunohistochemical data provides evidence for a close association 
between the sympathetic and sensory-motor varicosities. Such a relationship is 
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consistent with prejunctional actions of the sensory-motor fibres on the sympathetic or 
vice versa. On the other hand, anatomical and physiological considerations would 
favour a postsynaptic mechanism. The adrenergic fibres are present in far greater 
density on the vessel surface than are the sensory fibres. This fact, coupled with the 
reported low probability of neurotransmitter release from individual ·sympathetic 
varicosities (Hirst and Neild, 1980b; Brock and Cunnane, 1988; Lavidis and Bennett, 
1993), suggests that the likelihood of the release of noradrenaline from a sympathetic 
varicosity lying in close proximity to a sensory fibre would be low. Indeed, in the 
mesenteric arteries and the central ear artery, CGRP has been shown to have no effect 
on the release of noradrenaline (Maynard and Burnstock, 1989; Han, Naes and Westfall, 
1990; Kawasaki et al., 1990a) and so, in these arteries, CGRP has been proposed to 
operate postsynaptically. A more reasonable explanation, then, would be that in the iris 
arterioles, the neuropeptides act postsynaptically to cause the production of a second 
messenger molecule, for example nitric oxide, which could diffuse rapidly between the 
coupled smooth muscle cells. 
Sympathetic vasoconstriction in the mesenteric and submucosal arteries and the 
basilar artery is resistant to a-adrenoceptor antagonists and results from the summation 
of individual excitatory junction potentials, the initiation of a muscle action potential 
and the influx of calcium through voltage dependent calcium channels (Hirst, 1977; 
Hirst, Neild and Silverberg, 1982; Morgan, 1983). In these vessels non-adrenergic, non-
cholinergic (NANC) nerve stimulation produces inhibitory junction potentials in 
association with vasodilatation, which are both inhibited by capsaicin (Meehan, 
Hottenstein and Kreulen, 1991; Saito et al., 1989), thus indicating sensory-motor nerve 
activity. In addition, the sensory-motor neurotransmitter in these vessels, CGRP, causes 
a vasodilatation via an increase in cyclic AMP, which in turn activates K+ channels 
(Kitazono, Reistad and Faraci, 1993; Quayle et al., 1994; Nelson et al., 1990). The 
resulting hyperpolarization would thus antagonize the sympathetic nerve-induced 
depolarization and reduce calcium influx through voltage-dependent calcium channels. 
It appears then, that sensory-motor modulation of sympathetic-vasoconstriction occurs 
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via a hyperpolarization in arteries where the constriction occurs as a consequence of 
non-a-adrenoceptor activation and voltage-dependent events. 
In the present study, CGRP acts to inhibit vasoconstriction of these arterioles via 
nitric oxide production and the inhibitory effect of repetitive nerve stimulation on 
neurogenic vasoconstriction is also dependent on the synthesis of nitric oxide. 
Furthermore, there was no hyperpolarization associated with repetitive stimulation of 
iris arterioles every 15 s, but rather the magnitude of the depolarization decreased with 
each train of stimulus. In other vessels where a-adrenoceptors and voltage-independent 
events mediate sympathetic vasonstriction, sensory-motor modulation of this 
constriction also appears to be via the action of nitric oxide and independent of 
hyperpolarization. In the rat aorta, the effects of CGRP on vasodilatation are due to the 
production of nitric oxide (Fiscus et al., 1991; Gray and Marshall, 1992a; Hao et al., 
1994). Nitric oxide has also been reported to inhibit sympathetic vasoconstriction of 
blood vessels in the knee joint (Najafipour and Ferrell, 1993), and in the pulmonary 
artery (Cederqvist et al., 1991). In these latter vessels, sympathetic yasoconstriction is 
mainly mediated by a,-adrenoceptors (Lee et al., 1988; Khoshbaten and Ferrell, 1993; 
Suzuki, 1983). In the pulmonary artery, nitric oxide had no effect on the release of 3tt-
noradrenaline from sympathetic nerves, indicating that this modulation occurs 
postjunctionally (Cederqvist et al., 1991). 
One explanation for the nitric oxide-mediated effect of CGRP is that the 
intracellular calcium available for the CllB-adrenoceptor-mediated constriction of the 
arterioles is reduced. This hypothesis could be tested by imaging cytosolic calcium 
during repetitive nerve stimulation. In aortic smooth muscle, CORP-stimulated 
vasodilatation was associated with a reduction in the concentration of intracellular 
calcium (Ishikawa, Ouchi and Orimo, 1993). Endothelial nitric oxide may produce 
relaxation of vascular smooth muscle via the production of cyclic GMP (Moncada, 
1992). In tum, cyclic GMP may inhibit IP3-induced mobilization of intracellular 
calcium (Murthy et al.; 1993) by phosphorylating the IP3 receptor (Komalavilas and 
Lincoln, 1994), or may lower the concentration of stored intracellular calcium in 
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smooth muscle cells by activating the calcium extrusion pump in the sarcoplasmic 
reticulum (Itoh et al., 1985). 
This chapter demonstrates that in isolated iris arterioles, where 
intracellular calcium release mediates sympathetic vasoconstriction, sensory-motor 
nerves can exert an inhibitory effect on the vasoconstriction via the release of CORP 
and the synthesis of nitric oxide, through a mechanism that is independent of 
membrane hyperpolarization. 
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CHAPTER 6. 
MECHANISM OF 
SENSORY-MOTOR MODULATION 
OF SYMPATHETIC V ASOCONSTRICTION 
INTRODUCTION 
Previous studies indicate that mutual interations occur between sympathetic and 
sensory-motor perivascular nerves. While sympathetic neurotransmitters may act 
prejunctionally to inhibit the release of CGRP from perivascular sensory-motor nerves 
(Lindgren et al., 1987; Matran, Martling and Lundberg, 1989; Kawasaki et al., 1990a; 
Kawasaki et al., 1991; Li and Duckies, 1991; Fuder and Selbach, 1993), it has been 
shown in the rabbit central ear artery and rat mesenteric vessels that CGRP does not 
alter the sympathetic nerve-evoked efflux of 3H-noradrenaline, thus implicating a 
postjunctional. site of inhibition of sympathetic vasoconstriction (Kawasaki et al., 
1990a; Maynard and Burnstock, 1989). 
The predominant effector pathway for CGRP receptor activation is the 
stimulation of adenylate cyclase (Chatterjee et al., 1993; Watson and Girdlestone, 
1994). Intracellular interactions between receptor-activated changes in the level of 
cyclic AMP have been shown to alter the activity of the second messenger pathway 
involving IP3 (Abdel-Latif, 1989; Abdel-Latif, 1991). For example, elevation of cyclic 
AMP, with isoproterenol or forskolin, inhibits muscarinic receptor activated IP3 
formation in the iris sphincter muscle (Tachado, Akhtar and Abdel-Latif, 1989; 
Kharbanda, Nakamura and Kufe, 1993). Both cyclic AMP and cyclic GMP have 
recently been shown to inhibit IP3-dependent intracellular calcium release due to 
agonist stimulation (Murthy et al., 1993). Thus it has been suggested that interaction 
between these two second messenger pathways may be one mechanism for regulating 
contraction and relaxation of smooth muscle (Abdel-Latif, 1991). 
The previous chapter demonstrated that in iris arterioles, sensory-motor nerves 
release CORP which acts via the production of nitric oxide to inhibit sympathetic 
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vasoconstriction. In vessels such as the rat aorta, vascular relaxation by elevated cyclic 
AMP has been shown to occur indirectly via the production of nitric oxide (Gray and 
Marshall, 1992a; Gray and Marshall, 1992b ). 
This chapter investigates further the mechanism by which CORP, released from 
sensory-motor nerves, inhibits sympathetic vasoconstriction of iris arterioles, 1n 
particular the possible involvment of cyclic AMP, as well as nitric oxide. 
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RESULTS 
Effect of increasing intracellular cyclic AMP 
Three agents were used to test the effect of increasing intracellular cyclic AMP 
on the nerve-mediated contractile responses of the iris arteriole: dibutyryl cyclic AMP 
(1 mM; n=3), IBMX, a phosphodiesterase inhibitor (100 µM; n=3) and· forskolin, a 
direct activator of adenylate cyclase (50 µM; n=3). Increasing cyclic AMP with any of 
these three agents abolished the nerve-mediated constriction of the arterioles 
(Figure 6.1 B.). In addition, increasing cyclic AMP caused a dilatation of the arterioles 
(38.5 ± 1.1 µm, n=3, in forskolin, 50 µM; compared to 33.3 ± 1.2 µm, n=3, in control; 
P<0.05; Figure 6.1 A.). Forskolin(O.l µM) also inhibited nerve-mediated depolarization 
-
associated with sympathetic vasoconstriction (Figure 6.2), as well as inhibiting 
spontaneous depolarizationsof iris arterioles (Figure 6.3). 
Does the effect of increased cyclic AMP in the arterioles occur in the arteriolar 
cells or in the semory-motor nerves? 
After inhibiting sensory-motor nerve transmission by treatment with capsaicin 
(10 µM) for 15 min, forskolin (50 µM) still caused a vasodilatation and abolished 
vasoconstriction due to nerve stimulation every 3 min (n=3; Figure 6.4). This suggests 
that the effect of cyclic AMP is postjunctional and not prejunctional. 
Involvement of the GTP-binding protein, Gs 
To investigate the physiological relevance of the effect of cyclic AMP on 
sympathetic nerve-mediated responses, the involvement of the OTP-binding protein, 
Gs, was examined using cholera toxin, which causes ADP ribosylation and permanent 
activation of Gs (Cassel and-Selinger, 1977; Milligan and Mitchell, 1993). Cholera 
toxin (2 µg.m1- l) treatment for 1.5 hours caused a dilatation of the arterioles and 
prevented the nerve-mediated vasoconstriction (n= 3; Figure 6.5). 
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Figure 6.1 
A. Trace illustrating the effect of forskolin (50 µM) on the nerve-mediated contractile 
response of an iris arteriole. Dots indicate onset of nerve stimulation ( 10 Hz, 1 s ). 
Dotted line represents resting vessel diameter of arteriole. Note the vasodilatation in the 
presence of forskolin (50 µm). 
B. Effect of (left to right) dibutyryl cyclic AMP (Bt2cAMP; 1 mM), forskolin (50 µM) 
or isobutylmethylxanthine (IBMX; 100 µM) on the contractile respone evoked by 
nerve-stimulation (10 Hz, 1 s). Columns represent the mean and vertical bars represent 
the s.e.m. of 3 preparations. 
* indicates significant difference from paired control (t-test with Bonferroni correction). 
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Figure 6.2 Trace showing nerve-evoked depolarization and associated contraction recorded from an iris arteriole in control Krebs and after perfusing 
the bath with forskolin (0.1 µM) for 5 min, when the contraction was abolished, or for 13 min, when the depolarization was abolished. 
Dots indicate onset of nerve stimulation (] 0 Hz). 
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Figure 6.3 Trace showing intracellular recordings from a spontaneously depolarizing 
iris arteriole. 
A Spontaneous depolarizations recorded in control Krebs. Dot indicates time of 
nerve stimulation ( 10 Hz) to produce nerve-evoked depolarization. Note that the 
spontaneous depolarizations are abolished for 25 to 30 s after nerve stimulation. 
B Intracellular recording in the presence of forskolin (0.1 µM) at a time when the 
nerve-evoked contraction was blocked but the nerve-evoked depolarization was largely 
unaffected (dot indicates onset of nerve stimulation). Note that the spontaneous 
depolarizations are abolished in the presence of forskolin. 
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Figure 6.4 Effect of capsaicin pretreatment on the response to forskolin. 
A. Contractile responses of arteriole evoked by nerve-stimulation ( 10 Hz, 1 s every 3 
min) after perfusion of chamber with capsaicin (10 µM) for 15 min. 
B. The effect of subsequent addition of forskolin (50 µM) on the nerve-mediated 
contractile response of the arteriole in the continued presence of capsaicin (10 µM). 
Dotted line indicates resting vessel diameter of arteriole in capsaicin alone. Dots 
indicate time of onset of nerve stimulation (10 Hz, 1 s). 
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Figure 6.5 Trace illustrating the effect of cholera toxin (2 µg.mI-1) on the nerve-
mediated contractile response of an iris arteriole. Dots indicate onset of nerve 
stimulation (10 Hz, 1 s every 3 min). Note the vasodilation in the presence of cholera 
toxin. 
Involvement of cyclic AMP in sensory-motor modulation of sympathetic 
vasoconstriction 
The OTP-binding protein, Gs, stimulates adenylate cyclase to catalyse the 
production of cyclic AMP. Inhibition of adenylate cyclase with dideoxyadenosine 
(Schulze, 1982; 1 mM; n=8) prevented the loss of vasoconstriction in response to trains 
of stimuli every 15 s (Figure 6.6). Incubation in dideoxyadenosine (1 mM) caused a 
significant decrease in the resting diameter, indicating there is a basal level of cylic 
AMP production in the arteriole. 
Does the inhibition of vasoconstriction by increased cyclic AMP occur indirectly 
via the production of nitric oxide? 
Forskolin caused a concentration-dependent inhibition of nerve-mediated 
vasoconstriction· in the presence of the inactive D-NAME (10 µM, Figure 6.5). This 
inhibitory effect of forskolin was significantly reduced (P<0.05) in the presence of the 
nitric oxide synthase pseudosubstrate, L-NAME (10 µM), for eac.h concentration of 
forskolin tested (Figore 6. 7). In the absence of forskolin, there was no significant 
difference between the size of the control nerve-mediated constriction, when expressed 
as a percentage of the resting vessel diameter, recorded in the presence of L-NAME 
(28 + 3.1 %; n=lO) or D-NAME (25.5 + 2.2 %; n=lO) alone. 
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Figure 6.6 Effect of dideoxyadenosine ( 1 mM) on contractile responses evoked by 
nerve-stimulation ( 10 Hz, 1 s) every 15 s. Dot indicates the first of 6 pulses of stimuli 
applied every 15 s. A. Control contractile responses to nerve stimulation, B. contractile 
responses in the presence of dideoxyadenosine ( 1 mM) and C. contractile responses 
after washout in control Krebs. 
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Figure 6.7 Effect of forskolin on nerve-mediated contractile response (10 Hz, 1 s every 
3 min) in the presence of D-NAME (10 µM, open columns) and L-NAME (10 µM; 
stippled columns). Columns and vertical bars represent mean and s.e.m. of 3 to 4 
preparation . 
* indicates significant difference between D-NAME and L-NAME for the same 
concentration of forskolin (t-test with Bonferroni correction). 
DISCUSSION 
The predominant effector pathway following CORP receptor activation is the 
elevation of cyclic AMP (Chatterjee et al., 1993; Watson and Girdlestone, 1994). In the 
present study, elevation of intracellular cyclic AMP, using three different agents, 
produced a relaxation of the arterioles and an inhibition of nerve-mediated constriction. 
The physiological relevance of elevated cyclic AMP was tested by examining the 
presence of the GTP binding protein, Gs, in the arterioles using cholera toxin, which 
causes ADP ribosylation and permanent activation of Gs and adenylate cyclase (Cassel 
and Selinger, 1977; Milligan and Mitchell, 1993). Cholera toxin caused a vasodilatation 
and prevented the nerve-mediated constriction of the arterioles, suggesting that 
receptors coupled to Gs were present on the arterioles. 
Increases in cyclic AMP in sensory axons due to the activation of prejunctional 
receptors leads to an increase in neurotransmitter release from sensory-motor nerves 
(Rhoden and Barnes, 1990). For example, in the rabbit iris sphincter, activation of A2-
adenosine receptors on the sensory-motor nerves enhances sensory-motor nerve 
transmission (Gustafsson and Wiklund, 1986). It is possible that the activation of such 
receptors on the sensory-motor nerves, with the resultant elevated cyclic AMP, may 
produce an increased release of neuropeptides which may be responsible for the 
inhibition of sympathetic vasoconstriction via a postjunctional mechanism not involving 
cyclic AMP. This possibility was tested by examining the effect of forskolin on nerve-
mediated responses after treatment with capsaicin, to inhibit sensory-motor nerve 
transmission (Holzer, 1991 b ). In these experiments, forskolin still inhibited sympathetic 
vasoconstriction as well as producing a relaxation of the arterioles independently of 
sensory-motor nerve activity. These results thus show that the ability of cyclic AMP to 
inhibit arteriolar constriction is a postjunctional event and is not due to a prejunctional 
effect on sensory-motor nerves. 
CORP has been identified as the neurotransmitter which mediates the inhibitory 
effect of sensory-motor nerves on sympathetic nerve-mediated constriction in iris 
arterioles (Chapter 5). In the present study, inhibition of adenylate cyclase with 
dideoxyadenosine also prevented the loss of sympathetic vasoconstriction produced by 
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trains of stimuli every 15 s. These results provide evidence for the involvement cf 
adenylate cyclase and cyclic AMP in the sensory-motor interaction with sympathetic 
vasoconstriction. 
In the previous chapter it was demonstrated that the inhibitory effect of CORP 
on sympathetic vasoconstriction was due to the production of nitric oxide. Endothelial 
nitric oxide produces vasodilatation of vascular smooth muscle by activating the 
production of cyclic GMP (Moncada et al., 1991). In blood vessels such as the rat aorta 
and porcine palmar lateral vein, elevated cyclic AMP levels produce an increase in 
cyclic GMP, suggesting that an interaction occurs between these two second 
messengers (Gray and Marshall, 1992a; Gray and Marshall, 1992b; Wright, 
Amirchetty-Rao and Kendall, 1994). In the rat aorta, effects of increased cyclic AMP 
following activation of either 8-adrenoceptors or CORP-receptors are mediated 
indirectly via the production of nitric oxide by the endothelium (Gray and Marshall, 
1992a; Gray and Marshall, 1992b). In the present study, inhibition of nitric oxide 
synthesis with L-NAME prevented the inhibition of sympathetic nerve-mediated 
vasoconstriction produced by forskolin. This suggests that in the arterioles, elevation of 
cyclic AMP also inhibits nerve-mediated vasoconstriction indirectly via the production 
of nitric oxide. The activity of NOS has been reported to be affected by phosphorylation 
by a number of cellular kinases (Bredt, Ferris and Snyder, 1992). A phosphorylation 
site for the cyclic AMP-dependent protein kinase A on NOS has been identified (Bredt, 
Ferris and Snyder, 1992) and this may provide a mechanism for the above response in 
the arterioles. 
Elevation of intracellular cyclic AMP caused an inhibition of both spontaneous 
and neurogenically mediated depolarizations. One explanation for this is that cyclic 
AMP pathway is acting intracellularly to reduce the release of calcium. This is 
consistent with the cyclic AMP-dependent activation of nitric oxide to inhibit 
sympathetic vasoconstriction as described in the previous chapter. 
The present results indicate a postjunctional site for the inhibition of sympathetic 
vasoconstriction by neurally-released CORP. This interaction occurs as a result of the 
sequential activation of Gs, adenylate cyclase and NOS. 
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CHAPTER 7. 
SENSORY-MOTOR MODULATION 
OF SYMPATHETIC NERVE-EVOKED 
CONTRACTION -
A COMMON PHENOMENON? 
INTRODUCTION 
In the previous two chapters it was demonstrated that neurotransmitter released 
from sensory-motor nerves causes the pr-0duction of second messengers, including 
cyclic AMP, which act to inhibit sympathetic constriction of the iris arterioles. In 
bovine iris sphincter muscle there is also a recipricol effect between muscarinic 
receptor-activated IP3 formation and cyclic AMP formation (Tachado, Akhtar and 
Abdel-Latif, 1989; Tachado et aL, 1992). 
This chapter examines whether an interaction of such second messenger systems 
activated by sympathetic and sensory-motor nerves occurs in other sympathetic nerve 
target tissues, and could therefore be considered to represent a general regulatory 
mechanism. The rat iris dilator muscle was chosen for this study since a lB-
adrenoceptor activation mediates the sympathetic nerve-evoked contraction of both the 
iris dilator muscle and the arterioles found within the stromal layer of the iris 
(Takayanagi, Shiraishi and Kokubu, 1992; Hill et al., 1993; see Chapter 1.). 
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RESULTS 
lmmunohistochemistry 
Double-labelling immunohistochemical studies were designed to investigate the 
anatomical relationship of both the sympathetic and sensory-motor nerve fibres with the 
dilator muscle, using antibodies against tyrosine hydroxylase for the sympathetic fibres 
and antibodies against substance P for the sensory fibres. In relation to the iris dilator 
muscle, the sympathetic fibres farmed a fine, varicose network over the anterior sutface 
of the muscle (Figure 7 .1 A), while the sensory fibres were not found in this focal plane 
(Figure 7 .1 B). The sensory fibres were, however, distributed through the stroma 
anterior to the dilator layer (Figure 7 .1 C) where the sympathetic fibres could also be 
found (Figure 7 .1 D). These results were confirmed in iris sections, where the 
substance P-like immunoreactivity could be seen in the stroma but rarely in contact with 
the dilator muscle, while the tyrosine hydroxylase-like immunoreactive fibres were 
found along the anterior surface of the dilator muscle as well as in the stroma. Thus, the 
sympathetic and sensory fibres did not demonstrate the same anatomical relationship 
with the dilator muscle -as they did with the iris arterioles (see Figure 5.11). 
Effect of interval between stimulus trains 
A consistent contraction of the dilator muscle was produced by stimulation of 
the transmural nerves at 10 Hz for 1 s every 3 min or every 15 s (n=3 ; Figure 7.2). 
These results suggest that activation of the sympathetic nerves produced a contraction 
of the iris muscle which was not altered by rapid stimulation, as it was in the iris 
arterioles ( see Figure 5 .1). 
Expression of tachykinin receptors in the iris 
In order to determine whether the genes for the receptors for the sensory-motor 
neuropeptides were expressed in the iris tissue, RT-PCR was performed using receptor-
specific primers for the tachykinin receptor subtypes. The expression of CGRP 
receptors was not examined, as at the time of these experiments their sequence was 
unknown. 
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Figure 7.1 Double-labelling immunohistochemistry showing sensory, substance P 
(Panel 8 0) and sympathetic, adrenergic (Panel AC) nerve fibres within the stroma of the ~ ) 
rat iris. A dense network of varicose sympathetic fibres showing immunoreactivity for 
tyrosine hydroxylase can be seen along the anterior surface of the dilator muscle (Panel 
A). At the same focal plane, the sensory fibres are out of focus (Panel B). By contrast, 
when the sensory fibres within the stroma are in focus (Panel D), the sympathetic fibres 
can be seen in the stroma (Panel C). Calibration bar represents 50 µm. 
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Figure 7.2 Traces showing the dilator muscle contractile responses to trains of nerve-stimulation (10 Hz, 1 s) A. every 3 min and B. every 15 s. 
Dots indicate onset of nerve stimulation. 
Both NK1- and NK3-tachykinin receptor primers generated PCR products of the 
appropriate size; 537 base pairs for the NK1 -tachykinin receptor and 476 base pairs for 
the NK3-tachykinin receptor primer sets (Figure 7.3). Under similar conditions and 
using cDNA from the same RT pool, no PCR products were detected by the NK2-
tachykinin receptor primers in the iris tissue (Figure 7.3). The NK2-tachykinin receptor 
primers did, however generate a product of appropriate size (443 base pairs) from rat 
brain cDNA, as did the primer sets for the NK 1- and NK3-tachykinin receptors (537 
and 476 base pairs respectively). This demonstrates the presence of mRNA for both 
NK1- and NK3-tachykinin receptors in the dilator muscle and the iris stromal layer in 
which the arterioles are found. As it was not possible to dissect the dilator muscle away 
from the stroma and arterioles, it was not"possible to determine the exact location for 
the mRNA for these receptors. 
Autoradiographical localization of binding sites for SarSP and CGRP 
The distribution of binding sites for the NK1-tachykinin receptor agonist, SarSP, 
and for CORP wa~ investigated in whole mounts and sections of iris using 
autoradiography. The results obtained with both SarSP and CORP were similar and 
hence will be discussed together. In whole mount preparations of the iris, specific 
binding sites were detected over the whole surface of the dilator muscle. The larger 
arterioles running across the dilator muscle were further delineated by silver grains 
(Figure 7 .4 A for CORP and Figure 7.4 C for SarSP). In spite of the arterioles in these 
areas being of comparable size in all preparations (about 50 µm in diameter, see arrows 
in Panels B and D), the arterioles delineated by binding sites for CORP (Figure 7.4 A) 
were consistently larger than those delineated by binding sites for SarSP (Figure 7.4 C). 
In whole mounts incubated in the presence of an excess of unlabelled ligand, non-
specific binding of labelled ligands was seen as a lower density of silver grains over the 
surface of the dilator muscle. Blood vessels were no longer highlighted by silver grains 
(Figure 7.4 B, D, arrows). 
In order to determine the exact location of the neuropeptide binding seen in the 
iris whole mounts, in relation to the surface of the dilator muscle, transverse sections of 
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Figure 7.3 Agarose gel electrophoresis of RT-PCR products amplified with receptor-
specific primers for NK1- (lanes 2,3), NK2- (lanes 4,5) and NK3- (lanes 6,7) tachykinin 
receptors. RNA used in RT-PCR was isolated form iris dilator and stromal tissue. A 
specific band of 537 base pairs (lane 2) was generated with the NK1 primer pair and a 
476 base pair product (lane 6) from the NK3 primer pair. No PCR product was 
generated from the same cDNA pool with the NK2 receptor specific primers (lane 4). 
No PCR products were seen in the receptor-specific control experiments which contain 
no reverse transcriptase in the RT reaction (lanes 3, 5, 7). DNA size markers 
(X 17 4/HaeIIl) appear in lane 1. 
0.60kb-
0.31kb-
1234567 
Figure 7.4 Distribution of binding sites for BHSarSP and [125J]CGRP over whole 
mounts of the rat iris. Whole mounts were incubated with either 60 pM [ 125J]CGRP 
(Panel A, B) or 75 pM BHSarSP (Panel C, D). Whole mounts are oriented with the 
ciliary processes at the upper right corner and the sphincter muscle beyond the lower 
left corner. Non-specific binding was defined in the presence of an excess (1 µM) of 
cold ligands (Panel B, D respectively). Arrows indicate the edges of the arteriole in 
these whole-mounts, as determined from overexposed prints of the same negative. Note 
that the specific binding for both ligands was associated with both the dilator muscle 
and the arteriole of the iris. Calibration bar represents 150 µM for Panels A, B and 
7 5 µm for Panels C, D. 

the iris were incubated with BHSarSP. In these sections, silver grains were found 
throughout the stroma rather than being specifically associated with the anterior sutface 
of the dilator muscle (Figure 7.5 A, see also Figure 7.5 C for iris morphology, arrow 
marks the posterior surface of the dilator muscle). Non-specific binding in adjacent 
sections was low and could be seen over the whole of the iris sections (Figure 7 .5 B, D). 
Thus, binding sites for the NK1-tachykinin receptor agonist, SarSP, and for CGRP were 
distributed over the surface of the arterioles and throughout the stromal tissue of the iris, 
but did not appear to be specifically associated with the surface of the dilator muscle. 
Effect of SarSP and CGRP on sympathetic nerve-evoked contraction 
In order to determine a possible efferent functional role of the sensory-motor 
nerves on the iris dilator muscle, the effect of the the NK1-tachykinin receptor agonist, 
SarSP and the effect of CGRP on sympathetic contraction were tested. Neither SarSP 
(10 nM; n=3) nor CGRP (10 nM; n=3) altered the resting tone of the dilator muscle, nor 
did they have any effect on the size of the contraction fallowing trans mural nerve 
stimulation (Figure 7 .6). In contrast, these concentrations of SarSP and CGRP produced 
a dilatation and an inhibition of nerve-mediated constriction of the iris arterioles (see 
Figure 5.7; Table 5.1). 
Effect of increasing intracellular cyclic AMP 
Three agents were used to test the effect of increasing intracellular cyclic AMP 
on the nerve-mediated contractile response of the iris dilator muscle: dibutyryl cyclic 
AMP (1 mM; n=3), IBMX (100 µM; n=3), a phosphodiesterase inhibitor, and forskolin 
(50 µM; n=3), a direct activator of adenylate cyclase. Increasing cyclic AMP with any 
of these three agents produced a relaxation of the dilator muscle and a concomittent 
potentiation of the nerve-evoked contraction (Figure 7.7 A, B). 
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Figure 7 .5 Binding sites for BHSarSP in transverse sections of the rat iris. Total and 
non-specific binding were seen in sections incubated with BHSarSP in the absence 
(Panel A) or presence (Panel B) of an excess of unlabelled ligand. Panel Bis printed so 
that the background is comparable to that in Panel A, while Panel D is deliberately 
overexposed to demonstrate the position of the iris section. A similar iris section is 
stained with haematoxylin and eosin in Panel C with an arrow marking the position of 
the posterior surf ace of the iris, along which lie the two epithelial layers, the inner of 
which comprises the myoepithelial cells of the dilator muscle. Calibration bar 
represents 7 5 µm. 
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Figure 7.6. Traces showing the effect of SarSP (10 nM; Panel A) and B CGRP (10 
nM; Panel B) on the dilator muscle contractile response to nerve stimulation every 3 
min. Dots indicate the onset of nerve stimulation (10 Hz, 1 s). 
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Figure 7.7 
A. Trace illustrating the effect of forskolin (50 µM) on the nerve-mediated 
contractile response of the dilator muscle. Dots indicate onset of nerve stimulation 
(10 Hz, 1 s). 
B. Effect of (left to right) dibutyryl cyclic AMP (Bt2cAMP; 1 mM; n=3), 
forskolin (50 µM; n=3) or 3-iso-butyl-1-methyl-xanthine (IBMX; 100 µM ; n=3) on the 
dilator muscle contractile response evoked by nerve stimulation (10 Hz, 1 s ). Columns 
represent the mean and vertical bars respresent the s.e.m. of the number of preparations 
indicated in parenthesis. 
* indicate significant difference from paired control (t-test with Bonferroni correction). 
DISCUSSION 
The present study has compared the distribution and possible efferent function 
of capsaicin-sensitive sensory nerve fibres, and the expression and distribution of 
receptors for both substance P and CGRP in the dilator muscle and the arterioles of the 
iris. The results of this chapter demonstrate that Cl lB-adrenoceptors mediating 
sympathetic nerve-evoked contraction of the iris dilator muscle are not subjected to the 
same regulatory mechanisms as are CllB-adrenoceptors mediating sympathetic 
constriction of iris arterioles. 
The albino rat iris is supplied with nerves which are immunoreactive for the 
sensory neurotransmitters, CGRP and substance P (Olson et al., 1988). It was recently 
demonstrated that fibres containing both substance P and CORP were found mainly in 
the anterior half of the stroma and rarely near the dilator muscle (Hirai et al., 1994). On 
the other hand, recent imm unohistochemical studies of the relationship of the sensory 
and sympathetic fibres supplying iris arterioles have demonstrated that both the CORP-
and substance P-like immunoreactive fibres came into close proximity to the smooth 
muscle cells of these vessels (see Chapter 5). The confocal microscope was used to 
demonstrate that the varicosities of these peptidergic fibres lay close to the arteriolar 
smooth muscle cells, in the same focal plane as the adrenergic fibres. With regard to the 
dilator muscle, fibres showing substance P-like immunoreactivity did not lie in the same 
focal plane as the adrenergic fibres but were instead removed from the dilator muscle. 
Although the sensory fibres did not lie very close to the dilator muscle, it was still 
possible that they could release transmitter from a distance to influence the dilator 
muscle activity. 
The distribution of binding sities for the NK1-tachykinin receptor agonist, 
SarSP, and for CGRP in the iris were similar. Binding sites were distributed throughout 
the stroma but did not appear to be specifically associated with the anterior surface of 
the dilator. Thus the dilator muscle does not appear to have binding sites for these 
sensory neuropeptides. In contrast, specific binding sites for both SarSP and CORP 
were associated with the arterioles of the iris. Furthermore, it was observed that the 
arterioles delineated by the CGRP ligand appeared to be larger in diameter than the 
100 
blood vessels delineated by the SarSP ligand. Previous studies have demonstrated that 
the vasodilatory actions of substance Pare endothelium-dependent (Maggi et al., 1990; 
Stephenson, Burcher and Summers, 1986; Saito et al., 1990), as is the effect of CGRP 
on the iris arterioles (see Chapter 5). The apparently larger size of the arterioles 
following incubation with CGRP suggests that the CGRP binding sites are located on 
both the endothelial and smooth muscle cells. Unfortunately it was not possible to 
remove the endothelial cells from these arterioles to clarify this point. 
RT-PCR supported the autoradiographical results in demonstrating that mRNA 
for the NK1 -neurokinin receptor is expressed in the iris. In addition, these studies 
detected mRNA for NK3-, but not NK2-, tachykinin receptors in the iris. While it has 
been previously demonstrated that the NK3-tachykinin receptor is expressed in the 
whole eye (Shigemoto et al., 1990), this finding was unusual as neurokinin B levels in 
peripheral tissues are very low or, in many cases, undetectable (Hua et al., 1985; Too, 
Cordova and Maggio, 1989b ). Functional studies in the rabbit iris sphincter found that 
NK 1- and NK3-, but not NK2-, tachykinin receptor selective agonists were potent 
contractile agents (Hall, Mitchell and Morton, 1993; Hall, Mitchell and Morton, 1991; 
Wang and Hakanson, 1993). However, the tissue used in the present experiments 
contained only the dilator muscle and the connective tissue stroma containing the blood 
vessels; the ciliary processes and the sphincter muscle having been removed prior to the 
RNA extraction. Thus the observed expression of mRNA for the NK3-neurokinin 
receptor could not be due to the inclusion of the sphincter muscle. There appear to be no 
previous reports in the rat iris for the presence of neurokinin B, the endogenous 
preferred ligand for the NK3-neurokinin receptor (Maggi, 1995), although the receptor 
could be activated by less potent endogenous neurokinin ligands or the mRNA may not 
be translated into protein. Further studies are required to answer these questions. 
Neither CGRP nor the NK1-tachykinin receptor agonist, SarSP, at 10 nM, 
affected the tone of the dilator -muscle nor the ability of the sympathetic fibres to elicit 
contaction of the dilator muscle. At this concentration the inhibitory effect of these two 
peptides on iris arteriolar constriction is maximal (Table 5.1), while their vasodilatory 
effects in other blood vessels are maximal at much lower concentrations (Han, Naes and 
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Westfall, 1990; Kawasaki et al., 1990a; Kawasaki et al., 1988; Withrington, 1992). 
Furthermore, stimulus conditions which led to the activation of sensory-motor nerves in 
the arterioles failed to influence the sympathetic nerve-evoked contraction of the iris 
dilator muscle. These results support the binding studies which suggested that there are 
few, if any, receptors for substance P and CGRP on the rat dilator muscle surface. 
Previous studies indicate that substance P and CGRP released from sensory-
motor nerves mediate the ocular responses to injury, that is, miosis, conjunctive 
hyperaemia and an aqueous flare· response (see Unger et al., 1985). The present study 
demonstrates that neither CORP nor SarSP alter the tone of the iris dilator muscle. 
Consistent with this, substance P has also been shown to have no effect on the dilator 
muscle of rabbits and cows, even up to 10-µM (Soloway, Stjemschantz and Sears, 1981; 
Suzuki and Kobayashi, 1983), a concentration which causes contraction of the iris 
sphincter muscle· in several species (Tachado et al., 1991). The intravitreal injection of 
CGRP into the rabbit eye does not cause miosis, but causes vasodilatation and the 
aqueous flare response. Intracameral injection of substance P causes miosis, increase in 
intro-ocular pressure- and an aqueous flare response (Oksala, Stjernschantz and vo·n 
Dickhoff, 1989). The above results together indicate that the miotic pupil response 
occurs as a result of the release of substance P to cause contraction of the sphincter 
muscle, without a contribution from the dilator muscle, as the current results show it 
does not receive a functional sensory-motor innervation. 
In the dilator muscle, the absence of sensory nerve fibres was well correlated 
with the absence of of binding sites for SarSP and CORP and the absence of 
responsiveness of the tissues to applied neuropeptide. Such a correlation suggests that 
the nerve fibres may be important for the expression of thereceptors. 
In small cutaneous arterioles, there is a good correlation between the presence of NPY 
fibres and the ability of these arterioles to respond to exogenous NPY (Morris, 1994a). 
In the iris arterioles, however, there was a paucity of sensory fibres and an abundance of 
binding sites for SarSP and CORP, suggesting that there is not always such a close 
correlation between the presence of the nerves and the level of receptor expression. 
Mismatches between receptor localizations and neurotransmitter types have been 
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described in the brain (Herkenham, 1987) and removal of the cholinergic neurones 
innervating the sweat glands of the rat foot, either during development or in the adult, 
failed to produce any change in the expression of the muscarinic receptors in that tissue 
(Grant and Landis, 1991; Grant, Landis and Siegel, 1991). 
The presence of NK1-tachykinin and CGRP receptors within the stroma suggest 
that the sensory fibres may also be performing an efferent function perhaps in addition 
to their more conventional afferent role. Antigen-presenting cells derived from the bone 
marrow have been demonstrated in the iris and ciliary body of mouse eyes (Williamson, 
Bradley and Streilein, 1989) and these cells form a network within the stromal layer of 
the iris (Knisely et al., 1991). These cells may well bear on their surfaces the binding 
sites for neuropeptides demonstrated in the present chapter, since a number of 
neuropeptides, including substance P and CGRP, have been shown to positively and 
negatively modulate macrophage effector functions (Nong et al., 1989; Peck, 1987). 
In the present study, not only was there no evidence for a functional sensory 
AMP 
fibre innervation of the dilator muscle, but the response to cyclic "'Wf!S different than in 
the arteriole. Elevated·intracellular cyclic AMP caused a relaxation of the dilator muscle 
and a concomitant potentiation of the nerve-mediated contraction. This latter effect 
most likely occurred as a result of the change in resting tone of the tissue due to 
elevated cyclic AMP. Thus, an increase in cyclic AMP had the opposite effect 
on the sympathetic nerve-mediated contraction of the iris dilator muscle to that of iris 
arterioles, in spite of apparently identical receptor subtypes mediating both responses. 
The interaction between a lB-adrenoceptors and receptors coupled to increases in cyclic 
AMP in iris arteriole occurs as a result of the cyclic AMP-dependent activation of NOS 
(see Chapter 6). Since constitutive NOS is found in endothelial cells and not smooth 
muscle cells (Leone et al., 1991), the failure of cyclic AMP to inhibit the sympathetic 
nerve-evoked contraction of the dilator muscle appears to be due to the absence of NOS 
in the dilator muse le cells. 
In conclusion, there is no evidence that the dilator muscle receives a sensory-
motor innervation, nor that activation of these nerves can modulate sympathetic nerve-
induced contraction. While sensory-motor nerve activity produces a loss of sympathetic 
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vasoconstriction with repetitive nerve-stimulation thereby acting to maintain the blood 
flow to the iris in vivo, activation of sensory-motor nerves does not affect the contractile 
response of the dilator muscle produced by sympathetic nerve-stimulation thus 
permitting sustained pupil dilation. Furthermore, cyclic AMP does not interact with the 
sympathetic contractile response of the dilator muscle, as it does in the iris arterioles. It 
is therefore unlikely that activation of other receptors on the iris dilator muscle which 
are coupled to elevated cyclic AMP, such as B-adrenoceptors, could modulate the 
response to sympathetic nerve stimulation, as do CORP receptors on the arterioles. 
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CHAPTERS. 
GENERAL DISCUSSION 
Arterial smooth muscle tone is subject to physical, hormonal and nervous 
influences, all of which act to maintain blood flow within the body (Johnson, 1978). It 
is important to understand the mechanisms which control arteriolar diameter, as these 
small diameter vessels provide the greatest contribution to the resistance to peripheral 
blood flow (see Chapter 1). This thesis has investigated the peripheral nervous control 
of such an arteriole in the rat iris. 
Sympathetic nerve stimulation produces a constriction of iris arterioles which is 
due to the activation of postjunctional a lB-adrenoceptors. In contrast to previous 
studies where sympathetic neurotransmission in arterial vessels involves non-a-
adrenergic mechanisms (see Table 1.1), the results of this thesis suggest that non a-
adrenergic mechanisms do not exist in all resistance vascular beds. The arterioles in the 
current study are not being perfused, but rather superfused, with oxygenated Krebs. 
Non-a adrenergic neurogenic responses have been recorded in mesenteric arterioles 
(Hirst and Neild, 1980a) and the basilar artery (Hirst, Neild and Silverberg, 1982) under 
the same experimental conditions, and using similar stimulus parameters, so the purely 
a-adrenergic neurogenic responses recorded in the iris arterioles are not likely to be an 
artefact of the present experimental conditions. 
Smooth muscle contraction occurs following the elevation of intracellular 
calcium, which may occur as a result of the release of stored intracellular calcium or the 
influx of extracellular calcium (Hirst and Edwards, 1989). The contractile response of 
iris arterioles was only partly dependent on the influx of calcium through voltage-
dependent calcium channels, thus suggesting an initial voltage-independent mechanism. 
The findings of this thesis indicate that the sympathetic contractile response of iris 
arterioles occurs primarily as a result of the release of intracellular calcium, followed by 
the influx of extracellular calcium. 
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Hashimoto et al. ( 1986) demonstrated that a1-adrenoceptor 
pharmacomechanical coupling, that is, contraction occurring independently of 
depolarization (Somlyo and Somlyo, 1968), in vascular smooth muscle occurs as a 
result of stored intracellular calcium released following IP3 production. Consistent with 
this, the changes in amplitude and time to maximum depolarization recorded from iris 
arteriolar smooth muscle cells in response to increasing numbers of pulses in the 
stimulus train are consistent with the non-linear relationship between increases in the 
levels of IP3 and evoked membrane chloride currents (Parker and Miledi, 1989; Miledi 
and Parker, 1989). Further indications for the utilization of IP3-mediated intracellular 
calcium release for iris arteriole contraction came from preparations where spontaneous 
contractions and depolarizations were recorded. These had frequencies in the range 
previously described for oscillations in intracellular calcium from intracellular stores 
(Berridge and Galione, 1988). Such oscillations may occur as a result of a second 
messenger, such as IP3, acting at the sarcoplasmic reticulum to produce periodic uptake 
and release of calcium (Berridge and Galione, 1988). Caffeine abolished both the nerve-
evoked contraction and depolarization as well as substantially reducing the spontaneous 
depolarizations. Furthermore, the spontaneous depolarizations of iris arterioles were 
abolished by elevation of cyclic AMP, which has been shown to reduce levels of stored 
intracellular calcium in other smooth muscle tissues (Abe and Karaki, 1989; Ishikawa, 
Ouchi and Orimo, 1993). 
From the above, we would predict that the spontaneous contractions and 
depolarizations are being initiated by changes in intracellular calcium and would 
therefore be insensitive to inhibition of voltage-dependent calcium channels. The role of 
IP3 in the neurogenic contraction could be tested by determining whether the responses 
to exogenous IP3 mimic the nerve-evoked contraction and depolarizations. In addition, 
experiments on arteriolar neurogenic contractions in combination with the imaging of 
cytosolic calcium using pharmacological agents which interfere with the IP3 pathway, 
for example inhibitors of phospholipase C, or those which may lower stored 
intracellular calcium, for example cyclic AMP or cyclic GMP would further 
characterize how changes in intracellular calcium relate to the neurogenic contractile 
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response of the iris arterioles. These experiments could be done in the presence of 
voltage-dependent calcium channel antagonists to prevent any influx of calcium which 
occurs with supramaximal stimulus. 
While non-a adrenergic mechanisms appear to activate voltage-dependent 
contractile responses, a-adrenoceptors appear to mediate all the voltage-independent 
contractile responses that have been observed in response to sympathetic nerve 
stimulation (present study; see Hirst and Edwards, 1989 for review). In the 
anococcygeus muscle and rat tail artery, it has been reported that a-adrenoceptor 
mediated contraction preceded the depolarization, suggesting no cause and effect 
relationship between the depolarization and contraction (Byrne and Large, 1985; 
Cheung, 1984 ). Further evidence for the voltage-independence of neurogenic a-
adrenoceptor mediated contractions is that nerve-evoked a-adrenergic depolarization 
can produce contraction when the membrane potential is at a more hyperpolarized value 
than the threshold potential for an action potential (Cheung, 1984). Similarly, a small 
contraction of iris arterioles was observed in response to one stimulus pulse, which was 
associated with a change in membrane potential which would not be expected to open 
voltage-dependent calcium channels. Rather than being voltage-dependent events, a-
adrenoceptor mediated contractions and depolarizations can be seen to reflect changes 
in intracellular calcium (present study; Hirst and Edwards, 1989; Parker and Miledi, 
1989). 
With larger stimulus strengths applied to the iris arterioles, the resulting 
depolarization was sufficiently large enough to open voltage-dependent calcium 
channels and allow calcium influx through these channels to contribute to the 
depolarization and contraction. Thus, while neurogenic a-adrenoceptor contractions are 
not voltage-initiated, with sufficient stimulus, initiation of an action potential may 
superimpose over the associated depolarization to potentiate the level of intracellular 
calcium and cause an additional increment in the size of the contraction (see also Hirst 
and Edwards, 1989). 
Arterial smooth muscle cells are electrically coupled to form a syncitium (see 
Hirst and Neild, 1978). The smooth muscle cells of the iris arterioles show resting 
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membrane potentials and electrical coupling characteristics (Hirst et al, 1996, submitted 
for publication) comparable to those of other arterial vessels (Hirst and Edwards, 1989; 
Kuriyama, Kitamura and Nabata, 1995). The electrical properties of the arterioles 
therefore do not provide an explanation for the lack of a non-a adrenergic component of 
sympathetic neuroeffector transmission in iris arterioles. 
The only other mature arterial vessel where a purely a-adrenoceptor mediated 
contraction and depolarization have been recorded in response to sympathetic nerve 
stimulation is the pulmonary artery (Suzuki, 1983), however, a-adrenoceptor mediated 
sympathetic nerve-evoked responses occur in veins (Holman et al., 1968; Cheung, 
1985; van Heiden, 1988). It has therefore been suggested that a-adrenoceptors mediate 
sympathetic neuroeffector transmission 1n vessels which are subject to low perfusion 
pressures whereas in systemic arteries, which are exposed to higher perfusion pressures, 
the responses to· sympathetic nerve stimulation are resistant, to some degree, to a-
adrenoceptor antagonists (Hirst and Edwards, 1989). This may provide an explanation 
for the purely a-adrenoceptor mechanism for sympathetic neuro-effector transmisssion 
in the iris arterioles. It has been determined that, in cats, the blood pressure at the origin 
of the ciliary arteries is about 19 mmHg lower than in the common carotid artery and 
about 15 mmHg lower than in the femoral artery (Bill, 1963; Bill, 1966). The blood 
flow in the eye in rabbits has been estimated to be 0.32 mg.m1-l.gm-l, which is 46 % of 
the cerebral blood flow (Bill and Nilsson, 1985). The blood flow in the eye is therefore 
lower than in other parts of the circulatory system. Within the eye itself, the blood flow 
in the iris is almost one tenth of that in the choroid (Stjernschantz, Alm and Bill, 1976). 
It may be that non-a-adrenoceptor mechanisms are sensitive to the blood flow in vivo, 
their influence being down-regulated by a low blood flow or perfusion pressure. 
The activation of B-adrenoceptors causes hyperpolarization of the mesenteric 
and coronary arteries (Mulvany, Nilsson and Flatman, 1982; Itoh, Izumi and Kuriyama, 
1982). If a B-adrenoceptor blocker is not present in the perfusing solution then any 
depolarization produced by noradrenaline may be reduced by a B-adrenergic effect. It 
has been demonstrated that the depolarization dose-response curve for noradrenaline on 
the basilar artery is shifted to the left in the presence of a B-adrenoceptor antagonist 
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(Harder, Abel and Hermsmeyer, 1981). However, an a-adrenoceptor antagonist 
abolished all responses to nerve stimulation. In addition, a 8-adrenoceptor antagonist 
did not increase the magnitude of neurogenic vasoconstriction (results not shown), 
which would indicate the unmasking of an additional effect of noradrenaline. It is 
therefore unlikely that a voltage-dependent non-a-adrenergic response was being 
masked by 8-adrenoceptor activation in this preparation. 
The present study has only investigated arteriolar neurogenic contraction under 
one set of stimulus parameters, that is, 10 Hz for 1 s. It is yet to be determined whether 
the mechanism for iris arteriolar contraction varies with different stimulus frequencies. 
For example, the contribution of NPY to sympathetic-evoked vasoconstriction is 
reported to be more pronounced following longer trains of, or higher frequency, 
stimulation (Morris and Murphy, 1988; Pernow et al., 1989). NPY-like 
immunoreactivity has been located in tyrosine hydroylase-like immunoreactive 
sympathetic fibres associated with blood vessels in the rat iris (Olson et al., 1988), 
suggesting that under certain stimulus conditions NPY may play a role in sympathetic 
vasoconstriction. In- the presence of benextramine, to inhibit postjunctional a-
adrenoceptor responses to depolarization-evoked release of noradrenaline, KCl-induced 
contraction is reduced by 70 % in the presence of nifedipine (10 µM, Chapter 4). The 
remaining 30 % of the contraction may be produced by the depolarization-evoked 
neural release of NPY. This further suggests that with sufficient stimulus strength NPY 
may be released from sympathetic nerves supplying the iris arterioles. 
NPY Y 1 receptors, which are reported to mediate vasoconstricton and to 
potentiate constrictor response to noradrenaline (Grundemar and Hakanson, 1993), are 
coupled to a reduction in cyclic AMP (Watson and Girdlestone, 1994). In addition to 
producing hyperpolarization, B-adrenoceptor activation produces elevated cyclic AMP 
levels (Watson and Girdlestone, 1994), which could counteract, and possibly mask, any 
postjunctional responses that may have been produced by neurally-released NPY. 
However, as mentioned previously we have no evidence for the activation of 8-
adrenoceptors by neurally-released noradrenaline. Elevation of cyclic AMP by the 
activation of A2-adenosine or CGRP1 receptors present on the iris arterioles (Watson 
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and Girdlestone, 1994; Gould, Vidovic and Hill, 1995, Chapter 5) might however 
counteract postjunctional NPY Y 1 receptor-mediated contraction. 
Alpha-adrenoceptor subtypes may be sensitive to physical conditions such as 
pH. For instance, the exogenous noradrenaline curve on the rabbit aorta is competitively 
shifted to the right by acidosis (pH 7.24-6.51). The maximum tension produced by 
noradrenaline was no different between pH 7 .24-6.90 or during alkalosis (pH 7 .61-
8.04 ), but was decreased by 30 % at pH 6.51 (Stokke et al., 1984). The authors 
concluded that high concentration of hydrogen ions may exert a-adrenoceptor 
antagonist properties. A differential sensitivity of a 1- and a2-adrenoceptors to acidosis 
has been demonstrated in the pithed rat, where a2-adrenoceptor responses are favoured 
in acidosis (Grant, McGrath and O'Brien, 1 985). This may be due to an inhibitory effect 
on the adrenoceptor, as proposed above, or due to differences in the ionization state, and 
therefore the selectivity of the receptor agonist for different receptor subtypes with 
different pH. While the gas bubbling rate in the present experiments maintained the pH 
at 7 .4, the arteriolar neurogenic response of iris arterioles might show a different a-
adre~ergic pharmacology under different pH conditions. 
The in vivo blood flow at any given time will reflect a balance between 
vasoconstrictor and vasodilatory nervous influences. For instance, in the present study it 
was demonstrated that activation of sensory-motor nerves inhibits the sympathetic 
vasoconstriction of iris arterioles. This interaction occurs postjunctionally, and as a 
result of an interaction between the two neuroeffector pathways. In the rat, sensory-
motor vasodilatation is associated with an increase in vascular permeability (Holzer, 
1992). An increase in blood flow to an injured tissue would facilitate the delivery of 
macromolecules and leucocytes to the tissue to provide resistance to further damage by 
noxious stimuli, and to assist repair to the injury (Jancso, Jancso Gabor and Szolcsanyi, 
1967; Holzer, 1992). These sensory-motor nerves therefore play an important role in 
increasing blood flow to an injured site and combatting further tissue injury. 
In the iris arterioles the sensory-motor nerves are not acting via a 
hyperpolarization to antagonize sympathetic vasoconstriction but are acting via the 
cyclic AMP-dependent production of nitric oxide, which is proposed to be acting 
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intracellularly to reduce the release of calcium utilized for contraction. As discussed in 
Chapter 6, sensory modulation of sympathetic vasoconstriction appears to occur via the 
production of nitric oxide in arteries where voltage-independent events mediate 
sympathetic constriction, but via hyperpolarization in arteries where the constriction is 
voltage-dependent. This may represent a general principal for the interaction between 
neural vasoconstriction and vasodilatation; the mechanism for vasodilatation acts to 
oppose the mechanism of sympathetic vasoconstriction. In mesenteric and basilar 
arteries, where the sympathetic vasoconstriction occurs as a consequence of voltage-
dependent conductance changes (Hill, Hirst and van Helden, 1983; Hirst, Neild and 
Silverberg, 1982), acetylcholine produces an endothelium-dependent hyperpolarization 
which is responsible for the vasodilatation (Khan, Mathews and Meisheri, 1993; Rand 
and Garland, 1992). However in the pulmonary artery where Cl-adrenoceptors mediate 
sympathetic vasoconstriction (Suzuki, 1983), most of the vasodilatation produced by 
acetylcholine was abolished by inhibiting nitric oxide synthesis, but the 
hyperpolarization was unaffected, indicating that the hyperpolarization was not 
associated with the vasodilatation (Chen, Suzuki and Weston, 1988). 
The sensory-motor neurotransmitter, CGRP, acts postjunctionally to inhibit 
sympathetic vasoconstriction of isolated iris arterioles as a result of cyclic AMP-
dependent activation of nitric oxide synthesis. Using stimulus conditions which evoked 
sensory-motor activity in the iris arterioles, no functional sensory-motor activity was 
found in the iris dilator muscle. Despite both neurogenic contractile responses being 
mediated by the same adrenoceptor, the lack of the ability of cyclic AMP to inhibit 
neurogenic contraction in the dilator muscle was attributed to a lack of constitutive 
NOS in the dilator muscle cells. Thus, the dilator muscle is one example of a 
sympathetic target which does not receive functional sensory-motor innervation. It may 
be that sensory-motor nerves only innervate tissues where they may also be required to 
counteract the opposing neurogenic response. 
The physiological consequences of differences in the sensory-motor innervation 
of the iris arterioles and dilator muscle should be considered. Upon injury to the eye, 
activation of sensory-motor nerves to the arterioles causes dilatation to promote blood 
111 
flow to the iris for reasons described previously. In addition, sensory-motor activity 
causes constriction of the pupil by contracting the sphincter muscle (Tachado et al., 
1991). Pupil dilation occurs following sympathetic nerve stimulation. In some situations 
it may be necessary to maintain this dilatation for many minutes, however the delivery 
of oxygen to the iris would be severely affected if vasoconstriction was ·sustained for 
extended periods. Sensory-motor nerve activity, brought on by changes in pH or p02 
that may occur locally in the iris arterioles with repetitive sympathetic nerve-
stimulation, would counteract the vasoconstriction of the arterioles, but not the dilator 
constriction, thus providing a mechanism for the maintenance of blood flow to the iris 
during pupil dilation .. Whether such an interaction between sympathetic and sensory-
motor nerves occurs in the iris sphincter muscle has not yet been detemined. 
At the two highest concentrations tested, CORP produced a vasodilatation of the 
iris arterioles which was considerably longer-lasting than the inhibitory effect on the 
vasoconstriction (unpublished observations). This suggests that these two effects of 
CORP may be produced via two different mechanisms. Time did not permit 
investigation of the mechanism for vasodilation. It may be that in the iris arterioles, 
CORP 1-receptor activation leads to the elevated production of cyclic AMP which 
causes vasodilatation and also activates nitric oxide synthesis in endothelial cells to 
inhibit sympathetic vasoconstriction. It is tempting to speculate that pretreating with 
dideoxyadenosine, to inhibit adenylate cyclase, would inhibit CORP-mediated 
vasodilatation, but a vasodilatation would still be observed after inhibition of nitric 
oxide synthesis. In order to examine CORP-induced vasodilatation the arterioles would 
need to be preconstricted, preferably with an a-adrenoceptor antagonist to mimic 
sympathetic vasoconstriction, as it has recently been demonstrated that the mechanism 
for vasodilation is influenced by the preconstricting agent (Hayashi et al, 1994). 
It is yet to be determined whether the iris arterioles receive a functional 
parasympathetic innervation. Preliminary experiments in which the effect of 
sympathetic and sensory-motor nerves had been inhibited with guanethidine and 
capsaicin respectively, suggested that in unconstricted arterioles there is no 
parasympathetic innervation (results not shown), however in order to measure 
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vasodilatation these experiments need to be repeated in arterioles which have been 
preconstricted. A vasodilatation may only be consistently observed in preconstricted 
arterioles as indicated by the fact that a sensory-motor vasodilatation was not observed 
in all arterioles taken from sympathetically-denervated rats, although all arterioles 
received a functional sensory-motor innervation (Chapter 1, Chapter 5). 
In conclusion, this study has demonstrated a number of features of neurogenic 
constriction of iris arterioles, the first being that, unlike most other arterial vessels, the 
contractile response and depolarization are both purely due to activation of an a-
adrenoceptor. This suggests that not all resistance vessels utilize non-a-adrenoceptor 
mechanisms for constriction. The a-adrenoceptor arteriolar response occurs primarily 
as a result of the release of intracellular calcium, with a component at supramaximal 
stimulation being due to the influx through voltage-sensitive calcium channels. 
Sensory-motor ·activation releases CORP which acts postjunctionally to inhibit 
sympathetic constriction independently of hyperpolarization, via cyclic AMP-dependent 
activation of nitric oxide synthesis, which suggests that the mechanism of neurogenic 
inhibition biochemically opposes the mechanism for sympathetic contraction. Finally, it 
was demonstrated that an interaction between sympathetic and sensory-motor nerves 
does not occur in all tissues. It may be that sensory-motor nerves only innervate a tissue 
where there may be some purpose for an interaction with the second messenger system 
mediating an opposing neurogenic response. 
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